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Abstract  
Amyloid protein nanofibrils (PNFs) 
are self-assembling, misfolded 
structures formed by many proteins 
when exposed to denaturing 
conditions. PNFs offer several 
attractive features for utilisation in 
the creation of new 
bionanomaterials, such as 
nanometre dimensions, strength 
and stability, and ease of 
functionalisation through amino 
acid residues. However, if amyloid 
PNFs are to be used in 
bionanotechnology, then methods 
need to be developed to utilise 
inexpensive, crude proteins instead 
of pure protein preparations. This 
research focuses on utilising PNFs 
obtained from a low cost source, including fish eye lens crystallins, and whey protein isolate to develop novel PNF-
based nanoscaffolds, with potential applications in bionanotechnology. 
To ensure that crystallin PNFs can be effectively used as a versatile bionanoscaffold, biocompatibility and stability 
studies were done using cell viability and Thioflavin T dye binding assays, Transmission electron microscopy, and 
Infrared microspectroscopy. Crystallin PNFs were shown to be stable over all the conditions studied (pH and 
temperature extremes, presence of proteases and solvents), and showed no evidence of cytotoxicity. The results 
obtained from IR microspectroscopy illustrated the long-term (up to 3 years) structural integrity of crystallin PNFs. 
To obtain PNF-based functional nanoscaffolds, several enzymes of industrial relevance were successfully 
immobilised onto the crystallin PNFs via a versatile glutaraldehyde-based crosslinking approach. Dual-
functionalised PNFs were also obtained by co-immobilising enzymes onto the whey PNF scaffold. The functional 
PNF-based nanoscaffolds provided a significant increase in thermostability and reusability of industrial enzymes 
relative to the free enzyme in solution under the same conditions.  
To demonstrate that PNF-based scaffolds can be potentially used for creating active bionanomaterials, 
electrochemistry, surface-assembly, and cell attachment and proliferation experiments were done. 
Electrochemistry studies demonstrated that functionalised PNFs can be successfully used to develop single 
enzyme-, or dual enzyme-based biosensing elements, for glucose and lactose analysis. Surface-assembly studies 
established that PNF scaffold provides more surface area for biomolecule immobilisation, and can be used to create 
PNF-based active surfaces. The use of PNF-based scaffold for cellular growth resulted in improved attachment 
and proliferation of fibroblasts, suggesting a role for PNFs obtained from crude protein sources in the biomedical 
field. This work demonstrated the potential of PNFs obtained from crude proteins to develop functional 
nanoscaffolds with broad applications. The described work contributes to the existing knowledge of PNF-based 
bionanomaterials, and is very significant for the technological development and future applications of PNF-based 
materials in bionanotechnology.
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Chapter One  
Introduction  
1.1. Context  
Amyloid protein nanofibrils (PNFs) are highly stable, insoluble protein aggregates with a β-
sheet rich structure, formed by many proteins when subjected to denaturing conditions. 
Amyloid PNFs have been associated with the pathology of a range of diseases known as the 
amyloidoses. Recent findings have also shown the existence of functional amyloid fibril in 
nature that play a role in the host organism's survival. From the perspective of nanotechnology, 
amyloid fibrils are highly suited to incorporation within biomaterials because of their robust 
material properties, and nanoscaffold capability.  
Enzymes have been extensively used in the production of food, pharmaceuticals, and other 
biologically important products. Several enzymes used in industrial processes have low 
stability and are quite expensive, but when they are immobilised to an adequate support, the 
biocatalyst can be used numerous times, thereby lowering costs, and improving enzyme 
performance. This thesis aims to explore the advantageous properties of amyloid PNFs 
obtained from cheap, and readily available native proteins to act as a nanoscaffold for the 
immobilisation of important industrial enzymes - with the goal to create a functional 
bionanomaterial. The use of amyloid fibrils as a cellular scaffold with potential applications in 
tissue engineering is also explored.  
This chapter provides a background on amyloid fibril structure, their formation, the properties 
that make them useful for bionanotechnology, and various different applications of amyloid 
PNFs in bionanotechnologies. It will also discuss industrial catalysts, their limitations, and 
different immobilising strategies, to provide a context for the work described. 
1.2. Industrial catalysts and limitations 
In the drive towards green chemistry, the role of biocatalysts is of great significance as they 
are highly efficient and specific, biodegradable, have the ability to catalyse reactions under 
mild conditions (physiological pH and temperature), and generate less waste [1], making them 
both economically and environmentally more attractive than traditional organic synthesis [2]. 
The end use market for industrial enzymes is extremely wide-spread with numerous industrial 
commercial applications [3]. The global enzymes market is estimated to rise by 7% to $8.0 
billion in 2015 [4]. The increased demand for industrial enzymes is driven by a growing need 
for sustainable solutions.  
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However, most of the enzymes utilised in industrial settings suffer from a serious drawback of 
high production cost, poor stability and limited reusability [5]. Many enzymes are soluble in 
an aqueous environment, and may require separation from the product after the enzymatic 
reaction [6]. Additionally, industrial enzymes are prone to inhibition in the presence of 
industrial solvents, chemicals, and at times from side and end products of the enzyme’s own 
reaction [7]. Thus, often for a given biocatalytic process the native enzyme does not meet the 
requirements for large-scale application, and its properties need to be optimised or modulated.  
Substantial developments in many different scientific areas, such as enzyme engineering [8], 
biochemical engineering, involving development of novel bioreactor systems coated with 
composite materials with applications in biocatalysis [9, 10], or immobilisation techniques 
[11], have been made to overcome the limitations of native enzymes as biocatalysts.  
1.3. Enzyme immobilisation 
Immobilised enzymes are of particular interest, as immobilisation imparts stability and also 
allows the reuse and recovery of the biocatalyst, thus improving both technical performance 
and economy of industrial processes [12]. Additionally, immobilisation can be applied to any 
natural or engineered enzyme to further improve its catalytic performance, thus, enzyme 
engineering and immobilisation can be used in tandem. The term immobilised enzymes refers 
to “enzymes physically confined or localised in a certain defined region of space with retention 
of their catalytic activities, and which can be used repeatedly and continuously” [13]. The 
progress in immobilisation of enzymes has been summarised in several excellent reviews [14-
18]. The enzymes can be attached to the support via interactions ranging from reversible 
physical adsorption and ionic linkages to stable covalent bonds. A schematic representation of 
various immobilisation strategies used is shown in Figure 1.1. 
 
Figure 1.1. Schematics of the different enzyme immobilisation techniques. Taken from Hwang 
and Gu (2013)[19]. 
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The various approaches used for immobilising enzymes can be categorised in two general 
classes: the chemical and physical methods [20]. Physical methods involve weaker interactions, 
such as hydrogen bonding, van-der Waals forces, hydrophobic interactions, ionic binding, and 
affinity binding of the enzyme with the supporting material [21], or mechanical 
containment/entrapment of enzyme within the support [20]. In the chemical method, enzymes 
are immobilised to the scaffold via a covalent bond. The covalent bond formation is typically 
between amino acid residues found on the surface of the enzyme and active functional groups 
found on the scaffold. In general, bond formation involves the following side chains of amino 
acids: lysine (ε-amino groups), cysteine (thiol groups), aspartic and glutamic acids (carboxylic 
acid groups) [12].  
Three of the most commonly used techniques for immobilising enzymes include physical 
adsorption, entrapment/encapsulation, and crosslinking or covalent binding [21]. All three 
methods have been extensively reviewed [5, 12, 20, 21].The physical adsorption method is one 
of the cheapest and simplest enzyme immobilisation methods available and, in most cases, the 
catalytic activity of the enzyme is completely preserved [22]. The driving force causing the 
enzyme binding to the scaffold is usually due to a combination of weak forces [23]. A 
comparative analysis of the literature reports on the recent trends in the immobilisation of the 
enzymes by adsorption is presented in Krajewska et al. (2014) [24].  
Table 1.1. The advantages and disadvantages of three principle techniques used for 
immobilising enzymes [25, 26]. 
Immobilisation method Advantages Disadvantages 
Physical adsorption Cheap, simple and rapid 
immobilisation reaction, no 
conformational changes of 
the enzyme and complete 
preservation of enzymatic 
activity. 
Leaching of enzymes from the 
support during the catalytic 
reaction due to changes in 
reaction conditions (e.g. 
temperature, pH) or through 
mechanical shear forces. 
Encapsulation/entrapment 
 
Can be used for impure 
enzyme preparations, 
different enzymes can be co-
immobilised with minimal 
conformational changes of 
the enzyme. 
Limited application as only 
porous or sol-gel supports can 
be used, leaching of entrapped 




Multipoint covalent binding 
of enzyme to the support, 
easy availability of wide 
range of crosslinkers, and 





modification of support 
surface is necessary, 
reduction or even loss of 
catalytic activity resulting 
from conformational 
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Entrapment/encapsulation of enzymes is another simple and mild immobilisation technique. In 
entrapment, the enzyme is trapped within the confines of an insoluble matrix, whereas 
encapsulation refers to the formation of a membrane like physical barrier around the enzyme 
[17]. Encapsulation is an excellent immobilisation method to avoid any negative influence on 
the structure of an enzyme [26]. Many encapsulation methods have been developed, the sol-
gel method being the most prominent and widely used technique [27]. In the case of 
crosslinking, enzymes are irreversibly attached to the scaffold via a covalent bond, with the 
help of a crosslinking reagents or crosslinkers [11, 28]. The covalent bond formation is 
typically between amino acid residues found on the surface of the enzyme and active functional 
groups found on the carrier or scaffold. The advantages and disadvantages of all the three 
commonly used immobilisation methods are detailed in Table 1.1.  
Each immobilisation technique has its own advantages and disadvantages and a universally 
applicable method of enzyme immobilisation is not available [25]. Immobilisation of enzymes 
has been largely achieved using a trial and error approach, and several important factors need 
to be considered in order to achieve high loading of enzyme, with high retention of activity, 
and enhanced operational stability and durability. Several different factors, such as 
concentration, temperature and pH of the reaction, can influence the outcome of enzyme 
immobilisation and need to be considered when selecting appropriate immobilisation 
conditions. Some general factors to be taken into account while selecting and optimising an 
enzyme immobilisation technique are shown in Table 1.2.  
Table 1.2. Critical factors for the development of the optimised immobilisation protocol. 
Modified from Hartmann et al. (2013) [25].  
Factors Examples 
Carrier Composition, morphology, surface area, 
porosity, dimensions, functional groups, 
stability against solvent, cost and 
availability. 
Enzyme Purity, available functional groups, 
conformational flexibility, active site, 
stability towards reaction conditions, such as 
pH, solvents, temperature, size, molecular 
weight. 
Immobilisation process Immobilisation strategy, such as adsorption, 
crosslinking, or encapsulation, Immobilising 
conditions (pH, temperature, solvents, 
buffers, additives), reusability, costs of 
enzyme and carrier, toxicity, stability. 
 
Several modified/unmodified supports have been assessed for their efficiency for enzyme 
immobilisation [11, 18]. During the last decade, the newly emerging field of nanobiocatalysis 
has demonstrated its potential applications in enzyme stabilisation. Nanobiocatalysis is a sub-
field of biocatalysis, which explores more advanced nanostructured materials for the role of 
enzyme carrier [29].  
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The use of nanomaterials in enzyme immobilisation could achieve not only a much higher 
enzyme loading capacity, and a significantly enhanced mass transfer efficiency, but also 
excellent stabilisation [29, 30].  
1.4. Nanomaterials and nanobiocatalysis  
Nanostructured materials (NMs) can be defined as any material that has structured components 
with at least one dimension less than 100 nm [31]. The synthesis, characterisation and 
processing or manipulation of such NMs are all part of a rapidly growing field referred to as 
nanotechnology [32]. Methods used to generate NMs are commonly characterised as “top-
down” and “bottom-up” methods depending on the processes involved in creating nanoscale 
structures [33]. A top-down approach corresponds to methods that are controlled by external 
experimental parameters to create NMs/nanodevices with the desired shapes and 
characteristics, starting with patterns made on a large scale and reducing them to the required 
values before forming nanostructures [34]. The various top-down techniques for producing 
nanomaterials include photolithography, scanning beam lithography, molding, and printing. In 
contrast, bottom-up approaches seek to have molecular or atomic components built up into 
more complex nanoscale assemblies, in some cases through smart use of self-organisation [34, 
35].  
Different physical and biological bottom-up self-assembly processes have been reported in 
recent years to direct the assembly of nanoscale functional blocks into hierarchically ordered 
structures, and are reviewed by Thiruvengadathan et al. (2013) [36]. Recent research 
undertaken to synthesise functional NMs has highlighted the need and advantages in 
synergistically combining top-down fabrication methods with bottom-up self-assembly. For a 
comprehensive review on prominent nanofabrication tools and techniques used for developing 
novel and efficient functional NMs/nanostructured devices see [33, 35]. Many robust NMs with 
properties tailored to their applications as enzyme scaffolds, such as nanoparticles (NPs), 
nanotubes (NTs), nanoporous media, and nanofibres (NFs) have been developed. Figure 1.2 
shows images of the three nanostructures - NPs, NTs, and NFs, as observed under microscope.  
 
Figure 1.2. A representative TEM (transmission electron microscopy) images of (a) gold 
nanoparticles [37], (b) carbon nanotubes [38], and (c) crystallin protein nanofibrils (Taken as 
detailed in section 7.1.3). Scale bar is 200 nm. 
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Several nanobiocatalysis reviews have eloquently explained the different types of 
nanomaterials used for enzyme immobilisation, each with its characteristic pros and cons [30, 
39-41]. Some examples of nanostructured supports that have been successfully employed for 
enzyme immobilisation are listed in Table 1.3. 
1.4.1. Nanoparticles (NPs) 
NPs are defined as particles ranging in size from 1-100 nm, that may not exhibit size-related 
properties and differ significantly from those observed in fine particles or bulk materials [42].  
There exists a huge variety of different types of NPs ranging from carbon-based structures, 
such as spherical fullerenes, to the ones derived from natural materials, such as liposomes, 
gelatines, and alginates [43]. Additionally, NPs can be obtained from polymers [44], silicates 
or metals [45], such as gold, copper or silver NPs [46].  
NPs provide an ideal solution to the usually contradictory issues encountered in the 
optimisation of immobilised enzymes: minimum diffusional limitation, maximum surface area 
per unit mass, and high enzyme loading [47]. Recently, special interest has been given to 
magnetic NPs as they can be removed easily from the reaction medium, using an external 
magnetic field, for example silica-encapsulated nanomagentic particles used for β-lactamase 
immobilisation [48].  
1.4.2. Nanotubes (NTs) 
Nanotubes have distinct inner and outer surfaces, and large inner volumes (relative to the 
dimensions of the tube), and therefore can be modified differentially with any desired 
biomolecule, ranging in size from small molecules through to proteins. The three main types 
of nanotubes used in bionanotechnology based applications are carbon nanotubes (CNTs), 
peptide/protein nanotubes (PNTs), and template-synthesised nanotubes [49]. CNTs are further 
categorised as single- (SWCNTs) or multi-walled CNTs (MWCNTs) based on the number of 
graphitic layers surrounding the central tubule. SWCNTs are attractive for their higher surface 
area for enzyme interaction, but MWCNTs are preferred for their easier dispersibility and lower 
cost [50]. CNTs exhibit extraordinary mechanical, electrical, and thermal properties and have 
been extensively explored for several potential applications, such as biosensors, drug delivery 
systems, tissue engineering, and as multifunctional coating materials [51]. However, more 
work needs to be done towards defect free, cheap mass-production of CNTs [52]. The chemical 
inertness, and toxicological concerns associated with CNTs also limits their versatility and 
suitability [53]. 
The application of self-assembled hollow nanotubes synthesised from synthetic peptides in 
bionanotechnology is robust, practical, and affordable due to their advantages of 
reproducibility, relatively simple large-scale production, monodispersity, and simpler 
experimental methods [54]. Different types of peptide nanotubes are categorised on the basis 
of the peptide structure from which they are designed, such as, cyclic PNTs, dipeptide-based 
PNTs, or coiled coil PNTs [55].  
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Some of the challenges hindering peptide NTs synthesis and applications includes control 
during synthesis, stability in liquid environments, manipulation and conductivity [56, 57]. In 
contrast, the template synthesis method offers control in both size and shape. In template 
synthesis, nanoporous membranes act as templates for the synthesis of nanostructures of the 
desired material [58]. Hard templates used for template synthesis of NTs possess well-confined 
voids of uniform diameter, and NTs are prepared within cylindrical and monodisperse 
channels, pores, or connected hollow spaces of a nanopore membrane or other solid surface 
[49]. Template-synthesised NTs can be created from a wide variety of tube materials including 
proteins, silica, carbon, chitiosan/alginate, DNA [59]. 
Table 1.3. Some examples of different type of nanoscaffolds utilised for enzyme immobilisation. 
Nanomaterial used Type of nanoscaffolds Immobilised enzymes 
NPs Copper chelated magnetic 
mesoporous silica NPs; zinc 
oxide NPs; Au and Ag NPs 
Laccase [60];β-




NTs MWCNTs*; halloysite NTs 
(HNTs); SWCNTs* 
 
Glucose oxidase [63]; 
laccase [64], and lipase 
[65]; His-tagged NADH* 
oxidase [66] 
Nanoporous media Nanoporous silica, 
nanoporous alumina; 
MOFs*-  zeolitic 
imidazolate framework 90 
(ZIF-90) 
Horseradish peroxidase 
[67], and lipase [68]; 
alcohol oxidase [69]; 
catalase [70] 
 NFs Copolymer (styrene and 
maleic anhydride) fibres; 
polyaniline, polystyrene, and 
cellulose NFs; PNFs 
Horseradish peroxidase, 
and glucose oxidase [71]; 
lactase [72]; glucose 










hybrid films; PVOH-amyloid 
PNFs hybrid films 
α-Amylase [75]; 
horseradish peroxidase 
[76]; glucose oxidase 
[77],[78] 
 
*NADPH - Nicotinamide adenine dinucleotide phosphate-oxidase; NADP - Nicotinamide adenine dinucleotide 
phosphate; SWCPNTs – Single-walled carbon nanotubes; MWCNTS – Multi-walled carbon nanotubes; MOFs - 
Metal organic framework. 
The template synthesis method also allows distinct surface chemistries on the inside and 
outside [58]. Initially, while nanotubes are still embedded within the template, the inner surface 
is accessible for functionalisation, and the outer surface becomes available only once the 
nanostructures have been released by dissolving the template [59].  
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However, nanocatalysis-based applications of synthesised polymer-based nanotubes are 
currently limited by the fact that these structures do not maintain their shape indefinitely [79, 
80]. By far, porous anodic aluminium oxide (AAO) is the most preferred template, as it is 
relatively low cost, and provides large versatility with a long range ordered arrangement of 
homogenous pores availability [81]. 
1.4.3. Nanoporous media  
Materials having pores with diameters below 100 nm are considered as nanoporous materials. 
Several organic/inorganic materials with well-defined pore sizes, surface chemistries, and 
functionalities have been developed, such as zeolites, silica or alumina, activated charcoal, 
block co-polymers (polylactide, polystyrene, or polyacrylonitrile) [82].  
Nanoporous materials with pore sizes ranging from 2-50 nm have received a lot of attention as 
a nanoscaffold owing to their controlled pore structure, mechanical stability, and high surface 
area, and ease of functionalisation via simple physical adsorption methods [29, 82]. Typical 
disadvantages of these materials include continuous leaching of physically adsorbed enzyme 
molecules from nanoporous media [29]. Another challenge is to tailor-design materials for 
specific properties and functions [83]. Current research efforts in this field have been driven 
by the rapidly growing emerging applications of these materials in enzyme immobilisation, 
energy storage, and environmental applications [84-87].  
1.4.4. Nanofibres (NFs) 
Nanofibres are defined as long fibrillar structures with a diameter equal to or less than 100 nm, 
and are characterised by high specific surface area, flexibility, and superior directional strength 
[88]. Current fibre fabricating processes includes nanolithography [89], thermally induced 
phase separation [90], molecular self-assembly [91], and bio-fabrication alternatives [92]. 
Electrospinning has been regarded as the most promising approach to produce continuous 
nanofibres [93], and several different synthetic/natural polymers, proteins, and peptides have 
been used for generating nanofibres, such as poly(methyl methacrylate) (PMMA), polylactic 
acid (PLA) and polyacrylonitrile (PAN), chitosin, gelatin, silk, and collagen [94]. Although 
electrospun NFs have potential application in many fields such as energy devices, high 
temperature filtration, and efficient catalysis, it remains a challenge to understand the structure 
and performance of NFs. Furthermore, the performance and range of electrospun nanofibres 
have been limited due to the limited variety of organic electrospun NFs, and friability issues 
for inorganic electrospun NFs [93].  
Self-assembly of nanofibres holds promise as a low-cost, high-yield technique with a wide 
range of scientific and technological applications. Self-assembly is the spontaneous, bottom up 
organisation of molecules into ordered structures by using specific interaction, that may arise 
due to the intrinsic properties of the individual elements within the system or under the 
influence of applied external forces [36]. Many proteins and peptides serve as potential sources 
of self-assembled NFs.  
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Amyloid fibrils are a well-investigated example of self assembled polypeptides, and have been 
shown to be very versatile materials with potential applications in various fields [95]. In 
addition to the above mentioned nanomaterials, a relatively new class of materials, “hybrid 
nanomaterials” is also gaining attention in the field of catalysis for achieving specific physical 
and catalytic properties [19, 96-98]. Hybrid materials are unique conjugates of 
organic/inorganic nanostructure, or can also be obtained by combining different 
nanocomponents/nanostructures (Table 1.3).  
1.5. Amyloid PNFs 
Amyloid fibrils are a highly stable, insoluble form of proteins or polypeptides formed by the 
assembly of normally soluble protein or peptide monomers into intermolecular hydrogen 
bonded β-sheets [99, 100]. Amyloid, originally meaning starch-like, refers to the protein 
deposits that were reminiscent of starch when first observed by Rudolph Virchow in 1854 [101, 
102]. Later, in 1859, Friedreich and Kekule demonstrated that amyloid deposits were made of 
protein, leading to the study of amyloid deposits as a class of proteins with a propensity to 
undergo changes in conformation that result in fibril formation [102]. Apart from their 
association with protein misfolding diseases such as Huntington’s, Parkinson’s, Alzheimer’s, 
Type II diabetes, and Creutzfeld-Jacob disease [103, 104], amyloid structures are also naturally 
found in many functional roles [105-107]. Prominent examples of such functional amyloid 
materials include bacterial coatings [108], regulation of melanin synthesis [109, 110], natural 
adhesins [111], and structures for the storage of peptide hormones [112]. The presence of 
functional amyloid, along with a proposal that, if the correct conditions are found, amyloid 
fibril formation is a generic property of all proteins [99], elicited a lot of interest in the 
possibility of utilising in vitro-prepared fibrils as novel bionanomaterials.   
1.5.1. Amyloid fibril formation - protein folding and misfolding 
Once synthesised at the ribosome, proteins have to attain their native folded confirmation in 
order to function effectively. Protein folding is quite complex and susceptible to errors, 
resulting in the formation of several intermediate misfolded states as illustrated in Figure 1.3. 
To prevent and address protein misfolding problems, cells have protein quality control systems, 
which includes chaperones, and proteasomes. Chaperones play vital roles in helping proteins 
become folded in the first place or in aiding misfolded proteins to regain their correct 
conformation whereas, once a misfolded protein cannot be properly refolded, proteasome-, 
autophagy- or endoplasmic reticulum-associated protein degradation (ERAD) systems are 
deployed to degrade any misfolded proteins. The protein folding and unfolding process is 
thermodynamically driven [113] and is also governed by the external conditions, such as pH, 
temperature, pressure [114, 115], molecular crowding [116], and entropy [117].  
Depending on the conditions, proteins can adopt any of the possible competing conformational 
states - unfolded peptide chains, partially folded intermediate states/aggregates, or completely 
folded native forms (Figure 1.3).  
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The protein aggregation literature is extensive and various recent reviews describe our current 
understanding of the aggregation process [118-120]. In order to form amyloid fibrils, proteins 
need to undergo partial unfolding to form an intermediate conformational state. Partial 
unfolding can be induced by exposing the protein to denaturing conditions (in vitro), such as 
high temperature and pressure, low pH, or the presence of organic solvents. In these denaturing 
conditions, non-covalent interactions such as hydrogen bonding can still occur within the 
polypeptide, which stabilise the amyloid fibril structure [121]. Many polypeptides can achieve 
the amyloid folding motif as a nearly ubiquitous alternative folded state, despite having 
different amino acid sequences and native conformations [122]; however, different proteins 
have different propensities for forming amyloid fibrils. Amyloid fibril forming tendency is 
governed by many factors, such as hydrophobicity, net charge, propensity of constituent amino 
acid residues to form β-sheets, and the presence of aromatic residues in the polypeptide [123]. 
 
Figure 1.3. The process of protein folding, misfolding, and aggregation. Taken from Tyedmers 
et al. (2010) [124].  
1.5.2. Mechanism of amyloid fibrillation 
Fibrillation is universally recognised as a nucleation-dependent polymerisation reaction [99, 
125], with few exceptions [126], and is commonly depicted as a sigmoidal-shaped growth 
curve [127] (Figure 1.4).  
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The typical fibril formation process consists of three distinct phases characterised by protein 
misfolding, nucleation, and fibril elongation [128]. In the initial phase, called the “lag phase”, 
protein monomers associate and may attain a critical concentration of oligomers to form fibril 
nuclei. Nucleus formation is thermodynamically unfavorable, and requires a series of 
association steps of monomers, thereby, is a rate-limiting step [129]. At the end of the nucleus 
phase, larger ordered structures with intrinsic fibrillar (β-sheet) structures, termed as 
protofibrils are formed [130, 131]. The next phase is the “growth or elongation phase” in which 
further addition of monomers to the nucleus results in rapid growth or formation of fibrillar 
structures (ordered aggregates).  
 
Figure 1.4. Nucleation-dependent fibrillation process. Taken from Wilson et al. (2008) [132]. 
The formation of protofibrils (initial stable pre-fibrillar structures) is a precursor to mature 
amyloid fibril development in the (next phase) “saturation phase” (Figure 1.4). In the 
elongation phase, fibrils can be formed either by longitudinal addition, in which individual 
peptides are added to the end of each β-sheet, or by lateral addition, in which the fibril grows 
by adding an already-formed β-sheet to its side. Both mechanisms seem to contribute equally 
in the formation of mature amyloid fibrils [133]. The rate of the fibrillation process is 
influenced by the addition of seeded molecules (pre-formed fibrils) [130, 134], by the presence 
of foreign surfaces [135, 136], by deamidation [137] and acetylation [138], or by mechanical 
agitation [139].  
Although nucleation-dependent formation of amyloid fibrils is considered the main mechanism 
for the growth of fibrils, there are some unanswered questions to be explored, such as nature 
of the nucleus or amyloid aggregates [140], growth of amyloid nuclei [141], and the 
concentration dependence of the fibrillation process [142].  
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1.5.3. Amyloid fibril structure 
Irrespective of the native structure and nature of the proteins used for generating amyloid 
fibrils, amyloid and amyloid-like fibrils all exhibit a similar X-ray diffraction fingerprint -“the 
cross β-sheet pattern”[102, 143] as shown in Figure 1.5. The cross β-sheet pattern has two 
major features common in all the fibrillar structures: β-strands which lie perpendicular to the 
fibril axis, and β-sheet filaments running parallel to the fibril axis, formed by polypeptide 
backbones folding upon themselves at 4.8 Å (meridonial reflection), and interweaving β-
strands at a distance of 10-11 Å (equatorial reflection) depending on the side-chain composition 
of the β-sheets [144]. 
 
Figure 1.5. This shows a schematic of a characteristic cross β-sheet diffraction pattern, in 
which intermolecular β-sheets extend over the length of the fibril such that each β-strand within 
the β-sheets runs perpendicular to the fibril axis. Taken from Serpell (2000) [145].  
With the help of X-ray diffraction [143, 146], small angle X-ray scattering (SAXS) [147], 
atomic force microscopy (AFM) [130, 148], electron microscopy (EM) techniques [149-151], 
solid-state nuclear magnetic resonance (ssNMR) [152, 153], and birefringence and 
spectroscopic assays [154, 155], vital information about the size (widths in the range of 2–10 
nm and lengths from 1 up to 10 μm) [73], unbranched morphology, and the characteristic 
“cross-β” fibril comprising protofilaments has been attained [102]. The basic unit of amyloid 
fibrils is known as a protofilament, which itself is made up of a number of intertwined β-sheets 
as shown in Figure 1.6.  
The protofilament structure of amyloid fibrils is conserved across a range of proteins, although 
the way the protofilaments associate with each other can differ [145]. Mostly mature amyloid 
PNFs consists of 2-6 protofilments, where these protofilaments wind around each other in a 
rope-like manner to form a super coiled rope-like structure [156]. In addition to the rope like 
arrangement, protofilaments in a fibril can also arrange into a ribbon-like lateral-packing 
arrangement to form long ribbons, as has been demonstrated using β-lactoglobulin (β-lg) PNFs 
[157, 158] (Figure 1.6). 
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Figure 1.6. Surface representation of 3-D maps of the four different protofilament structure 
for insulin fibril structures (left), (a) - a pair of filaments, (b) - the four protofilament compact 
fibrils, (c) - the six protofilament fibrils, and (d) - the twisted ribbon. Right - molecular model 
of the common core protofilament structure (four β-sheets illustrated here) in a generic amyloid 
fibril, as determined using synchrotron X-ray diffraction on amyloid fibrils. Figures taken from 
Jiminez et al. (2002)[156]; and Finke et al. (2009) [119], respectively. 
1.6. Defining characteristics  
A number of techniques exist for the characterisation of amyloid fibrils, with the main ones 
being the binding of the histological dyes Congo red (CR) and Thioflavin T (ThT); fibrillar 
morphology by AFM, and transmission electron microscopy (TEM); and β-sheet secondary 
structure determination by Fourier transform infrared (FTIR) spectroscopy, and X-ray fibre 
diffraction [154]. X-ray fibre diffraction is one of the main methods used for amyloid fibril 
characterisation, where the amyloid fibril structures give characteristic diffraction patterns as 
discussed in section 1.6.3. In this thesis, the histological dye ThT, and TEM were used 
extensively. ThT was chosen as it is widely used to test for the presence of amyloid fibrils and 
because it is known to work reliably with the model amyloid forming protein, insulin.  
1.6.1. ThT binding of amyloid PNFs  
Thioflavin T is a benzothiozole dye with a high affinity for proteins containing β-sheet content 
and is the most widely used “gold standard” for selectively staining and identifying amyloid 
fibrils ex vivo, in vitro, and in animal model studies [155, 159, 160]. Unbound ThT dye has 
fluorescence excitation (from 385 nm to 450 nm), which on binding to β-sheet structure 
undergoes a characteristic spectral shift resulting in enhanced fluorescence emission (from 445 
nm to 482 nm). This spectral shift is used to differentiate bound ThT and unbound ThT and 
consequently the presence of amyloid structures [160].  
14 |                                                                                                  Chapter One - Introduction 
 
The main advantages of the ThT method are its simplicity, low ThT interaction with pre-
fibrillar structures (folded or unfolded intermediates/monomers), minimal impact on the 
fibrillation process, and that the method can be used to assess the amyloid formation both in 
vitro and in vivo [161]. A large number of studies have examined the binding mode of ThT for 
amyloid fibrils [159, 160, 162, 163]. The β-sheet structured cavities and channels found in 
amyloid fibrils have been proposed to be the binding locations of ThT [159, 164, 165].  
 
Figure 1.7. The directional binding of ThT for amyloid fibrils, where (a) shows a common 
cross-β structure of amyloid fibrils and a structural rationale for fibril-ThT interactions, and 
(b) schematic representation of channel model binding of ThT along surface side-chain 
grooves running parallel to the long axis of the fibril β-sheet structure. Taken from Biancalana 
et al. [160].  
The binding is highly directional, with the ThT long axis parallel to the elongation axis of the 
fibrils (Figure 1.7) and can be characterised by features such as ThT accessibility, binding 
stoichiometry, and affinity. In the same direction run channels (channel like motifs formed by 
the neighbouring rows of cross-strand chains, along the solvent exposed surface of fibrils) on 
the β-sheet of the amyloid fibrils, suggesting that these channels are the possible binding site 
of the dye [160, 165] as shown in Figure 1.7. In addition to the characterisation of the ThT 
binding site, the molecular form of ThT binding is crucial for understanding the binding 
mechanism [163]. Conflicting reports claims that the molecular form of ThT on binding to the 
amyloid fibrils is either monomeric [165, 166], dimeric [167] or a micelle [159].  
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1.6.2. TEM  
TEM is a useful technique to detect and distinguish fibril like morphology from other types of 
protein aggregates [154, 168]. Under the TEM it is possible to observe unbranched long 
fibrillar structures or higher-order assemblies of fibrils such as association of at least two 
strands to form a flat ribbon-like fibrils [169]. Negatively stained TEM images of amyloid 
PNFs are shown in Figure 1.8. TEM images can be used for obtaining both qualitative and 
quantitative information, such as length and width of fibrils, smoothness of the surface, number 
of protofilaments, and the periodicity of fibril twists [156, 168].  
 
Figure 1.8. TEM image of amyloid (taken as detailed in section 7.1.3), (a) whey PNFs, and (b) 
crystallin PNFs, showing the presence of unbranched, long fibrillar structures with smooth 
surface. Scale bar is 200 nm. 
The grids for amyloid fibril detection can be made of copper or nickel with 200–400 unit mesh 
spacing and are usually negatively stained using 2% uranyl acetate prepared in deionised water 
(dH2O) [154]. Negative staining provides good contrast, protects the sample from radiation 
damage and preserves morphology [168].  
1.6.3. FTIR 
A protein's FTIR spectrum consists of two prominent features, the amide I (~ 1650 cm− 1) and 
amide II (~ 1540 cm− 1) bands, where the former arise primarily from the C=O stretching 
vibration and the latter is attributed to the N-H bending and C-N stretching vibrations of the 
peptide backbone. Different secondary structures, such as α-helix, β-sheet, and β-turn, exhibit 
characteristic frequencies and intensities in the amide I band region as shown in Figure 1.9. 
Therefore, the FTIR spectrum of a protein is routinely used to characterise protein secondary 
structures in solution as well as in the solid state [170]. 
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Figure 1.9. A schematic representation of amide I region of FTIR spectrum (1700-1600 cm-1), 
showing spectrum peaks corresponding to different secondary structures including β-sheet 
(blue), random coil (green), and α-helix (red), and experimental band-shape (black). Modified 
from Walther et al. (1996) [171].  
FTIR is usually used in combination with other biophysical techniques, such as circular 
dichroism (CD), and electron microscopy (EM) to study protein aggregation or fibrillation 
processes [172].  Amyloid fibrils have a spectral signature frequency peak between 1611 and 
1630 cm− 1, while for native β-sheet proteins it extends from 1630 to 1643 cm− 1 [173].  
1.7. In vitro amyloid fibrillation 
A large number of proteins that are not known to form fibrils in disease or nature have been 
induced to form fibrils in vitro, these include bovine insulin [127], human serum albumin 
(HSA) [174], hen egg white lysozyme (HEWL) [175], ovalbumin and bovine serum albumin 
(BSA) [176], β-lg [177], whey protein isolate (WPI) [178], fish lens crystallins [179], and 
wheat glutenin proteins [180]. However, most research in the field of bionanotechnology has 
focused on pure, well-defined amyloid-protein systems or de novo-designed peptides [74, 181-
185]. In this thesis, three different amyloid-forming proteins were used, bovine insulin, crude 
crystallin proteins, and WPI, each possessing different interesting properties.  
1.7.1. Bovine insulin – a model amyloid forming protein 
Bovine insulin was used as a model amyloid-forming protein in this study, since it is extremely 
well characterised [127, 156, 172, 186-188]. With the size of a polypeptide, but having all the 
structural features of a large protein, insulin has been one of the most extensively studied 
proteins [189]. The polypeptide hormone insulin has a mainly helical native structure, with its 
two polypeptide chains linked by two inter-chain and one intra-chain disulfide bonds [190]. In 
vitro, insulin is readily converted to well-defined fibrillar structures by incubation at low pH 
and high temperatures [172, 188].  
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There is a large amount of literature available on bovine insulin amyloid PNFs, including detail 
of their morphology [127, 156], mechanism and kinetics of their formation [147, 172, 186, 
191], and potential applications in bionanotechnology [74, 181, 192-194]. An illustrative 
schematic of insulin fibrillation process is shown in Figure 1.10.  
 
Figure 1.10. Schematic mechanism of fibrillation process (A) represents a general fibril kinetic 
mechanism, and (B) shows representative insulin structures. Native protein structure (far left) 
under denaturing conditions disassemble, leading to an equilibrium between native and 
partially folded monomers (open triangle and red trapezoid, respectively). The partial unfolded 
or intermediate state may unfold completely as an off-pathway event (open circle) or aggregate 
to form a nucleus, followed by pre-fibrillar and consecutively fibrillar state (far right). (B) A 
crystal structure of the native insulin dimer (PDB 1GUJ), and proposed insulin fibrillation 
model. The α-chain is shown in green, and blue represents the β-chain. Cylinders and arrow 
indicate temperature-stable substructure (residues B9-B26 and A16-A20). Dashed lines 
indicate disordered regions, and balls represent the three disulfide bonds. Taken from Hua et 
al. (2004) [195]. 
1.7.2. The industrially relevant (low cost) amyloid forming protein sources 
The other amyloid fibril-forming proteins used includes WPI, and fish eye lens crystallin 
proteins (CPs). Amyloid fibrils formed from crude fish eye CPs and WPI were considered, 
since if amyloid fibrils are to be used successfully in bionanotechnology, there is a need for 
production of amyloid fibrils from a readily available and inexpensively sourced protein [100].   
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(a) Crystallins 
The healthy eye lens is transparent and functions to focus light on to the retina [196]. The 
crystallins are highly organised (supramolecular β-sheet structure) and stable proteins present 
within the lens [197]. The α-, β-, and γ- crystallins are the major structural proteins within the 
eye lens, and are responsible for its exceptional stability and transparency [198]. Previous 
studies have shown that the inherent stability of the β-sheet supramolecular structure adopted 
by the crystallins in the eye lens, and the chaperone ability of α-crystallin must be crucial for 
preventing protein aggregation in vivo [196, 199]. However, any disruption to the native 
crystallin structure can lead to protein aggregation, leading to the development of cataract 
[198]. 
 
Due to their ability to aggregate leading to the formation of amyloid fibrils both in vitro and in 
vivo [200], crystallin proteins have the potential to be of use in the creation of protein 
nanomaterials [201]. Previous work has reported the synthesis of amyloid PNFs from crude 
crystallin protein mixtures, extracted from bovine lenses obtained from the abattoir [200], and 
from fish eye lenses [179]. CPs extracted from hoki (Macruronus novaezelandiae) fish eye 
lenses were used in this research to prepare crystallin PNFs, by methods adopted from Healy 
et al. (2012) [179]. Fish eye lens crystallins were preferred mainly due to their ready availability 
from the seafood industry, and the fact that they are perceived safer than bovine products in 
the wake of bovine spongiform encephalopathy outbreaks. Additionally, previous work in our 
lab has shown that the fibril manufacture process from fish eye crystallins can be scaled up to 
produce large quantities of fibrils [202]. The main focus of this research was to characterise 
crystallin PNFs obtained from hoki fish eye lenses in terms of their applicability to 
bionanotechnological applications, and to create a functional crystallin fibril nanoscaffold by 
incorporating enzymatically active components.   
(b) WPI 
Whey proteins are reported to form a wide range of assemblies (fibrils, ribbons, spherulites, or 
spherical particles) depending on the conditions applied on heating [203]. Whey proteins from 
bovine milk have gained considerable attention as a fibril forming globular protein in the food 
sector [204]. In this study, an industrial grade WPI was used as an amyloid forming protein 
source, because of its relevance for practical applications. Commercial WPI, amongst other 
whey ingredients, are produced from whey obtained from cheese manufacturing.  
The main proteins in WPI are β-lg (70-80%), BSA and α-lactalbumin [205]. β-Lg was found 
to be the only protein that is incorporated into WPI fibrils, when they were formed by heating 
at pH 2 and low ionic strength [206]. β-Lg predominantly exists as dimer under physiological 
conditions, but dissociates to monomer at about pH 2-3, preserving its native structure [207]. 
A representative crystal structure of bovine β-lg is shown in Figure 1.11. Given the small 
molecular weight of 18.4 kDa [208], and globular nature, it has proven to be a well-suited 
model system for studying fibrillar protein aggregation [203, 209, 210]. 
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Figure 1.11. PyMOL image of the native structure of bovine β-lg. In this ribbon representation, 
the β-sheets are shown in orange, the α-helices in blue, and the disordered loops are shown in 
grey. This image was constructed using PyMOL from PDB file 2BLG.  
The literature available on obtaining β-lg fibrils by heating at 80 °C, pH 2 and low ionic 
strength for 10-24 h is extensive [203, 211-213]. The contributions of the Loveday group have 
been particularly important in the understanding of whey amyloid fibrillation, and factors 
influencing the process, such as pH, temperature, presence of salts and cations [214-217]. In 
this work, whey protein nanofibrils (WPNFs) were prepared from the commercially available 
whey protein isolate powder, using in-house methods, as published in Sasso et al. (2014) [73]. 
1.8. Amyloid fibrils and bionanotechnology 
 
Over the past decade, amyloid fibrils have attracted burgeoning interest in bionanotechnology 
due to them possessing a number of desirable properties suitable for many different 
applications in this field [100, 123, 193, 218-221]. The unique properties that make amyloid 
fibrils attractive for nanotechnological purpose include: (i) spontaneous formation of amyloid 
fibrils by any protein/peptides under certain denaturing conditions [121, 222], via a nucleation- 
dependent polymerisation process, where pre-formed amyloid fibrils can act as seed to form 
fibrils/accelerate the kinetics of fibril formation [95, 187, 223, 224]; (ii) high mechanical 
strength and stability comparable to silk and steel [225, 226], and the ability to self-assemble 
providing a bottom-up approach to material design [123, 227]; (iii) ability to form highly 
ordered amyloid fibril structures, such as gels, and films, in the micro or macroscale [183, 228, 
229]. (iv) ease of production and functionalisation of amyloid fibrils for specific applications 
[73, 181, 230-232], due to intrinsic side chain chemistry from their amino acid composition; 
(v) low cost production and large surface area due to nanometre size range [102]; (vi) structural 
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1.8.1. Applications of amyloid PNFs 
 
The research focus in the amyloid fibril field is broadening to include new horizons in 
nanotechnology. Amyloid fibrils have been identified as a novel nanomaterial and several 
applications are under scrutiny, with the most promising ones using amyloid fibril as potential 
nanowires for electronics, as functional templates and liquid crystals, as nanoscaffolds for 
enzyme immobilisation, for the production of amyloid-based gels in cell adhesion and wound-
healing, and as drug delivery systems [185]. In the past ten years amyloid fibrils have been 
explored for a multitude of different bionanotechnology applications, some of which are listed 
in Table 1.4.  
 
The main focus of this research was to demonstrate the potential of amyloid fibrils obtained 
from readily available sources as a novel nanoscaffold by immobilising enzymes. Amyloid 
fibrils have been used as nanoscaffold for enzyme immobilisation (Table 1.4), resulting in 
enhanced activity, improved stability and reusability of the enzymes. As stated before, the 
dimensions of amyloid PNFs, and readily available surface chemistry for adding functional 
groups makes amyloid fibrils an ideal choice for nanocatalysis applications. Two commonly 
used methods for creating functional PNFs or for immobilising enzymes onto amyloid PNFs 
are: 
(i) Attaching functionalities before fibrillation, such as creation of fusion proteins, where 
the protein of interest is rationally conjugated to an amyloidogenic sequence, followed 
by exposure to the fibril forming conditions, thereby, resulting in the fabrication of 
functional PNFs. A few examples of functional amyloid PNFs obtained by the fusion 
method include green fluorescent protein, barnase, carbonic anhydrase, glutathione-S-
transferase [234], and cytochrome b562 functionalised PNFs [235].  
(ii) Attaching or adding functional groups onto the mature fibrils, after fibrillation. This 
method relies on the availability of the different amino acid side chains onto the surface 
of mature PNFs. The chemistry of available amino acid residues can be exploited to 
attach biomolecules of interest to fibrils either via physical adsorption, crosslinking, or 
covalent attachment. Organophosphate hydrolase (OPH) and GOX have both been 
covalently attached to PNFs in this manner, making functional fibrils that could be 
used in bioremediation, antimicrobial films, and biosensing [73, 74, 78, 181]. 
 
In this work, functional amyloid PNFs were obtained by attaching important industrial enzymes 
onto the PNFs, post-fibrillation, using physical adsorption, and a covalent crosslinking 
approach. To understand the potential of PNFs to act as a versatile nanoscaffold, a diverse 
range of industrially relevant enzymes including GOX, β-galactosidase (β-gal), pectinase, α-
amylase, and laccase were studied. In addition to crystallin PNFs, PNFs obtained from whey 
fibrils were investigated for potential applications in bionanotechnologies.  
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Table 1.4. Summary of different biotechnologies utilising amyloid fibrils obtained from various 
amyloid forming proteins/peptides.  
 
Applications References 
 Amyloid nanowires A hybrid Au-Ag nanowire fabricated from amyloid fibrils of 
wild-type Sup35p [230]; Electronically active luminescent 
nanowire derived from insulin amyloid fibrils decorated with 
conjugated polymers [236, 237]; Insulin amyloid PNFs coated 
with polymer alkoxysulfonate (PEDOT) [238]; Ag-nanowires 
obtained from lysozyme amyloid fibrils with hollow channels 
filled with silver [239]; Insulin amyloid fibrils integrated 
organic solar cells [240]; Ultrathin Pt nanowires obtained by 
using insulin amyloids as a template [192]; Bi-functional 
protein nanowires obtained from Sup35p amyloid fibrils for 
immunoassays [241]; Functional nanowires obtained from 
amyloid peptides via bio-mineralisation [227]; β-Lg amyloid-
directed TiO2 nanowires for photovoltaics [242]. 
Drug delivery, cell 
growth, and tissue 
engineering    
 
Self-assembled amyloid fibrils from gonadotropin-releasing 
hormone (GnRH) analogues as stable drug depots [243]; 
Lysozyme amyloid networks for cell growth and spreading 
[232]; Functionalised transthyrethrin peptide amyloids for 
3T3(mouse fibroblasts) cell adhesion and proliferation [244]; 
Amyloid peptide hydrogels for wound healing [245]. 
Functional amyloids, 






Organophosphate hydrolase immobilised insulin amyloids for 
bioremediation [74]; GOX-functionalised insulin fibrils [181]; 
Multi-functionalisation of whey amyloids [73]; α-synuclein 
amyloid hydrogels with entrapped horseradish peroxidase 
[229]; Cytochrome b562 fused SH3 amyloids with affinity for 
metalloporphyrins [235]; A fluorescent molecular biosensor for 
methyl parathion (pesticide) detection by fusing the methyl 
parathion hydrolase enzyme and green fluorescent protein 
mutant (MPH-GFP) to Sup35 amyloids [246]. 
Novel hybrid materials 
for diverse applications                        
Amyloid peptide-polymer (PEG) conjugates as drug delivery 
systems [247]; β-Lg and gold platelets nanocomposite films 
with fluorescent, conductive and sensing properties 
[248];Graphene-amyloid based biodegradable nanocomposites 
[182]; MWCNTs and β-lg amyloid hybridised pH responsive 
hydrogels [249]; Temperature responsive poly(N-
isopropylacrylamide) (PNiPAM) coated β-lg amyloid hydrogels 
[233]; Insulin amyloid-PVOH composite films with 
antibacterial properties [78, 181]. 
1.9. Thesis objectives 
Amyloid fibrils have the potential of making an enormous impact in future technologies 
because of the many advantages they provide as a protein nanomaterial. However, if amyloid 
PNFs are to be used for commercial applications, then methods will be required to utilise 
inexpensive, crude proteins.  
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This prompted a study to investigate synthesis of amyloid PNFs from crude crystallin proteins 
- crude extracts obtained from fish eye lenses of Macruronus novaezelandie (Hoki) or from 
bovine lenses, and β-lg which offer a cheap and readily available source of fibril-forming 
protein material. Successful immobilisation of industrially important enzymes onto PNFs can 
lead to the creation of cheap and readily available protein-based highly efficient matrices.  
In the first instance this thesis focuses on considering practical issues, such as stability of 
crystallin PNFs in different solutions, over a range of pH and temperature, and to understand 
the behaviour of these fibrils under different conditions, so as to ensure that they can be 
effectively used as a versatile bionanoscaffold. Due to the association of amyloid fibrils with 
neurodegenerative diseases, the potential toxicity of crystallin PNFs was also investigated. The 
next section of this thesis involves characterisation of crystallin PNFs in order to evaluate the 
availability of functional groups on the surface of crystallin PNFs, which can be potentially 
used for functionalisation. Different immobilisation methods were employed to create a 
functional crystallin PNF scaffold.  
Previously, different studies have used insulin amyloid PNFs for immobilising enzymes, 
however, it is for the first time that crystallin PNFs were investigated as a versatile nanoscaffold 
for active biocatalysts. Finally, the last part of this thesis focus on using developed functional 
amyloid PNFs in bionanotechnologies. Electrochemistry and surface-assembly experiments 
were performed to illustrate that amyloid PNFs can be potentially used for creating active 
bionanomaterials. Both crystallin and whey PNFs were also investigated for their suitability as 
a biomaterial with potential to be used as substrates for the attachment and proliferation of 
cells. 
1.10. Thesis overview  
Chapter 2 is an investigation into the stability of amyloid fibrils formed from the three protein 
sources used in this thesis: bovine insulin, WPI, and crude fish crystallins. The main aim of 
this research was to explore crystallin PNFs as a novel bionanomaterial, therefore, the stability 
and cytotoxicity study was primarily focused on the crystallin PNFs. The results from infrared 
microspectroscopy (IRM) study to understand the long-term structural integrity of crystallin 
PNFs is also described in this chapter.  
Chapter 3 focuses on the characterisation of crystallin protein nanofibrils (PNFs) in terms of 
the availability of amino acid groups, which were then investigated for functionalising 
crystallin PNFs. Detailed information of the enzymes used in this thesis, and different 
immobilisation methods studied for creating functional crystallin PNFs is provided in this 
chapter.  
Chapter 4 presents a versatile glutaradehyde-based crosslinking approach to obtain functional 
crystallin amyloid fibrils with potential applications in bionanotechnology. The results from 
stability and reusability studies performed on the functionalised crystallin PNFs are presented 
in this chapter.  
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Chapter 5 details an investigation into the use of amyloid fibrils:  
(a) in the construction of a biosensing element for glucose and lactose detection. This 
entails the creation of PNF-based biosensing elements using GOX-, and β-gal-
functionalised fibrils, electrochemical characterisation of amyloid fibrils, and the 
biosensing capabilities of an electrode modified with functionalised amyloid PNFs. 
 
(b) in the creation of surface-assembled PNFs as a novel nanomaterial. Surfaces with 
amyloid PNFs attached via adsorption or covalent crosslinking were characterised by a 
range of methods. As a proof of principle, the surface-assembled amyloid PNFs 
nanoscaffold was functionalised with a biotechnologically important biocatalyst, 
leading to the generation of active bionanomaterials.  
 
(c) as a cellular growth scaffold. PNFs were blended with other biocompatible fibrous 
protein - silk to obtain silk:PNF blend films, and studied for their suitability as a 
biomaterial with applications in tissue engineering. Blend films were characterised 
using scanning electron microscopy (SEM), optical transmittance, wet contact angle 
analysis, and in vitro degradation, and investigated further as a scaffold for cell growth 
and proliferation.  
 
Chapter 6 summarises the major findings of this thesis, and future directions to be pursued 
from this work.  
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      Chapter TWO 
Stability and cytotoxicity of protein nanofibrils 
2.1. Introduction  
This chapter will provide stability information for PNFs under various conditions so as to 
ensure that they can be effectively used as a versatile bionanoscaffold for different industrial 
applications. An investigation of PNFs stability at a wide range of pHs, a variety of 
temperatures, in the presence of industrially related solvents, such as methanol (MeOH), 
ethanol (EtOH), isopropanol (iPrOH), dimethyl sulfoxide (DMSO) and acetonitrile (ACN), on 
the exposure to proteolytic enzymes such as bovine trypsin, pepsin and recombinant Proteinase 
K, and over long periods of storage was carried out. The ThT assay was used to detect the 
presence of fibrils under given conditions, followed by TEM imaging, to visually confirm the 
presence of fibrils. The stability and cytotoxicity study was primarily focused on the crystallin 
PNFs. For comparison, well characterised fibrils obtained from insulin and whey proteins were 
used. A further study using infrared microspectroscopy (IRM) was done to understand the long-
term structural integrity of crystallin PNFs. Apart from stability studies, association of amyloid 
fibrils with neurodegenerative diseases raises reasonable concerns to the biosafety of crystallin 
PNFs. Thus, a cytotoxicity study was done to assess the possible crystallin PNF toxicity to cell 
viability using the human endometrial adenocarcinoma (Hec-1a endometrial) cell line. 
2.2. Effect of proteases on PNFs 
One of the hallmarks of amyloid fibrils is their high resistance to proteases compared to the 
natively folded protein [1-3].  To assess the extent of fibril digestion, proteolytic enzymes such 
as bovine trypsin, pepsin and recombinant Proteinase K were used. Several in vitro digestibility 
assays using pepsin and trypsin have previously been conducted as they are physiologically 
relevant proteases [4-6]. Proteinase K is a broad-spectrum and highly active protease that has 
been used extensively to characterise the protease resistance of disease-related amyloid fibrils 
[7, 8].  
 
The ThT assay was selected as it is well accepted as an indicator of the presence of amyloid 
fibrils [9, 10]. Upon its incorporation into amyloid fibrils, ThT exhibits a considerable increase 
in the fluorescence intensity; however, the interaction mechanism between ThT and amyloid 
fibrils remains to be fully elucidated [11]. It has been suggested that ThT binds parallel to the 
fibril axis in the grooves between adjacent β-sheets or adjacent protofilaments [12], (see section 
1.8, Chapter One). As the ThT assay is known to be sensitive to pH and viscosity [13-15], care 
was taken to have appropriate ThT control measurements as shown in Figure 2.1 for each of 
the (i) buffers, and (ii) solvents used in this work. 
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Figure 2.1. (i) ThT fluorescence of buffers, where (a) 0.1 M sodium acetate, pH-2.0, (b) 0.1 M 
sodium acetate, pH-4.0, (c) 0.1 M sodium phosphate, pH-6.0, (d) 0.1 M sodium phosphate, pH-
7.2, (e) 0.1 M HEPES, pH-8.0, (f) 0.1 M HEPES, pH- 9.0, and (g) sodium borate, pH-11.0. (ii) 
ThT fluorescence of solvents, where (a) MeOH, (b) EtOH, (c) DMSO, (d) iPrOH, (e) ACN, and 
(f) dH2O, used for normalising ThT fluorescence of PNFs. Error bars represent the standard 
deviation of the mean of three replicates. 
 
PNFs were formed using in-house methods that had been adapted from the literature, see 
section 7.2. Briefly, for insulin PNFs (section 7.2.1), 5.8 mg/mL of insulin (obtained from 
Sigma-Aldrich) was dissolved in 100 mM NaCl, 25 mM HCl (pH 1.6), and sterile filtered [16]. 
The solution was incubated at 60 °C for 22 h. After heat incubation, the samples were cooled 
down on ice for 10 min and finally stored at room temperature for 7 days to allow for fibril 
formation. For whey PNFs (section 7.2.2), aqueous solution of WPI (10 mg/mL) was prepared 
and stirred for 10 min. The pH was adjusted to 2.0 with 100 mM HCl, using a pH probe. The 
solutions were left overnight at 4 °C while stirring, and then heated to 80 °C for 20-22 h in a 
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After cooling for 10 min on ice, the resulting whey PNF suspensions were kept at room 
temperature for at least 1 week before proceeding with the experiments [17]. For crystallin 
PNFs (section 7.2.3), proteins were extracted from fish eye lenses and PNFs were formed from 
this crude mixture, as previously described [18]. The presence of PNFs was confirmed using 
the Thioflavin T (ThT) (section 7.1.2) assay, and TEM imaging (section 7.1.3). 
 
For the proteolytic digestion study, pre-formed fibrils (section 7.2), at the final concentration 
of 10 mg/mL for both whey and crystallin PNFs, and 5.6 mg/mL for insulin PNFs were 
centrifuged at 12,500 rpm for 10 min using an Eppendorf® Minispin® Plus benchtop 
centrifuge. The supernatant was removed and the fibrils resuspended in appropriate buffers 
with and without enzymes, in an enzyme:fibril ratio of 1:20 (w/w). Fibrils in the presence and 
absence of proteases were incubated at 37 °C for 3 h, taking 200 µL aliquots at various time 
intervals (0, 20, 60, 180 min) (section 7.3.4). For data analysis, the fibril + buffer fluorescence 
at each time point was used to normalise the data. For characterisation purposes, the fibrils 
were negatively stained with uranyl acetate (UA) and analysed by TEM (section 7.1.3) and the 
degree of fibril digestion was assessed after 3 h by the ThT fluorescence decrease (section 
7.1.2).   
 
Insulin PNFs, used as a well characterised standard for comparison, proved to be the most 
resistant fibrils to proteolysis, followed by crystallin PNFs (in presence of all three proteases), 
as indicated by a constant ThT fluorescence over the entire duration of the experiment (Figure 
2.2). Both insulin and crystallin PNFs displayed high resistance towards protease digestion. 




Figure 2.2. ThT fluorescence of insulin PNFs (red), whey PNFs (green) and crystallin PNFs 
(blue) in presence of proteolytic enzymes, after 3h incubation at room temperature. ThT 
fluorescence is represented as % decrease in fluorescence compared to the control sample, 
where (a) trypsin, (b) pepsin, and (c) Proteinase K. Error bars represent the standard deviation 
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TEM micrographs of fibrils were also obtained following the 3 h digestion in order to assess 
the change of morphology of the fibrils before and after treatment. Although some enzymatic 
digestion was present in all samples, there were still considerable amounts of fibrils present 
after the 3 h digestion by pepsin, trypsin and even by Proteinase K (Figure 2.3), consistent 
with observations from ThT fluorescence, and also indicates partial digestion of the whey PNFs 
(shown in Fig. 2.3, sample h), whereas there was still a high fluorescence after 3 h of trypsin 
and pepsin digestion of the whey PNFs. The general pattern is a slightly higher resistance 




Figure 2.3. Representative TEM images of PNFs after incubation with proteolytic enzymes. 
Row 1: insulin PNFs - (a) control, (b) trypsin, (c) pepsin, and (d) Proteinase K. Row 2: whey 
PNFs - (e) control, (f) trypsin, (g) pepsin, and (h) Proteinase K. Row 3: crystallin PNFs - (i) 
control, (j) trypsin, (k) pepsin, and (l) Proteinase K. Scale bar is 100 nm. 
2.3. Effect of solvents on PNFs 
This part of the study focuses on PNFs resistance to common industrial solution (H2O) and 
solvents used especially in cleanroom-based microfabrication: MeOH, EtOH, DMSO, iPrOH, 
and ACN. After a washing step, fibrils were resuspended in the test solvent (section 7.3.1) and 
a ThT assay was then carried out (section 7.1.2.) on these samples after a 3 h incubation at 
room temperature. The influence of different solvents on each of the PNFs used was determined 
by comparing the decrease in ThT fluorescence to the control sample. For all three types of 
PNFs, a significant decrease in ThT fluorescence was seen in the samples resuspended in 
DMSO and ACN, with ACN-incubation exhibiting the largest decrease, as depicted in Fig. 2.4, 
sample c and e.  
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In the presence of MeOH, EtOH, iPrOH and H2O, all three types of PNFs exhibited high ThT 
fluorescence indicating fibril stability in the presence of these solvents. However, in 
comparison to insulin and crystallin PNFs, whey PNFs in the presence of methanol showed a 
considerable decrease in ThT fluorescence, which is hypothesised to be due to the fibrils 
degrading or dissolved. From the ThT fluorescence readings, in all the other solvents used, 
except DMSO and ACN, crystallin PNFs exhibited maximum stability, followed by insulin 
PNFs and whey PNFs, without any remarkable difference in ThT fluorescence after 3 h of 
incubation. 
 
Figure 2.4. ThT fluorescence of insulin PNFs (red), whey PNFs (green) and crystallin PNFs 
(blue) resuspended in various solvents, after 3 h incubation. ThT fluorescence is represented 
as % decrease in fluorescence compared to the control sample, where (a) MeOH, (b) EtOH, 
(c) DMSO, (d) iPrOH, (e) ACN, and (f) H2O. Fluorescence values have all had the appropriate 
control (solvent and H2O) value subtracted. Error bars represent the standard deviation of the 
mean of three replicates.  
 
The high decrease in ThT fluorescence for the samples resuspended in DMSO and ACN was 
expected, since organic solvents, mainly polar aprotic solvents including DMSO and ACN, 
have previously been shown to dissolve amyloid fibrils [19]. To validate the observed changes 
in ThT fluorescence, TEM analysis (section 7.1.3) was carried out to confirm the presence or 
absence of fibrils in each of the samples, see Figure 2.5. For all the three types of PNFs used, 
resuspension in water yielded PNFs typical of a control fibril preparation indicating that 
centrifugation and resuspension procedures had not damaged the fibrils, which appeared 
unchanged (Figure 2.5. sample g, n, u compared to a, h, o respectively).  
 
TEM images for the samples of crystallin, insulin and whey PNFs resuspended in EtOH, 
iPrOH, and MeOH also show the presence of clear fibrils (Fig. 2.5). In the case of ACN and 
DMSO, for insulin and whey PNFs (Fig. 2.5 - e, f, and l, m) no clear fibril morphology can be 
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However, for the crystallin PNFs incubated in DMSO and ACN, TEM images suggest the 
presence of fibrils but with slightly different morphologies (lack of ordered fibrils structure) 
(Fig. 2.5 - s, t). The results obtained are in agreement with a similar study done on crystallin 
PNFs by Domigan et al. (2013) [20], who investigated the effect of ACN by resuspending 
fibrils in 50% ACN. Loss of β-sheet content in amyloid aggregates in presence of DMSO and 
ACN has been reported previously [21].  
 
The significant decrease in ThT fluorescence and presence of disrupted fibrils in the TEM 
images for fibrils dissolved in DMSO and ACN could be due to inhibition of hydrophobically 
driven associations, leading to a lack in extensive self-assembly and disordered fibril structure 
[22]. Studies have revealed that pure DMSO can cause complete loss of β-sheet structure as it 
competes with protein carbonyl groups for hydrogen bonding to protein amine groups, leading 
to the destabilisation of secondary structures [23]. In the case of whey PNFs, TEM images 
obtained indicated that, in most of the solvents, fibrils are present but different morphologies 
were observed, illustrating fibril rearrangement in different solvent environments.  
 
The dark aggregates observed in the samples resuspended in solvents could be due to the 
formation of the stain crystals upon drying of the TEM grids, and are unlikely to be dissolved 
or fragmented fibrils, as it was also observed for the buffer-only sample (Fig 2.5 (a) control – 
with insulin insulin fibril buffer only). Uranyl acetate when used as a staining agent can form 
complexes with various buffers and solvents leading to the formation of different complexes 
with different charges [24]. Therefore, these dark aggregates are likely to be due to the 
interaction between solvent/buffer and the stain used for TEM, as this was not observed for the 




Figure 2.5. Representative TEM images of PNFs resuspended in solvents. Row 1: insulin PNFs 
- (a) control, (b) MeOH, (c) EtOH, (d) iPrOH, (e) DMSO, (f) ACN, and (g) H2O. Row 2: whey 
PNFs - (h) control, (i) MeOH, (j) EtOH, (k) iPrOH, (l) DMSO, (m) ACN, and (n) H2O. Row 3: 
crystallin PNFs - (o) control, (p) MeOH, (q) EtOH, (r) iPrOH, (s) DMSO, (t) ACN, and (u) 
H2O. Scale bar is 100 nm. 
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PNTs obtained from the dipeptide diphenylalanine (FF) have attracted a large amount of 
attention as platforms for cell culture and biosensing over the last few years [25-27] (as 
discussed earlier in section 1.6, Chapter One). However, a recent finding of instability of FF 
tubes in most solvents, including water and phosphate buffer raises some limitations for the 
use of protein-based materials in the applications involving solvent submersion, such as 
biosensing [28, 29]. Comparing the stability of crystallin amyloid fibrils with FF nanotubes in 
various solvents [29], it can be confirmed that crystallin PNFs are significantly more stable in 
solution than FF nanotubes, and therefore could be a more appropriate choice for biosensing 
applications. This high stability of crystallin amyloid fibrils could be attributed to the presence 
of a high proportion of interstrand bridges in the crystallins as compared to other proteins [30].  
 
In general, this comparative study of PNFs obtained from different sources has revealed that 
crystallin PNFs obtained from crude proteins obtained from fish eye lenses provide fibrils with 
better stability in a diverse range of solvents compared to PNFs derived from other protein 
sources. 
2.4. Effect of pH and temperature on PNFs 
Previous studies have characterised the effect of pH on fibril self-assembly [16, 31, 32]. 
However, not much literature is available on the long term stability of PNFs at different pH 
values post-assembly. To study the impact of pH on pre-formed PNFs, a wide range of buffers 
(section 7.3.2) at both acidic and alkaline pH values were selected. To test the effect of 
biological pH, 100 mM PBS (pH 7.4), was selected as a commonly used biological buffer 
solution. Fibril stability differed at varying pH, with crystallin PNFs displaying greater stability 
at alkaline pH values. For all PNFs, no observable decrease in ThT fluorescence was observed 
when fibrils were resuspended in solutions with pH values between pH 2.0 and 8.0, as shown 
in Figure 2.6.  
 
Figure 2.6. ThT fluorescence of insulin PNFs (red), whey PNFs (green) and crystallin PNFs 
(blue) at selected pH values, after 24 h incubation. ThT fluorescence is represented as % 
decrease in fluorescence compared to the control (buffer-only) sample, where a) pH-2.0, (b) 
pH-4.0, (c) pH-6.0, (d) pH-7.4, (e) pH-8.0, (f) pH-9.0, and (g) pH-11.0. Error bars represent 
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For whey and insulin PNFs between pH 9.0 and 11.0, a considerable decrease in ThT 
fluorescence was observed, indicating that the fibril structure was disrupted. The results 
obtained for insulin PNFs (grown under similar pH conditions) are consistent with recent 
findings [32], demonstrating the dissociation of insulin amyloid fibrils in this pH range using 
fibril recovery after centrifugal sedimentation. The ThT fluorescence data were supported by 
examination of the fibrils in each of the buffers by TEM (Fig. 2.7). In agreement with the ThT 
fluorescence measurements, abundant fibrils were observed between pH 2.0 and pH 8.0, all 
showing clear fibrils.  
 
Figure 2.7. Representative TEM images of fibrils over a wide range of pH. Row 1: insulin PNFs 
- (a) pH-2.0, (b) pH-4.0, (c) pH-6.0, (d) pH-8.0, (e) pH-9.0 and (f) pH-11.0. Row 2: whey PNFs 
- (g) pH-2.0, (h) pH-4.0, (i) pH-6.0, (j) pH-8.0, (k) pH-9.0 and (l) pH-11.0. Row 3: crystallin 
PNFs - (m) pH-2.0, (n) pH-4.0, (o) pH-6.0, (p) pH-8.0, (q) pH-9.0 and (r) pH-11.0. Scale bar 
is 100 nm. 
 
For whey and insulin PNFs, fewer fibrils were present at pH 9.0, and no clear fibrils were 
detected at pH 11.0, confirming their dissociation in this pH range, whereas crystallin PNFs 
retained morphology over the entire pH range. Although for insulin and whey PNFs no 
significant decrease in ThT fluorescence was observed for fibrils at below pH 8.0, fibrils at pH 
6.0 and 8.0 were morphologically distinct from those at pH 2.0 and 4.0. For insulin fibrils, 
fibrils at pH 6.0 and 8.0 appear short and discrete whereas for whey fibrils, fibrils at elevated 
pH values appear aggregated and clumped together (Fig. 2.7). The observation of slightly 
different morphologies at high pH values was not an unexpected result, as morphological 
differences have been seen previously with elevated pH in fibrils formed from bovine insulin 
[33] and from crude bovine crystallins [34]. 
 
To study the impact of temperature on pre-formed PNFs, fibrils in the respective buffers used 
to produce them (section 7.2) were incubated at selected temperatures for 24 h. The range of 
temperatures was selected according to the optimal temperature range of industrial enzymes, 
considering the application of protein fibrils as enzyme nanoscaffolds (section 7.3.3).  
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After a 24 h incubation at the selected temperatures, high ThT fluorescence readings were seen 
for all the samples as shown in Figure 2.8 (i). In agreement to the ThT results, a high ThT 
fluorescence readings were obtained for all the samples studied suggesting high stability of 
pre-formed PNFs at all the given temperature settings used. TEM images of the crystallin fibril 
samples at all the given temperatures confirmed the presence of fibrils with no major 




Figure 2.8. (i) ThT fluorescence of insulin PNFs (red), whey PNFs (green) and crystallin PNFs 
(blue) after 24 h incubation at a variety of temperatures (°C), where (a) -20, (b) 4, (c) 22, (d) 
37, (e) 60, and (f) 80. Fluorescence values represented as % decrease in fluorescence 
compared to the control sample. Error bars represent the standard deviation of the mean of 
three replicates. (ii) Representative TEM images of PNFs at variety of temperatures (°C). Row 
1: insulin PNFs at (a) -20, (b) 22, (c) 37, and (d) 80. Row 2: whey PNFs at (e) -20, (f) 22, (g) 




















  (ii) 
   (i) 
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2.5. Effect of crystallin PNFs on Hec-1a cell proliferation 
As discussed earlier in section 1.5, Chapter One, there are over 20 diseases, such as 
Alzheimer’s, diabetes (type II), and Parkinson’s disease, that are associated with amyloidoses 
[35-38]. It has been suggested that amyloid fibril related diseases share common amyloid 
aggregate structures and pathological pathways regardless of the source of protein [39, 40]. 
Amyloid fibrils generated from non-amyloid proteins have also been reported to be toxic. For 
example, the amyloid aggregates of the SH3 domain from bovine phosphatidyl-inositol-3'-
kinase and the amino-terminal domain of the E. coli hypF protein showed toxicity towards 
mouse embryo fibroblast cell line (NIH-3T3 cells) [41]. Bovine insulin has also been reported 
to form either toxic rigid fibrils with parallel β-sheet conformation or non-toxic filaments with 
anti-parallel β-sheet character under reducing conditions [42]. Therefore, it is important to 
study the biosafety of crystallin PNFs before exploring them for further applications. 
 
Despite extensive studies in recent years [40, 43-47], the identity of the culprits of cytotoxicity 
associated with amyloidoses still remains unclear [48]. Although non-fibrillar oligomers are 
the main focus of attention, a significant number of studies have reported that mature amyloid 
fibrils can also produce a cytotoxic effect [49-51]. For toxicity studies (section 7.4), Hec-1a 
cells were cultured in Minimum Essential Medium Eagle (MEM) (section 7.4.1) and cell 
viability (section 7.4.2) was measured in the presence and absence of crude crystallin proteins, 
mature amyloid fibrils, and sonicated (fragmented) fibrils. These conditions were tested as 
fibril length may play an important role in cell toxicity [52, 53].  
 
To cause the fragmentation of PNFs, sonication was investigated as it has previously been 
shown to cause the fragmentation of insulin amyloid fibrils [54, 55]. For fragmenting amyloid 
fibrils, mature crystallin PNFs were subjected to a range of sonication times (0-40 sec). The 
resulting solutions were assessed for fragmentation by TEM, and it was found that a sonication 
time of 20 sec was needed to fragment the crystallin PNFs (section 7.16.1). TEM images for 




Figure 2.9. Representative TEM images of crystallin PNFs, where (a) mature fibrils and (b) 
fragmented fibrils. Scale bar is 200 nm. 
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The crystal violet staining (CVS) assay (7.4.3), a method of similar accuracy as WST (water 
soluble tetrazolium salts) assays, [56, 57] was done to assess the potential toxicity of crystallin 
PNFs. The CVS assay is a simple and reproducible assay of cytotoxicity [58-60]. In the CVS 
method, the principle involved to calculate the cell viability is based on the dye taken up by the 
viable cells in culture after the cells are stained with crystal violet (DNA of the cells is stained), 
and the resulting colour intensity is then measured spectrophotometrically at 570 nm.  
 
The method of Gillies et al. (1986) [61] used to quantify the cell number in monolayer cultures 
as a function of the amount of the dye taken up by the cells has been extensively used with 
modifications for a wide number of applications including: to determine cytotoxicity or cell 
death produced by chemicals or toxins produced by microorganisms [62-64] and to determine 
cell proliferation [65] or cell viability [66]. Hec-1a cells were incubated with 10 mg/mL 
concentration of the crude protein, mature fibrils and sonicated fibrils, and the number of viable 
cells measured by the binding of crystal violet after 24 and 48 h. Even after 48 h incubation in 
comparison to the control, no substantial difference in the number of viable cells exposed to 
any of the given treatments was observed as demonstrated in Figure 2.10.  
 
Figure 2.10. Hec 1a cell viability, in the presence of (a) mature fibrils, (b) fragmented fibrils, 
(c) crude crystallin protein (10 mg/mL), (d) control - nutrient medium + PBS, (e) 10% DMSO, 
and (f) no-cell sample. Cell viability is represented as % decrease/increase in number of cells 
as compared to control (d), nutrient medium is set to 100%. Error bars represent the standard 
deviation of the mean of three replicates. Blank columns 24 h and filled columns 48 h 
incubation time. 
A further study was undertaken to assess whether there is any interaction between the cell and 
the proteins. The cells were pre-incubated in the absence of foetal bovine serum (FBS) to 
“starve” them overnight prior to the treatments (section 7.4.2). In comparison to the previous 
experiment there was an increase of cell viability in the presence of fibrils after 48 h incubation 
as depicted in Fig. 2.11. Similar results have been reported earlier for PNFs obtained from non-
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The control (buffer + media) shows that the buffer conditions do not change the cell viability. 
10% DMSO is toxic to cells and was therefore used as a positive control. The no-cell control 
also did not show any sign of viability, demonstrating that no contamination was present.  
 
Figure 2.11. Hec 1a cell viability, in presence of (a) mature fibrils, (b) fragmented fibrils, (c) 
crude crystallin protein (10 mg/mL), (d) control - nutrient medium + PBS, (e) control - 
starvation medium + PBS, (f) 10% DMSO, and (g) no-cell sample. Cell viability is represented 
as % decrease/increase in number of cells as compared to control (d), nutrient medium is set 
to 100%. Error bars represent the standard deviation of the mean of three replicates. Blank 
columns 24 h and filled columns 48 h incubation time. 
Our results suggest that Hec-1a cells are not adversely affected by the presence of crystallin 
amyloid fibrils at the studied concentration. There was also no indication that fragmented 
(sonicated) fibrils decreased cell viability, in contrast to literature reports [52]. Instead, the in 
vitro studies suggest that the cells can perhaps utilise the fibrillar proteins as a source of 
nutrients, although the contribution of non-fibrillar protein components requires further 
investigation [68]. Previous studies have shown that the inherent stability of the β-sheet 
supramolecular structure adopted by the crystallins in the eye lens and the chaperone ability of 
α-crystallin must be crucial for preventing protein aggregation in vivo. Aoyama et al. (1993), 
have also shown that the presence of α-crystallins in cultured cells leads to an enhanced survival 
of these cells after a period of stress [69]. Thus, a further investigation is required to investigate 
that the increased cell viability is due to the maintained chaperone activity of crystallins in the 
fibrillar structure or due to the non-fibrillar crystallins present in the cell culture.  
 
It is commonly agreed that the toxicity of fibrillar aggregates is caused by membrane disruption 
[70-73] and is often associated with Ca2+ release and oxidative damage [47]. Membrane 
disruption could be linked directly to the hydrophobicity and flexibility of the amyloid 
aggregate [47]. Therefore, the potential interaction of fibrils with cell membranes could differ 
[74], and further studies may be required using different cell lines with altered compositions of 
cellular membranes (see section 5.22, Chapter Five - attachment and proliferation of mouse 
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2.6. Long-term storage stability 
The long term stability of the crystallin amyloid fold was carried out at the Australian 
Synchrotron, using the IRM beamline (section 7.5). The analysis was focused on amide I 
vibrations (1600-1700 cm-1), which are commonly used as conformational markers for peptides 
and proteins [75]. Amide I vibrations mainly arise from stretching vibrational modes of the 
backbone carbonyl groups and correspond to different strengths/types of hydrogen bonds in 
which the backbone carbonyl groups are involved. They can hence be assigned to specific 
secondary structures [76]. IRM spectra were collected on crystallin fibrils aged for 2 to 37 
months kept at room temperature (section 7.5). These were compared to IRM spectra collected 
for recently formed fibrils kept under the same conditions (less than a month old). 
Typical IR absorbance spectrum of amyloid crystallin PNFs, across the whole amide 
fingerprint region is shown in Appendix A, Figure A1. Representative amide I vibrations are 
shown here as a function of the aging time together with the corresponding second derivative 
(Figure 2.12), left and right panel respectively. Independent of the aging time, the amide I 
region exhibited two well-defined infrared absorption peaks at around 1620 cm-1 and 1690 cm-
1 for all the samples, as for the recently formed fibrils (Fig. 2.12). Similar IR amide I vibrations 
including antiparallel β-sheet, random coil and turn, were previously reported for amyloid 
fibrils generated from a γD-crystallin domain [77]. In accordance with the literature, this pair 
of absorption peaks was assigned to extended antiparallel β-sheet networks, which are a 
hallmark of the amyloid fibril fold [76, 78].  
Less defined vibrations could be detected at around 1650 cm-1 and 1670-1680 cm-1 from the 
second derivative spectra (Table 2.1). These were assigned to respectively random coil and 
turn secondary structures [76]. The variation of the type of turn from one sample to another (1 
or 2 absorption peaks) is likely due to the variation in content of the types of crystallins [78]. 
Taken together, the IRM results show that the crystallin fibrils conserve the same 
conformational features for up to 37 months, when kept in solvent used to prepare the crystallin 
PNFs at room temperature (section 7.2.3). These features are typical of the amyloid fold and 
consistent with previous conformational characterisations of γD-crystallin amyloid fibrils [77]. 
 
Table 2.1. IRM amide I vibrations of aged crystallin PNFs (wavenumbers taken from minima 





sheet (cm -1) 
Random coil 
(cm -1) 
Turn (cm -1) Antiparallel β-
sheet (cm -1) 
0 1619 1655 1662, 1676 1693 
2 1620 1650 1663, 1670 1693 
5 1620 1650 1660, 1676 1689 
13 1618 1656 1664, 1675 1693 
27 1618 1652 1672 1693 
37 1621 1652 1670 1692 
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Figure 2.12. IR absorbance spectra (A, B, C, D, E, F) and 2nd derivative spectra d2A/dν2 (A”, 
B”, C”, D”, E”, F”) of crystallin amyloid PNF samples after long-term storage with periods 
of  A) 37, B) 27, C) 13, D) 5, E) 2 and F) 0 months. 
2.7. Conclusion 
 
Crude crystallin proteins extracted from fish eye lenses have been previously identified as an 
economically viable source of PNFs, allowing for amyloid fibril production in large quantities 
at a low cost [18],[78]. This chapter has investigated the suitability of this material as a 
bionanoscaffold, specifically in terms of stability under a variety of parameters. Crystallin 
PNFs were shown to be stable across a wide pH range, in a number of industrially relevant 
solvents, at both low and high temperatures, and in the presence of proteases.  
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A comparative study, including insulin and whey PNFs suggests that crystallin PNFs obtained 
from cheap and readily available protein source, offer similar and often improved stability 
properties. No evidence of cytotoxicity of crystallin PNFs has been found by preliminary 
cytotoxicity assays using Hec-1a cells. An IRM study illustrates the long-term (up to 3 years) 
structural integrity of crystallin PNFs. This study supports the use of crystallin PNFs as 
nanomaterials, particularly in applications such as biosensing and enzyme immobilisation, 
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Chapter Three 
Characterisation of crystallin amyloid fibrils – Towards 
functionalisation 
3.1. Introduction 
This chapter will explore the use of crystallin protein nanofibrils (CPNFs) - synthesised from 
crude fish eye lens protein extracts of Macruronus novaezelandie (Hoki), as a nanoscaffold for 
the immobilisation of important industrial enzymes. Enzyme immobilisation has widened the 
scope of industrial enzymes allowing not only reusing of the biocatalyst, with a benefit in terms 
of costs, but especially improving enzyme performances, leading to higher activity and stability 
[1]. PNFs in addition to their cheap availability, biocompatibility, self-assembly, and 
remarkable mechanical strength also offer a high surface-to-volume ratio, resulting in increased 
immobilisation capacity as compared to conventional 2D supports (as discussed earlier in  
section 1.9, Chapter One) and thus, are an exciting alternative to the currently used 
nanoscaffolds for enzyme immobilisation.  
In this chapter, a brief introduction about each of the enzymes used, their lysine group 
availability for crosslinking, and results from the various assays employed for characterising 
crystallin PNFs are presented. Different assays were used to identify surface-exposed amino 
acid residues in CPNFs, which can be potentially used for crosslinking. Additionally, results 
from the different methodologies: reversible immobilisation (physical adsorption), and 
irreversible immobilisation, involving crosslinking via functional groups such as lysine, 
sulfhydryl, and aldehyde used for functionalising crystallin PNFs will be discussed. In this 
work, GOX was first used as a model enzyme to test the potential of crystallin PNFs as a 
nanoscaffold, before expanding to a range of enzymes, such as β-gal, pectinase, α-amylase, and 
laccase. All of the above enzymes used in this work were purchased commercially as a 
lyophilised powder from Sigma-Aldrich and were characterised using enzyme-specific activity 
assays (as detailed in Appendix B). These activity-based assays were then routinely used to 
characterise functionalised PNFs. The enzymes ranged in size from ~30-180 kDa, included 
monomeric and dimeric quaternary structures, and are predominantly used in food industry 
relevant processes (discussed in section 3.2).  
3.2. Enzymes used for the immobilisation 
3.2.1. Glucose Oxidase (GOX) 
GOX (EC 1.1.3.4.) is a dimeric and glycosylated flavoprotein that catalyses the oxidation of 
glucose to gluconolactone, which spontaneously yields gluconic acid, producing hydrogen 
peroxide as a side product [2]. GOX is an industrially important enzyme with extensive 
commercial uses in the chemical, food and beverage, and biotechnology industries [3-5].  
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The crystal structure of GOX (Figure 3.1(a)) shows the surface of the enzyme with the lysine 
residues highlighted in pink. Previous research has shown that due to the presence of 
glycosylation, from the 24 lysine residues on the surface of the GOX dimer, only 5 are 
potentially available for crosslinking [6]. GOX is widely used in biosensing applications for 
the detection and estimation of glucose concentration in industrial and clinical analysis [7, 8]. 
Other uses include: as an antimicrobial agent for food storage and packaging [9], as a food 
preservative, by removing oxygen from fruit juices, and from mayonnaise to prevent rancidity; 
or by removing glucose for improving colour, flavour and shelf life of food products, such as 
dried egg powder [5], or as a textile bleaching agent [9, 10]. GOX due to its high stability and 
activity, is considered an ideal enzyme for immobilisation studies [2, 11], and has been 
successfully immobilised onto various scaffolds [12-14], including insulin PNFs [15, 16], 
where the resulting GOX-functionalised enzyme scaffold was then incorporated into a model 
poly(vinyl alcohol) (PVOH) film, and tested on E.coli for the antibacterial activity of GOX 
[15]. GOX was selected for this research as a model enzyme, as it is highly stable under a 
variety of conditions and its stability has been improved by using different immobilisation 
techniques [12, 17, 18].  
3.2.2. β-Galactosidase (β-gal)   
β-Gal (EC 3.2.1.23) is distributed in a wide variety of organisms including animals, plants and 
microorganisms, and is known to catalyse the conversion of lactose into glucose and galactose 
[19, 20]. β-Gal based industrial applications include production of lactose-hydrolysed products 
for lactose-intolerant or lactase-deficient people [21, 22], and as a biosensor for specific lactose 
determination in the dairy industry [23]. The X-ray crystal is shown in Figure 3.1(b), with the 
theoretically available lysine residues highlighted in pink.  
β-Gal has previously been immobilised to a wide range of supports including magnetic chitosan 
NPs [24], zinc oxide NPs [25], graphite [26], microporous polyvinylidene fluoride (PVDF) 
membrane [27], and silicon [28]. A huge amount of research into the immobilised β-gal focuses 
mainly on the development of biosensors for the detection of lactose [29-33]. Successful co-
immobilisation of GOX and β-gal on amyloid fibrils anchored to surfaces could lead to the 
creation of cheap, reliable and reusable active surface-coating nanomaterials for the production 
of lactose biosensor (discussed later, Chapter Five). 
3.2.3. Pectinase  
Pectinases have numerous applications in the food, textile and bionanotechnological processes 
[34, 35]. These enzymes catalyse degradation of pectin substances either via esterification 
(esterases reactions) or through depolymerisation (hydrolases and lyases) [36]. The crystal 
structure of pectinase is shown in Figure 3.1(c). Pectinases are an integral part of the fruit 
industry and are extensively used for clarification of fruit juices and wines by degrading pectin 
[36-38]. Another important application of pectinase is in the farming industry for the 
formulation of animal feeds where pectinases are used with other hydrolases to reduce viscosity 
[39].  
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To date, several supports, mainly polymers have been used for immobilising pectinase either 
by physical adsorption, entrapment, multipoint attachment or via covalent immobilisation [40-
43]. The proteinaceous building blocks of the PNFs nanoscaffold can offer a beneficial 
environment for pectinase immobilisation, decreasing the enzyme’s liability for denaturation. 
 
Figure 3.1. Crystal structure of (a) GOX dimer (PDB ICF3), (b) β-Gal (PDB IPX3), (c) 
Pectinase (PDB INHC), (d) α-Amylase (PDB 3KWX), and (e) Laccase (PDB 2H5U), showing 
the surface with the lysine residues coloured in pink, as visualised by using PyMol. 
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3.2.4. Amylase  
Starch is a very important raw material and a major constituent of food products. However, 
starch utilisation requires its degradation to maltodextrins, maltose, and glucose which can be 
achieved by using amylolytic enzymes [44]. Amylases have wide application in starch 
saccharification and degradation process leading to the production of various useful products, 
such as sweeteners, gelling agents, and adhesives [45, 46]. Amylases have gained considerable 
importance due to their wide spectrum applications in various industrial processes such as food, 
pharmaceutical, and fermentation industry [47]. Some of the main applications include 
production of glucose syrups, high fructose corn syrups, maltose syrups, reduction of viscosity 
of sugar syrups and haze formation in fruit juices [48]. In the brewing industries, amylases are 
extensively used for solubilisation and saccharification of starch for alcohol fermentation [49]. 
Previous studies have revealed that immobilisation of amylases on water insoluble carriers 
seems to be the most promising method to obtain stable and reusable forms of enzymes [50-
52]. Thus, amyloid fibril nanoscaffolds may provide a support that is beneficial towards 
amylase activity and stability. The crystal structure of the α-amylase enzyme (EC 3.2.1.1) with 
potentially available lysine groups for crosslinking, highlighted in pink is shown in Figure 
3.1(d). 
3.2.5. Laccase  
Laccases (EC 1.10.3.2) have gained great importance in enzymatic oxidation techniques due 
to their high non-specific oxidation ability, and are used extensively for diverse 
biotechnological applications. The crystal structure of fungal laccase from Cerrena maxima 
showing the surface with the lysine residues coloured in pink is shown in Figure 3.1(e). Some 
of the major laccase using industries include the textile industry for bleaching and waste water 
treatment [53, 54], the paper industry for delignification [55] and the biopulping [56], 
pharmaceutical [57], and food industry [58]. Several laccase substrates, such as phenols, thiol-
containing proteins, and fatty acids are important components of various beverages and foods. 
Modification of all such compounds by laccase may lead to sustainable processes with new 
functionality, quality improvement, or cost reduction [59]. Laccases have also been applied to 
eliminate undesirable phenolics responsible for browning, turbidity development and haze 
formation in beverage industries so to enhance or modify the appearance of clear fruit juices, 
beer and wine, and also in biosensing [60, 61]. Different methodologies have been reported for 
laccase immobilisation, such as adsorption, entrapment, encapsulation, and covalent binding. 
The scope of laccase applications has widened further by immobilisation techniques, as 
recently reviewed by Fernández-Fernández [62]. 
All the enzymes studied in this work are important industrial biocatalysts with many possible 
applications in biotechnological processes. However, there are still many constraints to their 
application, due to processing conditions such as, extreme pH values, high temperatures, very 
high ionic strength, presence of surfactants and solvents, huge substrate volumes. All such 
limitations clearly highlight the need for the choice of very robust catalysts for the process. 
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3.3. Characterisation of CPNFs as immobilisation scaffolds 
In this work, initial attempts were made to immobilise GOX onto crystallin PNFs using the 
methods of Pilkington et al. (2010) [15], who showed that GOX can be covalently immobilised 
to insulin PNFs using glutaraldehyde (GA). The extent of crosslinking was then assessed by 
SDS-PAGE (section 7.1.1), which implied that no immobilisation of GOX to the crystallin 
PNFs was occurring, and that only GOX crosslinked to other GOX molecules (strong band at 
160 kDa corresponding to the GOX dimer) was observed despite extensive efforts (see 
Appendix C, Figure C1). As the established method did not result in successful immobilisation, 
a number of alternative methods using different lysine residue-based crosslinking molecules, 
such as formaldehyde (FA), and methylglyoxal (MG) were studied, by altering various 
variables. A summary of different conditions tried is given in Table 3.1. 
Table 3.1. Details of different conditions attempted for immobilisation of GOX to crude 
crystallin PNFs (GOX - glucose oxidase, CPNFs - crystallin protein nanofibrils, and X - 
crosslinker), where arrow indicates 15 min incubation time. 
Conditions Details 
Reaction order One step reaction: GOX + CPNFs + X 
Two step reaction: GOX + CPNFs       X 
                                     GOX + X        CPNFs 
                                     CPNFs + X      GOX 
Total reaction time 30-180 min; 12-24 h 
Pre-incubation time 15-60 min 
Reaction temperature 25, and 37 °C 
Crosslinker GA, MG, FA, and GA+FA 
Crosslinker concentration GA 10-200 mM, MG and GA 1-4% 
Crystallin fibril concentration 2-10 mg/mL 
GOX concentration 0.5-2 mg/mL 
*This value is approximate. Fibrils were formed using the standard in-house conditions and then concentrated 
and resuspended in PBS (pH 7.4) by centrifugation.  
None of the crosslinking conditions detailed in Table 3.1 were successful, with all resulting in 
GOX dimer formation. In addition to GOX, several attempts to immobilise other enzymes to 
the crystallin PNFs using GA were also tried, but successful immobilisation conditions could 
not be found. Thus, in order to detect lysine residues, as well as N-terminal amines, and to 
investigate the lack of crosslinking via lysine residue-based crosslinkers for crystallin PNFs, 
the amino group availability of crystallin PNFs was assessed using the o-phthaldialdehyde 
(OPA) assay, and the ninhydrin assay.  
3.3.1. Assessment of amino group availability 
3.3.1.1. OPA assay 
The OPA assay is based on the reaction of o-phthaldialdehyde with primary amines, in the 
presence of a reducing agent, such as 2-mercaptoethanol. When OPA reacts with primary 
amines it produces a fluorescent isoindole product as shown in Figure 3.2. 
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The fluorescent isoindole produced can then be detected spectrophotometrically at 340 nm. 
The OPA assay was carried out according to in-house methods [63] (section 7.6.1), with a 
standard curve (section 7.6.1.1) created using lysine concentrations ranging from 0.2-2.0 mM, 
see Appendix D, Figure D1(a).  
                                          
Figure 3.2. Reaction scheme of OPA reagent with a primary amine, in the presence of a 
reducing agent, to produce a fluorescent product that can be detected at 340 nm [63]. 
3.3.1.2. Ninhydrin assay 
The reaction of ninhydrin with primary amino groups to form the purple dye commonly known 
as Ruhemann's purple was discovered by Siegfried Ruhemann in 1910. The ninhydrin assay 
functions by reaction of ninhydrin solution (triketohydrindene hydrate), with ϵ-amino groups 
and N-terminal amines, to produce a purple coloured compound 
diketohydrindylidenediketohydrindamine (Ruhemann’s purple) which can be detected at 570 
nm [64] (Figure 3.3). The procedure of Moore [65], as modified by Friedman et al. (1984) 
[66], was used according to in-house methods (section 7.6.2), with a standard curve (section 
7.6.2.1) constructed using lysine concentrations from 0.2 to 2.0 mM, see Appendix D, Figure 
D1(b).  
                  
Figure 3.3. Reaction scheme of ninhydrin reagent with primary amines to produce a 
fluorescent product, Ruhemann’s purple that can be detected at 570 nm [64]. 
3.4. Amino group availability assay for PNFs 
In order to validate the use of fluorescence-based amino group assays, it is important to 
calculate a theoretical amino group concentration of the protein. It is not possible to calculate 
an exact amino group concentration of PNFs, due to the unknown solvent accessibility of 
particular residues and a lack of information regarding the number of native monomers 
involved per fibril. Thus, it was decided to validate the use of lysine residue-based assays by 
using the two assays described above for whey protein isolate (WPI), as it is relatively easy to 
determine the theoretical amino acid concentration of WPI due to available sequence 
information.  
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3.4.1. Amino group availability assay for whey protein, and whey PNFs 
Both the OPA, and the ninhydrin assays were done on native whey protein isolate (1 mg/mL) 
and whey PNFs (formed from 1 mg/mL native whey protein isolate) to validate the use of these 
assays. The results of these assays are shown in Table 3.2.  
Table 3.2. Summary of calculated amino group availabilities of native whey protein isolate 
and whey PNFs, using the OPA (section 7.6.1) and ninhydrin assays (section 7.6.2). 
Theoretical amino group composition estimated from β-lg sequence is also given. 
Sample OPA assay (μM)* Ninhydrin assay 
(μM)* 
Theoretical (μM) 








Whey protein nanofibrils 
(1.0 mg/mL)** 
160±10 166±12 N/A 
*OPA and ninhydrin assay concentration is calculated from standard curve. As the standard curve was 
constructed using lysine, therefore values were multiplied by two to obtain amino group concentration. 
**Fibrils were formed at 10 mg/mL concentration and diluted to 1.0 mg/mL after washing and 
centrifugation to ensure that there aren’t any additional free proteins available in the solution. 
The WPI used in this study mainly consists of β-lg, therefore the theoretical amino acid 
concentration of WPI was determined from the β-lg sequence (Fig. 3.4). The β-lg monomer (β-
lg occurs as monomer at the pH (2.0) used in this study) has a total of 15 lysine residues, of 
which 5 lysine groups are accessible at the surface [67, 68]. All other lysine groups on the 
protein and the N-terminal amine group of the β-lg monomer are partially “buried” within the 
molecule so they are inaccessible [67]. By comparison with the theoretical amino group 
concentration of WPI, the amino group availability as ascertained by each of the two assays 
indicate a very good correlation between the two assays (Table 3.2), suggesting that both 
assays are suitable to assess the amino group availability of PNFs formed from crude crystallin 
proteins.  
 
Figure 3.4. Primary sequence of bovine β-lg (PDB 1BEB) showing lysine residues in red.  
3.4.2. Amino group availability assay for crystallin protein, and crystallin 
PNFs  
The theoretical amino group concentration for crystallin proteins is unknown as: 
1. Mixtures of crude crystallin proteins were used in this study and it was difficult to 
determine the initial concentration of each protein involved. 
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2. The proteins have a heterogeneous population of post translational modifications 
(discussed in section 3.6). 
However, a detailed study of hoki crystallin proteins done by Domigan (2012) [68], revealed 
that crude crystallin proteins consists of all the three main classes of crystallin proteins named 
as α-, β-, and γ-crystallins. On comparing the results from Domigan (2012) with the elution 
profiles for bovine crystallins [69, 70], it was observed that hoki crystallins have higher 
amounts of γ- and lower amounts of β-crystallins. Both these observations seems to be a 
common feature of fish crystallin proteins as supported by the literature [71-76]. 
A sequence study (on γ-crystallins from D.rerio) and results from OPA and ninhydrin assays 
showed that crystallin proteins do have high concentration of amino groups available for 
crosslinking, and lack of crosslinking suggests the presence of some other interference (results 
not shown). To understand this, both OPA (section 7.6.1) and ninhydrin (7.6.2) assays were 
done on the crude crystallin protein solution, the amorphous aggregate removed during 
fibrillation process, and on the crystallin PNFs obtained after fibrillation (section 7.2.3). 
Results of these assays are summarised in Table 3.3. 
Table 3.3. Summary of calculated (using the OPA and ninhydrin assays) amino group 
availability of crude crystallin protein solution, amorphous aggregate removed while making 
fibrils, and crystallin amyloid fibrils. Sample concentration is calculated from standard curve 
obtained using lysine, therefore values were multiplied by two to obtain amino group 
concentration.  
Sample OPA assay (μM) Ninhydrin assay (μM) 








Crystallin protein nanofibrils 
(10 mg/mL) 
26±7 32±12 
*Removed while fibrillation process, and re-dissolved in extraction buffer. All samples had same 
concentration and volume. 
Results obtained from the amino group availability studies show that the lysine rich 
components were getting removed along with the amorphous aggregates during the fibrillation 
process (Table 3.3) as anticipated. To ascertain whether there is any variability associated with 
crude crystallin proteins due to post translational modifications (section 3.6) or batch-to-batch 
variations, the OPA assay was also done on crude proteins extracted from different batches. 
Results obtained as shown in Figure 3.5 verify that there is a difference between the lysine 
residue group availability of crystallin proteins extracted within the same batch (Fig. 3.5, 
sample a and b) and from the different batches (Fig. 3.5 sample c). The lack of crosslinking 
via amine groups in crystallin PNFs indicates that only few lysine groups are available for 
crosslinking, and the remaining lysine groups are involved in forming/stabilising or are buried 
within the amyloid fibril structure, thus, they are not accessible.  
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Figure 3.5. Amino group availability assay as determined by the OPA assay. Blank bar - crude 
crystallin protein extract, and filled bar - crystallin PNFs prepared from the same batch sample 
- a and b, and from different batch - sample c. Error bars represent the standard deviation of 
three replicates. 
The results obtained by using amino group-based assays, suggested that there is insufficient 
availability of lysine groups in crystallin PNFs for the crosslinking reaction, and in order to 
achieve effective immobilisation, other methods such as immobilisation via other amino acid 
residues, oxidation of crystallin PNFs or crosslinking via polysaccharide chains needs to be 
utilised. Thus, further work was done to determine the potential functional residues available 
on the surface of crystallin PNFs, and to develop an efficient method for functionalising 
crystallin PNFs via these functional groups. A schematic representation of the amyloid fibrils 
with surface amino acid residues available for immobilising enzymes (via crosslinking or 
adsorption) to obtain functionalised PNFs is shown in Figure 3.6. 
 
Figure 3.6. A schematic representation of different amino acid residues studied in this work to 
obtain functionalised crystallin PNFs, where x- can be lysine, sulfhydryl, or aldehyde residue. 
3.5. Assessment of sulfhydryl/thiol group availability 
Sulfhydryl/thiol groups due to their strong nucleophilic nature are very reactive and useful 
targets for coupling reactions [77].Thus, it was decided to attempt crosslinking via sulfhydryl 
groups using either homo-bifunctional or hetero-bifunctional crosslinkers, such as, bis-
(maleimido) ethane (BMOE), and succinimidyl trans-(maleimidylmethyl) cyclohexane-1-
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1. Selective crosslinking: The rarity of free sulfhydryl groups present in most proteins 
makes the reaction more selective [77].  
2. Easy to modify: Sulfhydryl groups in proteins are generally present as disulfide bonds. 
Thus, free sulfhydryl/thiol groups can be easily generated by reduction of these native 
disulfide bonds by using reducing agents, such as dithiothreitol (DTT), and Tris-(2-
carboxyethyl) phosphine hydrochloride (TCEP); or alternatively thiols can be 
introduced into a protein by using sulfhydryl-addition reagents,  such as 2-
iminothiolane (Traut’s reagent) [78].  
3. Control over reaction: Use of hetero-bifunctional crosslinkers for coupling 
sulfhydryl-reactive groups with amine-reactive groups provides greater flexibility and 
control over the crosslinking reaction [77].   
Some proteins do contain free sulfhydryl groups available for crosslinking, but often it is 
required to introduce such groups artificially [78]. Hence it was important to evaluate the 
number of sulfhydryl groups present on the crystallin PNFs which could potentially be used 
for immobilising enzymes. To assess the availability of sulfhydryl groups in crystallin amyloid 
fibrils, Ellman’s assay was used.  
3.5.1. Ellman’s assay  
Ellman’s assay, also known as the dithio-bis-(2-nitrobenzoic acid) DTNB assay, works by 
reacting DTNB with free sulfhydryl groups to yield a yellow-coloured product, 2-nitro-5-
thiobenzoic acid (TNB) which can be detected at wavelengths of 412 nm (Fig. 3.7). Ellman’s 
assay was carried out according to in-house methods (section 7.6.3) [79], with a standard curve 
created using cysteine concentrations ranging from 0.2–2.0 mM, see Appendix D, Fig. D1 (c). 
 
Figure 3.7. Reaction scheme of Ellman’s reagent with free sulfhydryls to produce a measurable 
yellow-coloured product product, 2-nitro-5-thiobenzoic acid (TNB) that can be detected at 412 
nm [80]. 
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3.5.2. Sulfhydryl group availability of crystallin PNFs 
Ellman’s assay (section 7.6.3) was used to gain preliminary information about the presence of 
sulfhydryl groups, before the crosslinking experiments. Both crude crystallin protein solution 
at 10 mg/mL and crystallin PNFs obtained from this crude protein mixture were studied for 
sulfhydryl group availability. The results of Ellman’s assay as summarised in Table 3.4, 
showed that there is a significant amount of reduction in the available sulfhydryl groups in 
crystallin PNFs as compared to the crude crystallin protein mixture.  
Table 3.4. Summary of calculated sulfhydryl group availability of crude crystallin protein 
solution, amorphous aggregate removed while making fibrils, and crystallin PNFs. Sample 
concentration is calculated from standard curve obtained using cysteine. 
Sample Ellman’s assay value (µM) 
Crude crystallin protein solution 289 ± 14 
Redissolved protein aggregate 112 ± 8 
Crystallin protein nanofibrils 12 ± 6 
Fibrils were formed using the standard in-house conditions and then concentrated and resuspended in 
PBS (pH 7.4) by centrifugation 
This result was not unexpected since, a similar result was observed with the amino group 
availability (section 3.4.2). It is likely that sulfhydryl groups are buried within the fibrillar 
structure and are not accessible.  
Free sulfhydryl groups undergo dimerisation in the presence of atmospheric oxygen to give 
disulfide bonds, which stabilise secondary and tertiary structures [81-86]. In general free 
sulfhydryl groups in proteins are protected by a microenvironment to prevent non-native dimer 
formation [78]. However, in the case of crystallin PNFs, the process of formation of crystallin 
PNFs is based on the denaturation of crystallin protein and involves disruption of the 
microenvironment. Thus, it is possible that available sulfhydryl groups are involved in 
stabilising the fibril structure, resulting in fewer sulfhydryl groups on the surface of crystallin 
PNFs as compared to the crude crystallin proteins. Lack of abundant free thiol groups on the 
crystallin PNFs surface suggested that in order to obtain a successful functionalisation of 
crystallin PNFs via sulfhydryl groups, different methodology is required. Two alternative ways 
studied were (i) use of reducing agents (e.g. dithiothreitol (DTT), and tris(2-
carboxyethyl)phosphine (TCEP) to reduce the existing disulfide bonds, or (ii) introducing 
sufhydryl groups by using chemical reagents, such as 2-iminothiolane (Traut’s reagent).  
3.5.2.1 TCEP reduction of crystallin PNFs 
For reducing sulfhydryl groups, TCEP, a sulfhydryl-free compound, was used. Bond breaker 
TCEP solution was preferred as TCEP is non-volatile, odourless, and unlike most other 
reducing agents, resistant to air oxidation [85]. Compared to DTT, TCEP is more stable, 
effective and water-soluble, and is able to reduce disulfide bonds over a wide range of pHs and 
temperatures [86, 87].  
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The reduction was carried out as detailed in section 7.6.4. For characterising free sulfhydryl 
groups, Ellman’s assay was done on the reduced crystallin fibril sample (section 7.6.3). To 
remove any residual TCEP solution in the treated sample, PNFs were washed and collected by 
centrifugation, before performing the assay (section 7.6.4).  
As shown in Figure 3.8, the reduction of crystallin PNFs using TCEP yielded free sulfhydryl 
groups. As compared to initial sulfhydryl group readings, a significant increase in the assay 
reading was observed for the fibrils treated with TCEP, suggesting successful reduction of 
crystallin PNFs with TCEP. These TCEP-treated samples were then used further for 
crosslinking reactions using Sulfo-SMCC, a sulfhydryl group-based crosslinker, see Table 3.5 
(b). 
 
Figure 3.8. TCEP reduction of crystallin PNFs, where blank bar - initial sulfhydryl group 
concentration, and filled bar - sulfhydryl group concentration after TCEP reduction. Fibrils 
were characterised using Ellman’s assay, absorbance readings were taken at 412 nm. Error 
bars represent the standard deviation of the mean of three replicates. 
3.5.2.2. Introducing sulfhydryl groups onto CPNFs, using Traut’s reagent 
Another approach usually used for crosslinking via sulfhydryl groups is to introduce sulfhydryl 
groups into a protein, by using sulfhydryl-adding reagents. The most commonly encountered 
and commercially available protein thiolation reagents are those which exhibit reactivity 
towards amines, such as SATA (N-succinimidyl S-acetylthioacetate), SATP (N-succinimidyl-
S-acetylthiopropionate), and Traut’s reagent [78].  
 
Figure 3.9. Schematic representation of Traut’s reagent reaction with primary amines (-NH2) 
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The results from the lysine-based assays (section 3.4.2) suggest a lack of sufficient amine 
groups on the crystallin PNFs, thereby, any method involving amine groups cannot be used for 
functionalising crystallin PNFs. However, as previous work on whey PNFs demonstrated 
successful thiolation of whey PNFs using Traut’s reagent [16], so it was decided to perform 
Traut’s reaction (Figure 3.9) on both whey, and crystallin PNFs to further confirm the lack of 
sufficient amine groups onto the surface of crystallin PNFs. The thiolation of PNFs (section 
7.6.5) and availability of sulfhydryl groups on the surface of modified PNFs was characterised 
via Ellman’s assay as detailed in section 7.6.3, and is shown in Figure 3.10.  
  
   
Figure 3.10. (i) OPA and (ii) Ellman’s assay for crystallin amyloid fibrils (CPNFs), and whey 
protein nanofibrils (WPNFs). Blank bars - initial readings, and filled bars - readings taken 
after treating with Traut’s reagent. Error bars represent the standard deviation of the mean of 
three replicates. 
As stated earlier, Traut’s reagent targets the primary amines present on the surface of the fibrils, 
therefore, crosslinking of Traut’s reagent to the free amino groups of the fibrils was also 
determined by assessing the decrease in amine-residue group availability, using the OPA assay 
(section 7.6.1). The addition of Traut’s reagent decreases the free amino group concentration 
on the surface of whey PNFs, Fig. 3.10(i), and increases the amount of free thiol groups on the 
surface of the whey PNFs as shown in Fig. 3.10(ii). For crystallin PNFs, addition of Traut’s 
reagent did not result in any increase in the amount of free thiol groups, as anticipated due to 
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This corroborates the observation that due to the lack of sufficient amine groups on the 
crystallin PNFs, any method involving amine groups cannot be used for functionalising 
crystallin PNFs. Traut’s reagent reaction chemistry is specific to amines and hence, it worked 
effectively for whey PNFs.    
Inefficient crosslinking via both lysine residues and thiols (results summarised in Table 3.5) 
suggested the need for other effective crosslinking methods. Previous work by Domigan 
(2012), had recommended that the possible glycosylation of the crystallin proteins could be a 
reason for the observed lack of crosslinking via amino groups [68]. In this work, crystallins 
were tested for presence of glycosylation and the possibility of using oxidised PNFs for 
creating functional fibril scaffolds was explored.   
3.6. Post translational modifications 
Several studies have shown that eye lenses grow throughout the lifetime of an individual, and 
significant changes occur in the structure and function of lenses with aging [88-93]. The major 
post-translational modifications include phosphorylation, truncation, deamidation, 
glycosylation, glycation, racemisation, isomerisation, deoxidation, acetylation, and 
carbamylation [77, 94-96]. The accumulation of all such post translational modifications in the 
lens proteins, specifically crystallins, is considered to be the major cause of cataract 
development [97]. The attachment of sugar residues is the most common [98] and complicated 
post-translational modification that a protein can undergo [99]. The attachment of 
carbohydrates or extended sugar chains to proteins can be attained both enzymatically 
(glycosylation), and non-enzymatically (glycation) [77]. Crystallin proteins are one of the 
important proteins subjected to glycosylation [100], and glycation [101] and are the possible 
target sites for crosslinking reactions.  
Glycation typically involves the addition of a carbohydrate to a protein via a reaction between 
reducing sugars and amine groups of proteins [102]. A reducing sugar may modify protein 
amine groups, such as those on lysine residues, through Schiff base formation followed by an 
Amadori rearrangement to give a stable ketoamine product [77] as shown in Figure 3.11. The 
aldehyde group of a reducing sugar first forms a Schiff base linkage with the amine group via 
a nucleophilic addition. The chemically unstable Schiff base then undergoes chemical 
rearrangement, resulting in the formation of a stable ketoamine (Amadori product).  
Amadori adduct formation is slow but much faster than the reverse reaction, leading to 
accumulation of Amadori glycation products on the protein [103, 104]. This results in a blocked 
amine containing a sugar derivative [77]. Although most proteins are glycated through their 
lysine residues [105], other sites for glycation may include side chains of arginine, histidine, 
tryptophan and cysteine residues [106].  
 




Figure 3.11. Schematic representation of a reaction between a reducing sugar and amine 
groups of proteins, such as those on lysine residues. A reducing sugar may modify protein 
amine groups, through Schiff base formation followed by an Amadori rearrangement to give a 
stable ketoamine product, Hermanson, (2013) [77]. 
In contrast to the glycation, lysine amine groups are not targeted directly in the case of 
glycosylation but, depending upon the attachment site of carbohydrates, it could hinder access 
to available amino acid residues of proteins. In glycosylation, one or several carbohydrate 
chains covalently attach to the amide group of asparagine residues (N-linked), or to hydroxyl 
groups of serine and threonine residues (O-linked) of the protein polypeptide chain [98, 107] 
(Figure 3.12).  
         
Figure 3.12. Common attachment sites for carbohydrate chains on glycoproteins, Hermanson, 
(2013) [77].  
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3.7. Crystallin proteins and glycosylation 
The presence of carbohydrates in crystallin proteins was investigated by staining SDS-PAGE  
with Pro-Q Emerald 300 staining solution (Molecular Probes, Invitrogen) (section 7.7), which 
reacts with periodate-oxidised carbohydrate groups, creating a fluorescent signal on 
glycoproteins (Molecular Probes, 2007). The detection of glycoproteins using Pro-Q Emerald 
300 stain has been reported to be suitable for sensitive direct fluorescence detection of 
glycoproteins in gels or electroblots [108]. The staining method is based on periodic acid-
Schiff’s base (PAS) reaction mechanism (discussed in section 3.7.1), and involves oxidation 
of glycols present in the glycoprotein to aldehydes using periodic acid, followed by staining 
with Pro-Q Emerald dye. The dye reacts with the aldehydes on the glycoproteins to generate 
the fluorescent conjugate which can be then visualised with 300 nm UV illumination [109].  
Crude crystallin proteins, along with crystallin PNFs were run on an SDS-PAGE (section 
7.1.1), and stained for glycoproteins using Pro-Q Emerald 300 staining solution (as detailed in 
section 7.7.1). GOX was also run as a positive glycoprotein control, as GOX is known to 
possess a carbohydrate shell [110]. A representative SDS-PAGE stained with Pro-Q Emerald 
300 is shown in Figure 3.13. Positive staining for glycoproteins was seen for the GOX control 
(Lane 1), and also for bands containing mixtures of crude crystallin proteins at a final 
concentration of 5 mg/mL in Lane 2, and 10 mg/mL in Lane 3. Similarly, positive staining was 
seen for crystallin PNFs which are too large to enter the gel, and so remain in the well at the 
top of the gel (Lane 4 and Lane 5).  
 
Figure 3.13. SDS-PAGE gel of crystallin proteins stained for glycoproteins. Lane 1 – Ladder, 
Lane 2 - GOX (glycoprotein positive control), Lane 3 - crude crystallin protein solution (5 
mg/mL), Lane 4 - crude crystallin protein solution (10 mg/mL), Lane 5 - crystallin PNFs (~5 
mg/mL), Lane 6 - crude crystallin PNFs (~10 mg/mL).  
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From these results, it can be confirmed that fish crystallin proteins do contain carbohydrates, 
which would at least hinder access to available amino acid residues of crystallin proteins and 
can be targeted for crosslinking reactions. Positive glycoprotein staining for crystallin proteins 
as indicated by the presence of the fluorescent bands (Figure 3.13) confirmed the presence of 
carbohydrate moieties in crystallin proteins, which could be potentially used for immobilisation 
reaction [77].  
3.7.1. Periodate oxidation of glycoproteins 
To achieve successful crosslinking via carbohydrate groups, periodate oxidation of 
carbohydrate residues was investigated (section 7.7.2). The periodate oxidation reaction also 
known as the Malaprade reaction [78], involves treatment of the glycoprotein with periodic 
acid or its salt in aqueous solution, such as sodium metaperiodate [111]. The reaction of sodium 
metaperiodate oxidises the vicinal diols in the glycoprotein and usually cleaves adjacent 
hydroxyl groups in sugar residues to create amine reactive aldehyde groups as shown in Figure 
3.14. The aldehydes obtained contain a highly electron-deficient carbon atom and are prone to 
nucleophilic attack, thus are an excellent target for the crosslinking reactions [112].  
 
Figure 3.14. Schematic representation of the oxidative cleavage of carbohydrates. Sodium 
metaperiodate can oxidise (a) internal diol groups, (b) terminal diol groups or (c) terminal 
hydroxylamine groups to yield aldehyde groups, Hermanson (2013) [77]. 
3.7.2. Periodate oxidation of crude crystallin proteins 
In order to investigate the effect of the sodium metaperiodate treatment, glycoprotein staining 
(section 7.7.1) was done on the crude crystallin proteins. Crude crystallin protein mixture was 
treated with different concentrations of sodium metaperiodate for 1 h, at 26 °C, in dark 
conditions (section 7.7.2) to prevent over oxidation and decomposition of periodate, leading to 
the production of more reactive species [113]. The oxidation reaction was done at pH 4.5, as 
the optimum pH for periodate oxidation reaction is considered to be between pH 3-5 [113].  
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To assess the extent of oxidation, crude crystallin proteins (~10 mg/mL) after treatment with 
sodium metaperiodate was run on the SDS-PAGE (section 7.1.1), and stained with Pro-Q 
Emerald 300 staining solution (section 7.7.1). A representative SDS-PAGE is shown in Figure 
3.15. Positive staining for glycoproteins was seen for the crude crystallin proteins (control-
Lane 1).  
With the increasing concentration of sodium metaperiodate - 10 mM (Lane 2), 20 mM (Lane 
3), 30 mM (Lane 4), 40 mM (Lane 5), and 50 mM (Lane 6) - a decrease in glycoprotein stained 
protein band on gel, and appearance of new bands in the well (Lane 5, 6, and 7) was observed, 
confirming the presence of oxidised proteins. This presence of a new band suggests the 
formation of protein aggregates, proposing that with higher concentrations of sodium 
metaperiodate, more aldehyde groups are generated. The presence of aldehyde groups in large 
amounts can lead to a number of intramolecular interactions [114] and aggregation of protein 
is either due to the amine to aldehyde or aldehyde to aldehyde linkages. 
 
Figure 3.15. SDS-PAGE gel of crystallin proteins (CPs) stained for proteins (left-hand image), 
and glycoproteins (right-hand image) after treatment with sodium metaperiodate. From left to 
right - Lane 1 - Ladder; Lane 2 - crude crystallin proteins-only; Lane 3 - CP + 10 mM sodium 
metaperiodate; Lane 4 - CP + 20 mM sodium metaperiodate; Lane 5 - CP + 30 mM sodium 
metaperiodate; Lane 6 - CP + 40 mM sodium metaperiodate; and Lane 7 - CP + 50 mM sodium 
metaperiodate. 
This intramolecular crosslinking of oxidised glycoproteins in the presence of multiple aldehyde 
and hydroxyl groups is well reported in literature [115], [116]. The appearance of new 
glycoprotein stained bands after treating crude crystallin protein mixture with sodium 
metaperiodate (Lane 2-Lane 6), compared to the untreated crystallin proteins (Lane 1) on the 
gel, confirms that the sodium metaperiodate treatment was effective for producing reactive 
aldehyde groups, which can be further targeted for immobilisation reactions.  
3.7.3. Periodate oxidation of crystallin PNFs  
Oxidation of crystallin PNFs was obtained by the same method used for crude crystallin protein 
mixtures.  
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The results obtained from crude crystallin protein treatment with sodium metaperiodate 
suggested that a final concentration of 30 mM sodium metaperiodate was effective to yield 
carbonyl groups, and higher concentrations may result in aldehyde-amine or aldehyde-
aldehyde linkages. Therefore, a final 30 mM concentration was used for oxidising crystallin 
PNFs (section 7.7.3). Crystallin PNFs at ~10 mg/mL concentration were treated with 30 mM 
of sodium metaperiodate solution prepared in sodium acetate buffer, pH 4.5 and incubated for 
2 h at room temperature. Considering that the availability of carbohydrate moieties can be 
different in fibrillar structures compared to the crude proteins in solution, thereby, incubation 
time of 180 min was preferred instead of 60 min used for crystallin protein solution to ensure 
that the reaction is complete with aliquots taken at regular intervals. As stated earlier during 
gel electrophoresis, due to size restrictions, PNFs remain in the well at the top of the gel, thus 
glycoprotein staining could not be used for confirming oxidation of crystallin PNFs. 
Alternatively, the 2, 4-dinitrophenylhydrazine (DNPH) assay was used to characterise 
aldehyde groups in oxidised crystallin PNFs.   
(a) DNPH assay to evaluate the oxidation reaction: The DNPH assay of carbonyl groups 
provides a convenient technique for detecting and quantifying oxidative modification of 
proteins [117]. DNPH reacts with protein carbonyls via a nucleophilic addition-elimination 
reaction to produce a bright orange or yellow hydrazine product, as illustrated in Figure 3.16.  
 
Figure 3.16. Schematic representation of DNPH reaction with protein carbonyl groups, 
producing a protein-DNP hydrazine product (yellow to orange solid) that can be detected 
spectrophotometrically [117]. 
In order to eliminate any unreacted sodium metaperiodate, treated fibrils were washed, 
centrifuged, and the pellet was re-suspended in PBS (pH 7.4). Initially, carbonyl group 
quantification was done as described by Levine et al. (1990) [117], and absorbance 
measurements of hydrazine derivatives of carbonyl groups formed by reaction with DNPH 
were made at a wavelength of 370 nm. As unbound DNPH itself absorbs at the same 
wavelength (370 nm) and could interfere with the results [117], care was taken to eliminate 
any residual DNPH.  
To remove any unreacted DNPH, extensive organic solvent washing of crystallin PNFs was 
done before taking measurements but still high background absorbance measurements were 
obtained, and is a common drawback for the DNPH assay [117]. Another approach usually 
used to remove any unbound DNPH from protein samples is via gel filtration [118]. However, 
gel filtration method was not feasible for PNFs, due to the size restrictions and thus a new 
method as described by Mesquita et al. (2014) (section 7.8) was used [119].  
76 |                                          Chapter Three – Characterisation of crystallin amyloid fibrils 
 
In this method, addition of NaOH to the reaction shifts the maximum absorbance of hydrazine 
derivatives of carbonyl group in oxidised protein from 370 to 450 nm and eliminates the 
interference of free DNPH [119]. 
(b) DNPH assay to characterise oxidised crystallin PNFs: The DNPH assay was done for 
periodate oxidised crystallin PNFs (section 7.8) and the absorbance was measured at 450 nm. 
The increase in absorbance at 450 nm for treated fibrils as compared to the untreated fibrils 
due to the formation of hydrazine derivatives of carbonyl groups, confirms that 30 mM sodium 
metaperiodate is effective in yielding carbonyl groups on the surface of oxidised crystallin 
fibrils, see Figure 3.17(i). Also, the DNPH assay was done on samples taken at different time 
intervals. The results obtained as shown in Figure 3.17(ii), indicate an increase in carbonyl 
groups over the time period of 2 h. The presence of carbonyl groups was detected after 30 min 
of the reaction, which further increased after 60 min of the reaction and reached a maximum 
within 120 min. Interestingly, there is a drop in absorbance for the sample taken at 180 min. 
This decrease over the longer duration is due to the formation of multiple aldehyde groups 
which are prone to a number of intermolecular reactions, thereby converting oxidised 
carbohydrate moieties into more stable forms [105]. 
 
 
Figure 3.17. (i) Carbonyl group availability assay for crude crystallin amyloid fibrils 
(CPNFs), before and after sodium metaperiodate treatment, absorbance was measured at 450 
nm, where sample a - carbonyl group availability of untreated CPNFs, and sample b - carbonyl 
group availability of CPNFs after sodium metaperiodate treatment (oxidised CPNFs). (ii) 
Carbonyl group availability characterised by the DNPH assay for deglycosylate/oxidised 
crystallin amyloid fibrils (CPNFs), over the time period of 2 h, absorbance measured at 450 


































    (i) 
   (ii) 
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After the periodate oxidation method development, the oxidation conditions chosen for 
crystallin PNFs were: a final concentration of ~10 mg/mL crystallin PNFs; with 30 mM final 
concentration of sodium metaperiodate solution; incubated for 120 min, at 26 °C in dark 
conditions. The oxidised crystallin PNFs were investigated further for immobilisation 
experiments (Table 3.5, c and d). For functionalising oxidised crystallin PNFs, aldehyde 
group-based crosslinking methods were studied. Aldehydes are electrophilic in nature due to 
the presence of electron-deficient carbon groups and thus are highly reactive towards 
nucleophilic functional groups, such as primary amines.  
3.8. Aldehyde group-based crosslinking reaction  
The reaction of an aldehyde with an amine proceeds with the formation of α-hydroxyamine 
intermediate, followed by spontaneous dehydration to form an imine or Schiff base (Figure 
3.18). This leads to the formation of a conjugate between the carbohydrate moiety of one 
protein and the amine groups of another protein. In this work, oxidised crystallin PNFs provides 
the carbohydrate group (aldehyde) and immobilisation of the enzymes was achieved by 
targeting their amine groups either via direct coupling reaction or reductive amination reaction. 
 
Figure 3.18. Schematic representation of direct coupling reaction of carbonyl groups with 
amine groups (a) the α-hydroxyamine intermediate formation followed by spontaneous 
dehydration to form an imine or Schiff base. However, carboxylate anion is a very poor target 
for nucleophilic attack, (b) the mesomeric effect from the hydroxyl group increases the electron 
density around the carbon, and (c) the likely predominance of the anionic carboxylate 
formation (around pH 5.5-6.5) prevent direct coupling reaction of aldehyde with amine [78]. 
3.8.1 Direct coupling reaction 
The aldehyde groups generated by the sodium metaperiodate oxidation (section 7.7.3) of 
crystallin PNFs can be coupled to the available amine groups on the surface of the enzyme via 
a direct reaction, generating an imine or Schiff base, Figure 3.18 (a). However, Schiff bases 
formed with amines are highly unstable and rapidly hydrolyses (reverses) in aqueous solution, 
[120], [121], and it is common practice to reduce the Schiff base to generate a secondary amine 
linkage (stable alkylamine linkage) instead, via a reductive amination reaction [122]. 
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3.8.2 Reductive amination reaction  
Reductive amination is usually fast and is very efficient method for obtaining stable secondary 
and tertiary amines [123]. In reductive amination, the Schiff base linkage obtained by the direct 
coupling of aldehyde with an amine is reduced to a stable, irreversible secondary amine bond 
by using a reducing agent as illustrated in Figure 3.19. The transformation of carbonyl groups 
to amines can be obtained either by direct reductive amination reaction or by indirect reaction. 
In the direct reductive amination reaction (Figure 3.19, scheme 1), both the conversion of a 
carbonyl compound to the intermediate imine and reduction of the intermediate imines formed 
to obtain stable amine linkages is carried on simultaneously in one step reaction only, in the 
presence of a suitable reducing agent. On the other hand, indirect reductive amination (Figure 
3.19, scheme 2) is a stepwise reaction, in which intermediate imine/Schiff base are formed first 
by the reaction between a carbonyl group and the primary amine. This intermediate is then 
reduced with a suitable reducing agent to obtain a stable amine.  
 
Figure 3.19. Schematic representation of the reductive amination reaction. Scheme 1 - shows 
direct reductive amination, when the carbonyl compound and the amine are mixed with the 
proper reducing agent without prior formation of the imine intermediate. Scheme 2 - shows 
indirect reductive amination, a stepwise reaction which involves the preformation of the 
intermediate imine followed by its reduction in a separate step, adapted from Cho and Kang, 
(2005) [124]. 
Several reducing agents and variety of methods [125-130] have been successfully used for the 
reductive amination reactions. Care should be taken while using a reducing agent depending 
upon if the reductive amination reaction is to be carried on directly or indirectly. For direct 
reductive amination, reducing agents that are more reactive towards intermediate imines than 
the carbonyl groups, and are stable under mild acidic conditions, such as sodium 
cyanoborohydride (NaBH3CN), and sodium triacetoxyborohydride (NaBH(OCOCH3)3 
(STAB) should be used [131], see Table 3.5 (d). 
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3.9. Conclusion 
The use of different amino acid availability assays for characterising crystallin PNFs was 
demonstrated. After successfully characterising crystallin PNFs for the available amino 
residues, different immobilisation methods were used to functionalise crystallin PNFs, 
including physical adsorption, crosslinking via amine-thiol groups, and aldehyde-based cross-
linking approach. GOX was successfully immobilised onto the crystallin PNFs via both 
physical adsorption and amine-thiol linking. The oxidised CPNFs were also successfully 
functionalised by GOX, and β-gal via indirect reductive amination, in the presence of STAB. 
However, none of these methods was consistent (Table 3.5), and thus a modified GA-based 
method in search of a reliable crosslinking approach was studied further (Chapter Four).  
Table 3.5. A brief summary of various crosslinking methods used for functionalising crystallin 
PNFs, with all the variables considered, and success rate for each of the crosslinking reaction, 
where  - good immobilisation efficiency,  - poor immobilisation efficiency, and Х - no 
immobilisation. 
(a) Physical adsorption  
Details Conditions/Variables Success/Comments 
Crystallin PNFs (10 mg/mL) 
were directly added to the 
enzyme (GOX)(section 7.9.1.1) 
Reaction: 
CPNFs + GOX (2 mg/mL) 
CPNFs + GOX (1 mg/mL) 









24 h reaction at 4°C. 
Comment: 
N/A for other enzymes 
 
(b) TCEP reduced PNFs: physical adsorption, and crosslinking via Sulfo-SMCC  
 
Details Conditions/Variables Success/comments 
Crystallin PNFs were treated 
with TCEP(section 7.6.4), and 
TCEP treated CPNFs (10 
mg/mL) were then added to the 
enzyme (GOX) - physical 
adsorption (section 7.9.1.2) or 




CPNFs + GOX (2 mg/mL) 
CPNFs + GOX (1 mg/mL) 











24 h reaction at 4°C. 
Х 
Comment: 
N/A for other enzyme, and 
reproducibility issues due to 
inefficient TCEP reduction. 
*Sulfo-SMCC is a highly reactive hetero-bifunctional crosslinker, with two distinct reactive groups: 
an amine-reactive N-hydroxysuccinimide (NHS ester) and a sulfhydryl-reactive maleimide group [77]. 
NHS esters react with primary amines at pH 7-9 to form stable amide bonds and maleimides react with 
sulfhydryl groups at pH 6.5-7.5 to form stable thio-ether bonds. Sulfo-SMCC chemistry is compatible 
with sulfhydryl residues, and was used to functionalise PNFs via sulfhydryl and amine residues of 
PNFs, and enzymes respectively, in order to overcome the problems faced due to the lack of lysine 
group availability of crystallin PNFs.  
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(c) Direct coupling reaction 
 
Details Conditions/Variables Success/Comments 
Crystallin PNFs were treated 
with sodium metaperiodate 
(section 7.7.3), and oxidised 
CPNFs (10 mg/mL) were then 
added to the enzyme 
(GOX)(section 7.9.3) 
Reaction: 








Rapid hydrolysis of Schiff 
bases formed resulting in 
inefficient crosslinking** 
**Direct coupling reaction: It is well reported in the literature that Schiff bases formed with amines 
rapidly hydrolysis (reverses) in aqueous solution and for achieving a successful conjugation, it is 
customary to reduce the Schiff base to a stable alkylamine linkage, known as reductive amination 
reaction [122].  
 
(d) Reductive amination reaction: In the presence of reducing agents  
Details Conditions/Variables Success/Comments 
Crystallin PNFs were treated 
with sodium metaperiodate 
(section 7.7.3), and oxidised 
CPNFs (10 mg/mL) were then 
added to the enzyme (GOX) in 
the presence of  
Sodium borohydride (section 
7.9.4.1) 
 (i) either added directly - I step 
reaction 
(ii) or after 15 min incubation 
of the enzyme with CPNFs - II 
step reaction. 
Reaction: 
In the presence of  
NaBH4 or  
H3BO3 activated NaBH4 
O-CPNFs + GOX (2 mg/mL) 
I step reaction 




25, 37, and 4 








***   
*** Reductive amination using NaBH4: The stability of NaBH4 in water is dependent on the pH of the 
solution and is believed that borohydride activity begins to be lost below pH 9 [78]. Thus, H3BO3 
activated NaBH4 was not used further for any reaction and care was taken to perform the reaction at 
around pH 9 (using 1M NaOH). Although the initial reaction was maintained at around pH 9, an 
interesting increase in pH was observed after 15 min of incubation time, to pH 9.6. The pH increase 
was caused by the hydrolysis of NaBH4 in water (equation 1), leading to the formation of the strongly 
basic meta-borate ion in the reaction [132] (see equation 2).   
                              NaBH4 + 2H2O                            NaBO2 + 4H2               …equation 1 
                                 BH4
- + 2H2O                               4H2 + BO2
-                          …equation 2 
Further, to prevent NaBH4 hydrolysis, reduction time was reduced to 5 min and alternatively 
experiments was done in the presence of solvents, in order to favour condensation of an amine with an 
aldehyde to form an imine [133](section 7.9.4.1), but successful immobilisation conditions could not 
be found. The use of NaBH3CN despite of its greater pH stability and selectivity was not used due to the 
toxicity associated with the NaBH3CN itself, as well as with the side products(hydrogen cyanide and 
sodium cyanide) formed during the reaction [134]. Alternatively, STAB was preferred as it is mild, 
convenient, and more reactive toward protonated imines than aldehydes [130]. Additionally, STAB is 
more selective of a reducing agent than NaBH4 at neutral or slightly acidic pH (pH 6)[130],[135]. 
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Details Conditions/Variables Success/Comments 
Alternatively,  
reductive amination reaction 
was done in the presence of 
sodium triacetoxyborohdyride 
(STAB): STAB was dissolved in 
isopropanol(section 7.9.4.2)              
Reaction:                                            
O-CPNFs + GOX (2 mg/mL)  










****Inefficient reductive amination reaction: Other factors contributing towards unsuccessful 
reductive amination include the presence of water in the reaction system, preventing formation of the 
intermediate imines or Schiff bases and decomposing the hydride reagent [135]. To compensate for any 
decomposed hydride, the reaction was done with additional amounts of STAB. In general, polar aprotic 
solvents, such as DME (dimethoxyethane), ACN, or THF (tetrahydrofuran) are considered suitable for 
this reaction [130]. The use of these solvents despite of their suitability was avoided in this work due to 
the fibril stability issues in polar aprotic solvents (as discussed in Chapter Two). Additionally, attempt 
to develop a practical complete solvent-based reaction system was also hindered by the poor solubility 
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Chapter Four 
Glutaraldehdye-based crosslinking of PNFs 
4.1. Introduction 
In this chapter learnings from the previous chapter were applied to functionalise crystallin 
PNFs. GA-based crosslinking of oxidised crystallin PNFs was developed to achieve a 
reproducible and versatile crosslinking method. To understand the potential of crystallin PNFs 
to act as a versatile nanoscaffold, a diverse range of industrially relevant enzymes including 
GOX, β-gal, pectinase, α-amylase, and laccase (section 3.2, Chapter Three) were studied. The 
extent of functionalisation was evaluated using gel electrophoresis (SDS-PAGE), TEM, 
enzyme-activity assays, thermostability and reusability studies.  
4.2. GA-based crosslinking  
GA as shown in Figure 4.1. is one of the most commonly used and studied homo-bifunctional 
crosslinking agents for immobilising enzymes [1]. Glutaraldehyde has had great success as a 
crosslinker because of its commercial availability, low cost, and high reactivity [2, 3]. 
 
                                           Figure 4.1. Structure of glutaraldehyde [1]. 
Crosslinking by GA is based on the availability of free amino groups on the surface of the 
enzyme, mainly provided by lysine and arginine amino acids [4]. However, GA is known to 
react not only with amine groups but with several other functional groups of proteins, 
including, thiol, phenol, imidazole moieties, and with itself [5]. The mechanism by which GA 
reacts with proteins is still under debate [1],[6], and several studies have revealed that GA in 
aqueous solutions can exist in more than one molecular forms such as a monomer, dimer, trimer 
or polymer, leading to many different possible reaction mechanisms [3]. The possible reaction 
mechanism could progress either via a Schiff base formation (see Figure 3.18, Chapter Three) 
or via the formation of a pyridinium crosslink as illustrated in Figure 4.2.  
 
As discussed earlier (section 3.6, Chapter Three), both glycosylation and glycation could result 
in a blocked amine by a sugar derivative [1]. The results from glycoprotein staining and 
aldehyde group-based assay suggested the presence of carbohydrate groups on the surface of 
crystallin PNFs (section 3.7, Chapter Three).  
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Thus, in the first part of this chapter, GA binding to the oxidised crystallin PNFs will be 
discussed, and results from the amine and aldehyde group-based assays will be presented to 




Figure 4.2. Proposed mechanism of GA crosslinking via the formation of pyridinium crosslink, 
Meade et al. (2003) [6].  
 
As the structure of the glycoprotein shell in crystallin PNFs is unknown, the presence of 
carbohydrates may influence the binding of GA to surface lysine residues, by limiting access 
of the crosslinker to free amino groups (section 3.6, Chapter Three). Therefore, an additional 
treatment based on periodate oxidation using sodium metaperiodate was used (section 7.7.3) 
to expose lysine (-NH2) groups on the surface of the PNFs (Figure 3.14, Chapter Three),
 in 
order to create free amine moieties to react with the GA. The effect of periodate oxidation on 
the availability of lysine residues for crosslinking was assessed using the amino group-based 
assays (as discussed earlier in Chapter Three, section 3.3.1, and 3.3.2), OPA assay (section 
7.6.1), and the ninhydrin assay (section 7.6.2). The results of these assays are summarised in 
Table 4.1. 
Table 4.1. Summary of calculated amino group availability of crude crystallin PNFs, using the 
OPA and ninhydrin assays. Sample concentration is calculated from a standard curve obtained 
using lysine, therefore values were multiplied by two to obtain the amino group concentration.  
Sample OPA assay (µM) Ninhydrin assay (µM) 
Crude crystallin protein 324± 20 327±21 






Crude crystallin protein 
fibrils 




Oxidised crude crystallin 
protein fibrils 
104±21                           98±13                            
*All the samples used above were at the concentration of 10 mg/mL. 
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As ascertained by each of two assays, an increase was observed in the amino group availability 
of the oxidised crystallin PNFs indicating that deglycosylation/oxidation was successful. These 
results are in agreement with the results obtained by the DNPH assay (section 3.7, Chapter 
Three, and further experiments were conducted to assess GA binding to the oxidised crystallin 
PNFs.  
4.2.1. GA-activation of crystallin PNFs 
The conditions chosen for GA-activation of oxidised crystallin PNFs were based on a 
previously established method of GA-based crosslinking for insulin PNFs [7, 8]. The reaction 
was done using a starting concentration of ~10 mg/mL oxidised crystallin PNFs, with a starting 
concentration of 2.5 mM GA in PBS (pH 7.4), at 26 °C for 1 h (section 7.10). Previous work 
done by Pilkington et al. (2010), has shown that GA crosslinking occurs very quickly under 
the chosen conditions [9]. Thus, 1 h was selected as the reaction time to achieve efficient 
crosslinking, whilst preventing aggregate formation.  
Due to the high reactivity of GA and as the crosslinking targets are the same on both proteins 
(enzymes and crystallin PNFs-mainly lysine groups), GA crosslinking can lead to the formation 
of large, often poorly defined protein aggregates if the reaction is not completed in a controlled 
way [10]. Hence to obtain effective crosslinking and to avoid the formation of aggregates, a 
two-step GA-activation protocol was used (section 7.10). In two-step protocol the GA is first 
reacted with one of the proteins, creating an activated protein, followed by the addition of the 
second protein. This protocol limits the intramolecular crosslinking, and maximises the 
intermolecular crosslinking [1]. The chemical procedure used for GA-based covalent 
crosslinking on the modified crystallin PNFs is illustrated in Figure 4.3, and is useful for the 
attachment of any moiety containing free surface amine groups to the nanoscaffold.  
 
Figure 4.3. Schematic representation of functionalised crystallin PNFs showing crosslinking 
(top) - where crosslinker (GA) is first attached to oxidised crystallin PNFs, followed by the 
addition of biomolecule/enzyme, and non-covalent association (bottom) - where 
enzyme/biomolecule is physically adsorbed onto the oxidised crystallin PNFs via side chains 
of available amino acids (lysine, cysteine, carboxylic acid groups). 
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The functionalisation of CPNFs, including surface modification and enzyme immobilisation, 
was achieved via a three-step process. The first step involves the surface modification of the 
CPNFs via periodate oxidation (refer to section 3.7.3, Chapter Three), followed by two-step 
GA- activation process (illustrated in Figure 4.3), leading to the covalent attachment of the 
enzyme to the newly introduced functional groups. In addition to the covalent crosslinking via 
GA, physical adsorption (non-covalent association) was also investigated for immobilising 
enzymes onto the oxidised crystallin PNFs. The concentration of GA present can also have a 
major influence on the crosslinking reaction and procedure needs to be thoroughly investigated 
to achieve optimised conjugation. Therefore, it was decided to remove any excess or unreacted 
GA after 1 h incubation, by washing the GA-treated oxidised crystallin PNFs, and recollecting 
the fibrils by centrifugation. The collected GA-activated fibrils were then resuspended in PBS 
(pH 7.4) (section 7.10). To demonstrate that GA-activated oxidised crystallin PNFs could be 
collected by centrifugation, a ThT assay was done, and OPA and DNPH assays were used to 
determine the extent of GA binding.  
4.2.2. ThT assay for characterising GA-activated crystallin PNFs 
The ThT assay was done as detailed in section 7.1.2. This assay is pH dependent [11], therefore 
GA-activated oxidised PNFs and oxidised PNFs were re-dissolved in ThT buffer (pH 8.0), 
prior to the ThT assay. Upon centrifugation, the fluorescence of the supernatant (sample c) 
compared to the initial fluorescence of the crystallin amyloid PNFs dropped to about the level 
of the blank solution (sample d), containing ThT only (Figure 4.4). Upon comparing the ThT 
fluorescence of the oxidised crystallin PNFs (sample a) with GA-activated oxidised crystallin 
PNFs (sample b), no significant change in ThT fluorescence can be observed. This confirms 
that centrifugation can be used to collect PNFs and GA does not have any negative impact on 
the native β-sheet conformation of the PNFs. 
 
Figure 4.4. ThT fluorescence of crystallin PNF samples (CPNFs), where a - oxidised CPNFs- 
initial, b – GA-activated oxidised CPNFs-collected after centrifugation, c - supernatant 
collected post-centrifugation, and d - blank solution containing ThT dye and buffer only as a 
control. All measurements were carried out in triplicate and the errors bars represent the 



















93 |                                          Chapter Four – Glutaraldehyde-based crosslinking of PNFs 
 
4.2.3. Amino group characterisation of GA-activated crystallin PNFs 
To investigate the extent of GA binding to the oxidised crystallin PNFs, the OPA (section 7.6.1) 
and ninhydrin assays (section 7.6.2) were used. The result obtained as shown in Figure 4.5 (i), 
suggests that the number of free amino groups has decreased upon addition of GA to the 
oxidised crystallin PNFs samples (sample c), as compared to the oxidised crystallin PNFs only 
(control-sample b) consistent with successful conjugation to GA.  
                                   
                                  
Figure 4.5. (i) Amino group availability assays for crude crystallin PNFs, where grey bars - 
OPA assay, absorbance measured at 340 nm and black bars - ninhydrin assay, absorbance 
measured at 570 nm. Sample a - crystallin PNFs, b - oxidised crystallin PNFs, and c - GA-
activated oxidised crystallin PNFs. (ii) Carbonyl group availability of oxidised crystallin 
amyloid fibrils (O-CPNFs) characterised by DNPH assay, absorbance measured at 450 nm, 
where a - GA + O-CPNFs (at time, 0), b - GA + O-CPNFs (after an h), c - GA + O-CPNFs 
(post-centrifugation in pellet), d - unbound GA + buffer (post-centrifugation in supernatant). 
Error bars represent the standard deviation of the mean of three replicates. 
4.2.4. DNPH assay to evaluate GA binding  
The DNPH assay (section 7.8) was done to assess if there was any decrease in aldehyde group 
availability of GA, during the reaction. After 1 h incubation, the aldehyde group availability 
upon GA binding to the oxidised crystallin fibrils compared to the initial value of the oxidised 
































     (i) 
     (ii) 
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The presence of aldehyde groups in the pellet (due to the GA binding) and in the supernatant 
(due to the excessive unbound GA, being removed) further confirms that GA has been 
successfully crosslinked. Both the amino group-based assay and the DNPH assay support that 
oxidised crystallin PNFs can be effectively activated by using GA. However, there are some 
discrepancies between the GA binding results obtained from the amine-based and aldehyde-
based (DNPH) assay. The extent of GA binding as indicated by the OPA assay (section 4.2.3 - 
decrease in the value after the reaction with GA) is dissimilar to the value evaluated from the 
DNPH assay. There is a significant amount of decrease in aldehyde group availability of GA 
after the reaction (supernatant sample (d) – Figure 4.5 (ii)), which is less likely to be possible 
only through lysine-amine linkages, as lysine group availability on the surface of oxidised 
crystallin PNFs (as characterised by the OPA assay, Table 4.1) is not equivalent to the amount 
required for the observed reduction in aldehyde group availability of GA.  
The results implicates that GA binding is not necessarily occurring via lysine-amine linkages 
and is possible that some other binding is also occurring. As explained in section 4.1, it is 
difficult to state the exact reaction mechanism for the GA binding, and is likely that some 
aldehyde-aldehyde linkage is also occurring between the aldehyde groups of the oxidised 
crystallin PNFs and the GA, known as an aldol condensation reaction [4]. Figure 4.6 shows 
some fundamental aldol condensates of GA, formed in aqueous solution [12].  
                    
Figure 4.6. Structures of monomers and polymers forms (cyclic and open chain hemialdals, 
hydrates, and aldals) (repeating units) of GA in aqueous solution (above dotted line), and some 
fundamental aldol condensates drawn in their aldehyde group form (below the line), Holmquist 
and Lewin (1991) [12].  
 
“The success of GA as a crosslinking agent is based on the large number of different types of molecules present 
simultaneously in the reagent solution” - Peters et al. (1977) [13]. 
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4.3. Functionalising CPNFs with GOX - a model enzyme system  
To investigate enzyme immobilisation onto GA-activated crystallin PNFs, GOX was used as a 
model enzyme. As mentioned earlier (section 3.2.1), the GOX dimer has 5 lysine residues 
potentially available for crosslinking.  
4.3.1. GOX-GA crosslinking method development 
To study the impact of GA on GOX activity, GOX at the starting concentration of ~2.2 mg/mL 
was incubated with 0.5 mM, 1 mM, and 2 mM GA solution prepared in PBS (pH 7.4) in 1:1 
ratio, for 1 h at 26 °C. The SDS-PAGE (Fig. 4.7) was done (section 7.1.1), followed by the 
GOX activity assay (see Appendix B, Section B1.1) to investigate the impact of GA binding on 
the activity of the enzyme (GOX). 
 
Figure 4.7. SDS-PAGE of GOX crosslinked intramolecularly, using different concentrations 
of GA for 1 h at 26°C. L - Ladder, Lane 1 - 0 mM GA, Lane 2 - 0.5 mM GA, Lane 3 - 1 mM 
GA, and Lane 4 - 2 mM GA.  
GOX runs as a single protein band at ~80 kDa upon SDS-PAGE (Figure 4.7, Lane 1). When 
GOX is crosslinked to another molecule of GOX with GA (Lane 2) there is a decrease in the 
protein band at ~80 kDa, and a new larger protein band at ~160 kDa appears, indicating 
crosslinking and dimer formation. This provides evidence that GOX at ~2.2 mg/mL (starting 
concentration) has sufficient lysine groups available for crosslinking even when using the 
lowest final concentration of 0.5 mM GA. To assess the impact of GA binding on the GOX 
activity, the Amplex Red assay was done (Appendix B, section B1.1) on the samples used for 
SDS-PAGE (Figure 4.7). The GOX activity assay (Figure 4.8) shows no significant difference 
between GOX only (sample a) and GOX with GA samples. This suggests that the addition of 
GA does not affect or interfere with the readings of the Amplex Red reagent. However, a small 
negligible increase was observed in absorbance readings on the addition of GA (sample b, c 
and d compared to sample a). 
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Figure 4.8. Activity of GOX when crosslinked to another GOX molecule for 1 h at 26 °C with 
different concentrations of GA, where a - GOX + 0 mM GA, b - GOX + 0.5 mM GA, c - GOX 
+ 1 mM GA, and d - GOX + 2 mM GA.  
This observed increase in the presence of GA is likely to be caused by the production of an 
auto-fluorescent reaction product of GA on reaction with proteins. GA has been used 
previously for inducing auto-fluorescence in microscopy studies [14]. The auto-fluorescent 
product is characterised by a broad emission spectrum from 475-700 nm and therefore can be 
detected at the wavelength used for the Amplex Red assay (450-485 nm). 
4.3.2. Immobilising GOX onto GA-activated crystallin PNFs 
GA-activated oxidised crystallin PNFs at a concentration of ~10 mg/mL was incubated with 
~2.2 mg/mL of GOX in 1:1 ratio (250 µL each) for 1 h at 26 °C, and the reaction was quenched 
with an equal part of 100 mM Tris buffer (pH 8.0) (section 7.11.1). The crosslinked samples, 
and controls were evaluated with SDS PAGE (Figure 4.9). The SDS-PAGE shows that when 
GOX is immobilised to the GA-activated oxidised crystallin PNFs, the GOX band (Lane 3), as 
compared to the GOX only control (Lane 1) and GOX with oxidised crystallin amyloid fibrils 
only (Lane 2), cannot be seen. This is due to amyloid fibrils being large and insoluble are 
unable to enter the polyacrylamide gel, as shown by the oxidised crystallin PNFs controls 
(Lanes 4 and 5). Thus, if GOX has been successfully immobilised to the fibrils, the immobilised 
GOX cannot enter the polyacrylamide gel [8].  
The SDS PAGE in Figure 4.9, therefore, provides evidence that GOX can be immobilised to 
GA-activated oxidised crystallin PNFs. To establish how much GOX activity was associated 
with the crystallin PNFs, the samples from Figure 4.9 were tested using the Amplex Red 
activity assay (Figure 4.10). The GOX-functionalised crystallin PNF samples were centrifuged 
to collect the PNFs, and the supernatant retested for GOX activity (Appendix B, section B1.1). 
To ensure that after subsequent washes no activity is found in the supernatant and rest of the 
enzyme is crosslinked to the CPNFs, activity assays were also done on the supernatant collected 
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Figure 4.9. SDS-PAGE of GOX immobilisation onto GA activated oxidised crystallin amyloid 
fibrils (O-CPNFs). L - Ladder; Lane 1 - GOX only (control), Lane 2 - GOX + O-CPNFs, Lane 
3 - GOX + GA activated O-CPNFs, Lane 4 - O-CPNFs only, and Lane 5 - GA activated O-
CPNFs. Highlighted section correspond to the molecular weight of GOX. 
As shown in Figure 4.10, ~9% of the GOX activity is lost after centrifugation even in the 
absence of fibrils. When GOX is immobilised to the GA-activated crystallin amyloid fibrils 
(sample c), ~67% more GOX activity is centrifuged with the GA-activated oxidised crystallin 
PNFs. Upon comparison of the activity of the supernatant of the samples, GOX with GA 
activated oxidised crystallin PNFs has significantly less activity in the supernatant, ~21% 
which demonstrates the effectiveness of the immobilisation. As expected, no GOX activity was 
detected for crystallin PNFs only (sample d) and for GA activated crystallin PNFs (sample e), 
implying that the presence of GA is not interfering with the GOX activity assay. This provides 
evidence that there is active GOX immobilised to the PNFs. 
 
Figure 4.10. Amplex Red activity assay for GOX-functionalised GA-activated O-CPNFs, 
where grey bars - initial GOX activity and black bars - GOX activity in the supernatant (after 
centrifugation), where a - GOX only (control), b - GOX + O-CPNFs, c - GOX + GA activated 
O-CPNFs, d - O-CPNFs only, and e - GA activated O-CPNFs. Error bars represent the 


















98 |                                          Chapter Four – Glutaraldehyde-based crosslinking of PNFs 
 
The results in Figure 4.10, also demonstrate that when GOX is incubated with oxidised 
crystallin PNFs (with and without GA-sample b and c), the initial activity (grey bars) of the 
enzyme is almost completely preserved, implying that the presence of crystallin PNFs does not 
inhibit activity. Both the SDS-PAGE and the activity assay done for characterising immobilised 
samples, provides evidence that GOX has been successfully covalently immobilised to the 
PNFs. 
Table 4.2. The amount of activity retained in the supernatant for GOX immobilised onto the 
GA activated CPNFs sample, collected after second wash as determined by the Amplex Red 
assay (Appendix B, section B1.1).  
Sample GOX activity% 
Supernatant 1(After first wash) 21±9 
Supernatant 2 (after PNFs washed twice) 8±4 
Note: All measurements were carried out in triplicate and the errors bars represent the standard deviation of the 
mean. No activity was observed in the supernatant after the third wash.  
4.3.3. TEM as a tool to investigate GOX-functionalised crystallin PNFs 
Once GOX had been immobilised to the GA-activated crystallin PNFs, TEM was used to assess 
any change in the morphology of the amyloid fibrils (section 7.1.3). The representative images 
of the structure and morphologies of GOX-functionalised amyloid fibrils and controls as 
viewed under TEM are shown in Figure 4.11.  
TEM images of GOX alone show a cloudy pattern as grid assembly and staining may cause the 
GOX dimer to be in a denatured anhydrous state (Figure 4.11- c). The addition of GA causes 
the formation of denser cloud structures (Figure 4.11- d). When GOX is added to oxidised 
crystallin PNFs, there is some association (Figure 4.11- e and f). The sample with GOX 
covalently crosslinked to GA activated oxidised crystallin amyloid fibrils shows an increased 
association, as expected (Figure 4.11- g and h). It is important to consider that not all GOX is 
immobilised to the fibrils, as cloudy structures (Figure 4.11- g) similar to those observed in 
the GOX only sample are visible. The results obtained are in agreement to similar study done 
on GOX functionalised insulin PNFs by Pilkington et al. (2010) [9], who reported that GOX 
appeared as small round structures on the fibrils (as can be seen in Figure 4.11- g and h) and 
overall fibril morphology remained unchanged upon the addition of GOX and GA. 
4.4. Crystallin PNFs as a versatile biomolecule nanoscaffold 
After successfully immobilising GOX, the reproducibility and versatility of this method was 
further investigated by immobilising other commercially important enzymes: β-gal, pectinase, 
α-amylase and laccase. The concentrations of other enzymes were chosen so that they offered 
a comparable amount of amine groups as accessible by GOX at ~2.2 mg/mL for the 
crosslinking reaction (see section 7.11.2). 
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Figure 4.11. Representative TEM images of GOX crosslinked samples and controls, where a -  
O-CPNFs, b - GA activated O-CPNFs, c - GOX only, d - GOX + GA, e and f - GOX + O-
CPNFs, and g and h - GOX + GA activated O-CPNFs. Scale bar is 200 nm. 
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4.4.1. Method development for functionalising CPNFs with other important 
industrial enzymes. 
As described in (section 3.2), the surface of all the enzymes used in this work, do have lysine 
residues theoretically available for crosslinking with GA. Enzyme concentration was 
determined by using Bradford assays (section 7.1.5) and the amino group availability via the 
OPA assay (section 7.6.2) for all the enzymes. For the crosslinking reaction, the GA-activated 
CPNFs (10 mg/mL) were mixed with enzymes in 1:1 ratio, and incubated for 1 h at 26 °C 
(section 7.11.2). 
4.4.2. Characterisation of functionalised crystallin PNFs 
(a) Gel electrophoresis: After the crosslinking reaction had taken place, crosslinked samples 
and associated controls were analysed by SDS-PAGE (section 7.1.1) to confirm that enzymes 
had been successfully immobilised to the crystallin PNFs. As stated earlier, if enzymes have 
been successfully immobilised to the PNFs, they cannot enter the polyacrylamide gel. The 
results of the SDS-PAGE for each of the enzymes used for the crosslinking experiments are 
shown in Figure 4.12. The SDS-PAGE results for (a) β-gal, (b) pectinase, (c) α-amylase, and 
(d) laccase immobilised samples as shown in Figure 4.12, illustrates that when enzyme is 
added to the crystallin PNFs (non-covalent association, Lane 2), the protein bands appear to be 
similar to the enzyme only protein bands (Lane 1). However, when the enzyme is covalently 
crosslinked to the GA-activated CPNFs, there is a significant decrease in the protein band 
intensities as compared to the controls (Lane 1 and 2). The SDS-PAGE results suggest that the 
enzymes have been covalently crosslinked to the GA-activated CPNFs. The SDS-PAGE results 
(Figure 4.12 (a) for β-gal, and 4.12 (b) for pectinase), show several other protein bands in 
addition to the bands corresponding to the molecular weight of the native enzyme, implicating 
impurities associated with the enzymes. 
 
Figure 4.12. SDS-PAGE of (a) β-Gal, (b) Pectinase, (c) α-Amylase, and (d) Laccase 
immobilisation onto GA-activated oxidised crystallin PNFs (O-CPNFs). L - Ladder; Lane 1- 
Enzyme only (control), 2 - Enzyme + O-CPNFs, 3 - Enzyme + GA-activated O-CPNFs, 4 - O-
CPNFs only, and 5 – GA-activated O-CPNFs. Highlighted sections (white) corresponds to the 
molecular weight (kDa) of the enzymes, and black indicates the presence of other protein bands 
due to impure enzyme preparations. 
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The enzyme preparations used in this study were obtained commercially and very little 
information is available on either the purity of the enzyme or on the method of purification. An 
attempt was made to purify pectinase, which resulted in 65% loss of pectinase activity. It is not 
an unexpected result as previous studies have shown that commercial enzymes are not purified 
further in order to retain maximum activity [15]. Hence, the commercial enzymes were used as 
such, without any further purification, as purification often results in poor yield of the enzyme, 
frequently below 10% of the activity of the original material [15] and also to ensure that the 
process was relevant and scalable in a commercial setting, in which a purification step may 
prove prohibitively expensive.   
(b) Activity assay based characterisation: To establish how much enzymatic-activity was 
associated with the functionalised crystallin PNFs, the samples from Figure 4.12 were assayed 
for activity (Appendix B, section B1.1 - B1.5). Firstly, the activity of all samples was tested in 
solution, and then in order to test the extent of crosslinking, the samples were centrifuged to 
collect the amyloid fibrils, and the supernatant retested for activity using enzyme-specific 
activity assays. For β-gal activity, the o-nitrophenyl-β-D-galactoside (ONPG) assay was used 
(section B1.2). The activity of pectinase was determined by the 3, 5-dinitrosalicyclic acid 
method (DNS assay) [16] using pectin as a substrate (section B1.3). For determining the 
activity of free and immobilised amylase (section B1.4), DNS assay was used for measuring 
the amount of reducing sugar produced using starch as a substrate, in addition to the potassium 
iodide (KI) assay (results shown in Appendix E, Figure E1). The activity of crosslinked laccase 
samples were assayed by monitoring the absorbance increase from oxidation of syringaldazine 
at 530 nm (section B1.5) [17].  
The Bradford assay (section 7.1.5) was used for determining the initial protein concentration 
and protein concentration in the supernatant (post-centrifugation), to assess the amount of 
enzyme being immobilised. An initial activity reading was taken for each of the samples and 
this was used as the 100% value. The results obtained from the enzyme-specific activity assays 
presented as a relative percentage of the initial reading, and the protein concentration (mg/mL) 
as determined by the Bradford assay for each of the crosslinked enzyme samples are shown in 
Figure 4.13.  
Upon centrifuging, only enzymes crosslinked to the fibrils were collected and any free enzymes 
remained in the supernatant. The decrease in both the activity and protein concentration from 
the initial value to the supernatant samples upon immobilisation (Figure 4.13 (i-iv), sample c) 
demonstrates the extent of the crosslinking. When enzymes are covalently crosslinked to the 
GA-activated crystallin PNFs, the samples (sample c) show a significant drop in enzymatic 
activity and protein concentration, in agreement with the electrophoretic studies when 
comparing to the enzyme only samples (Figure 4.13 (i-iv), sample a). This confirms that when 
enzyme is added to the GA-activated crystallin PNFs, covalent crosslinking does indeed occur. 
A slight drop was also observed when the enzymes were added to the crystallin PNFs in the 
absence of GA (Figure 4.13 (i-iv), sample b), which can be attributed to non-covalent 
association or physical adsorption of the enzyme on to the PNFs. 
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Figure 4.13. Bradford (black bars) and activity (grey bars) assay studies of functionalised 
CPNFs and control samples, where a - enzyme only, b - enzyme + CPNFs (non-covalent 
association), and c - enzyme + GA-activated CPNFs (covalent crosslinking). (i) β-Gal, (ii) 
Pectinase, (iii) α-Amylase, and (iv) Laccase samples. 
The amount of enzyme being immobilised onto crystallin PNFs and activity retained by the 
immobilised enzyme for all the enzymes used for crosslinking experiments, as determined from 
Figure 4.13, is shown in Table 4.3. The immobilisation efficiency and retained activity results 
(Table 4.3) indicate a very good correlation between the protein concentration and activity-
based assays. 
Table 4.3. The amount of the enzyme immobilised onto crystallin PNFs - CPNFs (non-covalent 
association), and GA activated crystallin PNFs- GA-CPNFs (covalent crosslinking).  
    Enzyme  Crosslinked 
samples 
Immobilisation efficiency% Retained activity% 
     β-Gal CPNFs 15  ± 2 8.0 ± 6 
GA-CPNFs 46  ± 8 36  ± 8 
  Pectinase CPNFs 17  ± 2 12  ± 3 
GA-CPNFs 43  ± 9 34  ± 7 
 α-Amylase CPNFs 10  ± 2 10  ± 4 
GA-CPNFs 56  ± 4 59  ± 4 
   Laccase CPNFs 16  ± 9 9.5 ± 7 
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The amount of immobilised enzyme was calculated using the following equation: E Immobilised = 
(E Loaded - E Supernatant) and is represented as IE = [(E Immobilised )/( E Loaded )] × 100, where IE (%) 
is the immobilisation efficiency, and E Immobilised (mg/mL) is the amount of enzyme immobilised 
onto crystallin PNFs. E Loaded is the initial concentration of enzyme, and E Supernatant (mg/mL) is 
the concentration of enzyme in the supernatant as determined by using the Bradford method 
(section 7.1.5). The amount of activity retained by the immobilised enzyme was calculated as: 
Retained activity = Activity (Initial - Supernatant), where initial activity of all enzymes was 
given an activity of 100%, and activity in supernatant is the sum of enzymatic activity retained 
in the supernatant after wash 1 and wash 2 respectively, as determined by enzyme-specific 
activity assays (Appendix B) and represented as a relative percentage values.  
For all the enzymes used in this work, covalent crosslinking using GA-activated CPNFs yielded 
better immobilisation efficiency rates as compared to the non-covalent association (Table 4.3). 
Additionally, the activity assay results suggest that the covalent crosslinking of enzymes onto 
GA-activated crystallin PNFs does not have any adverse impact on the activity of the 
immobilised enzymes. GOX, α-amylase and laccase crosslinking resulted in better 
immobilisation efficiencies as compared to the β-gal and pectinase, with GOX (section 4.3.2) 
showing the maximum retained activity ~67%. The poor immobilisation efficiency and activity 
retention values of β-gal and pectinase as compared to the other enzymes is likely due to the 
impure enzyme preparation (see SDS-PAGE image, Figure 4.12). Studies have shown that the 
purity of the enzyme has a significant impact on the activity and effectivity of immobilisation 
[18, 19].  
(c) TEM investigation of functionalised crystallin PNFs: TEM was used (section 7.1.3) to 
investigate the morphology of the functionalised crystallin PNFs (Figure 4.14).  
 
Figure 4.14. Representative TEM images of β-gal-functionalised GA activated oxidised 
crystallin amyloid fibrils (O-CPNFs). Sample a - β-gal-only, b – GA-activated O-CPNFs, and 
c and d - β-gal + GA-activated O-CPNFs. Scale bar is 200 nm. 
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Upon immobilisation of β-gal to the amyloid fibrils, the presence of rounded structures was 
seen, suggesting successful functionalisation of crystallin PNFs (sample c and d) as compared 
to GA-activated crystallin PNFs only (sample b). Similar results were also seen for pectinase, 
α-amylase, and laccase functionalised CPNFs (Figure 4.15). The TEM results provide 
corroborating evidence of successful functionalisation of activated CPNFs, without having any 
adverse impact on the morphology of the fibrils.  
 
Figure 4.15. Representative TEM images of functionalised crystallin PNFs, and controls 
viewed at 89,000 × magnification. From top, Row 1 - Pectinase, Row 2 - α-Amylase, and Row 
3 - Laccase, where sample a, d and g - native enzyme; sample b, e and h – GA-activated 
CPNFs; and sample c, f and i - enzyme + GA-activated CPNFs (covalent crosslinking). Scale 
bar is 200 nm.  
4.5. Impact of functionalisation  
The thermal inactivation of native enzymes is one of the important limitations for their 
application in industrial settings. The possible effect of using crystallin PNFs as nanoscaffolds 
for immobilising enzymes on the preservation of enzymatic activity upon heating was 
investigated using α-amylase-functionalised crystallin PNFs. α-Amylase samples were 
considered instead of pectinase samples as α-amylase had better immobilisation yield and also 
because α-amylase was relatively pure enzyme preparation as compared to the pectinase.  
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4.5.1. α-Amylase-functionalised crystallin PNFs VS free α-amylase 
For the thermostability experiments, samples were pre-heated at 40, 55, and 75 °C over 24 h, 
followed by cooling at room temperature immediately, prior to the activity measurements 
(section 7.12). The activity of all individual samples at time zero were given an activity of 
100%, and subsequent measurements were compared relative to this measurement (Figure 
4.16).  
 
Figure 4.16. Thermostability studies of α-amylase-functionalised crystallin PNFs at (a) 40 °C, 
(b) 55 °C, and (c) 75 °C, over the time period of 24 h, where black bars – 100% activity at t = 
0, blue bars - covalent crosslinking, green bars - free enzyme, and red bars - non-covalent 
association. 
The results (Figure 4.16) show that as the temperature increases, the stability of the free 
enzyme reduces rapidly as compared to the immobilised form. At 40 and 55 °C (Figure 4.16 
(i) and (ii)), the covalently immobilised α-amylase retains ~65-75% of its activity after the 
time period of 24 h, whilst the free enzyme (α-amylase), retains ~40-45% activity. At 75 °C 
(Figure 4.15 (iii)), the covalently immobilised α-amylase retains ~55% of its relative activity, 
compared to ~15-20% for the free enzyme. When α-amylase is associated to CPNFs without 
any crosslinker (non-covalent association), only ~3% activity is retained at 40 and 55 °C and 
complete loss of activity is observed at 75 °C. This decrease or complete loss of activity 
suggests the inactivation of enzyme caused by the denaturation and the leakage of enzymes 
from crystallin PNFs due to heating and diffusional effects (common limitations of adsorption 
method, as discussed earlier in section 1.4, Chapter One). In contrast, at all the selected 
temperatures, 40 °C, Figure 4.16 (i), 55 °C, Figure 4.16 (ii), and 75 °C, Figure 4.16 (iii), the 
sample which retains the greatest relative activity is the sample where α-amylase is covalently 
immobilised to the crystallin PNFs using GA. These results suggest that covalent crosslinking 
using GA is an effective method for functionalising crystallin PNFs without any major loss of 
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4.5.2. Effect of GA on thermostability of crystallin PNFs functionalised with 
α-amylase 
To investigate the impact of GA alone on the thermal stability of crosslinked samples, activity 
assays using the same conditions were also done on the GA crosslinked α-amylase samples (α-
amylase and GA only, without crystallin PNFs) (section 7.12) (Figure 4.17).  
The samples containing GA crosslinked α-amylase retained about the same amount of activity 
as the free α-amylase control, implying that the presence of GA is not providing the increase 
in thermostability and therefore, it is most likely that this improved thermostability is due to 
the PNFs. Increased thermal stability has been reported for a number of immobilised enzymes, 
and the support material is thought to preserve the tertiary structure of the enzyme providing 
conformational benefits, which protects the enzyme against heat denaturation [20]. Previous 
work by Raynes et al. (2011) reported a significant increase in the relative thermostability of 
organophosphate hydrolase (OPH) activity when it was crosslinked to the insulin PNFs, both 
in the presence and absence of GA [8]. However, in contrast to these results no increase in 
temperature stability was observed when organophosphate hydrolase was crosslinked to the 
crystallin PNFs using GA [8].  
 
Figure 4.17. Thermostability studies of free α-amylase (green bars), and α-amylase in the 
presence of GA (red bars) at (a) 40 °C, (b) 55 °C, and (c) 75 °C, over the time period of 24 h. 
The activity of all individual samples at time zero were given an activity of 100% (black bars). 
The loss in relative activity was characterised by using starch-iodine assay, absorbance 
measured at 620 nm. Error bars represent the standard deviation of the mean of three 
replicates. 
This is not an unexpected result as multipoint interaction between the protein molecule and the 
matrix during immobilisation often involve some structural readjustment on the part of the 
protein molecule. Enzymes immobilised on the same support by the same method can behave 
differently. In a previous study by Sardar et al. (1997), successful immobilisation of a variety 
of enzymes to polymeric support resulted in varied thermostability results [21]. Therefore, it is 
likely that the increased stability of α-amylase is because of the way it is orientated upon 
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Additionally, glycosylated crystallin PNFs were used for the crosslinking studies by Raynes et 
al. (2011) in contrast to the de-glycosylated/oxidised crystallin PNFs used in this work. De-
glycosylated crystallin PNFs have more functional groups available for the effective 
crosslinking, therefore, leading to the better covalent crosslinking as observed by this method. 
4.6. Storage stability and reusability of crystallin PNFs functionalised with 
α-amylase 
The operational stability of immobilised enzymes is one of the most important factors affecting 
the utilisation of an immobilised enzyme system. In order to investigate the enzyme-
nanoscaffold, the α-amylase-functionalised crystallin PNFs were examined by using the same 
conditions repeatedly 4 times over the time period of 30 days, with samples being washed, and 
stored at 4 °C in between each use (section 7.13). The measured activities are shown in Figure 
4.18. The relative activity of immobilised enzymes (Figure 4.18) shows an initial drop over 
the first two days, with an activity loss ranging from approximately 10-15%. It was observed 
that the covalently bound enzyme demonstrated overall activity loss of approximately ~18% 
after 4 runs over the time period of 30 days.  
 
Figure 4.18. Timecourse of % activity of α-amylase-functionalised CPNFs, stored at 4 °C, over 
the time period of 30 days, where grey bars - amount of starch hydrolysed, as characterised by 
starch-iodine assay, and black bars - amount of reducing sugars produced as detected by the 
DNS assay. 
In general, enzymes in solution are not stable and their activity decreases gradually. The 
activity measurements were also carried out for the free enzyme stored at 4 °C for a period of 
16 days using the same conditions. The free enzyme lost all its activity within 16 days (Figure 
4.19). Kahraman et al. (2007) has previously reported a complete loss of free α-amylase 
activity at 4 °C within 15 days [20]. These results indicate that the catalytic activity of the 
immobilised α-amylase is preserved over consecutive uses and immobilised α-amylase retains 
~80% of its activity for at least 30 days without any inconsistency in results. Sohrabi et al. 
(2014) reported that α-amylase immobilised on modified magnetite nanoparticles retained 
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Retained activities of α-amylase immobilised on various other supports, such as beads or 
microspheres, and hybrid materials were previously stated as 75-90% after 25 days of storage 
[20], [23-25]. The result suggests that the covalent crosslinking method developed here has 
improved the stability of α-amylase and helps to maintain the activity longer.  
 
Figure 4.19. Storage stability of free α-amylase. The loss in activity was characterised by using 
starch-iodine assay, absorbance measured at 620 nm. Error bars represent the standard 
deviation of three replicates. 
4.7. Conclusion 
Crystallin PNFs show potential as a versatile nanoscaffold for active biocatalysts. For all the 
enzymes used in this work, regardless of the size, tertiary or quaternary structure, catalytic 
activity, and substrate recognition, the covalent attachment of the enzyme via GA was found 
to be more effective than the non-covalent association. The degree of immobilisation and 
retained catalytic activity post-immobilisation differed between biomolecules; however, no 
significant loss in the activity of immobilised enzymes was noticed.  
A thermostability study resulted in the immobilised α-amylase displaying better 
thermostability than the free enzyme. The covalent attachment of the enzymes onto crystallin 
PNFs also resulted in improved stability and reusability. The GOX- and β-gal-functionalised 
crystallin PNFs were further investigated for use in a model biosensing application, such as the 
creation of a glucose and a lactose based electrochemical sensing platform (see Chapter Five, 
Part A). The future goals of this research should include extending this functionalisation 
method to other functional moieties, growth factors and biomolecules, as well as using the 
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Chapter Five 
An investigation into the use of amyloid PNFs 
5.1. Introduction 
This chapter combines the experimental approaches of the previous two chapters to investigate 
the creation of materials with surface-assembled amyloid PNFs. Modifying surfaces (metal, 
glass or cellulose) by attaching amyloid PNFs can provide an easy way for the handling and 
recovery of the nanoscaffold, while retaining the benefits of an increase in surface area [1], and 
can also lead to the development of novel amyloid fibril-based functional materials. The self-
assembling nature of amyloid PNFs, and availability of intrinsic side chain chemistry from 
their amino acid composition, could also potentially allow for a bottom-up approach to 
functional bionanomaterial design [2, 3]. Amyloid fibrils obtained from crystallin and whey 
protein (as detailed in section 7.2) and functionalised PNFs (prepared via crosslinking as 
detailed in Chapter Three and Four) were used to investigate the creation of materials with 
surface-assembled PNFs. 
 
The first part of this chapter, focuses on the development of a PNF-based biosensing element.  
Both GOX- and β-gal-functionalised PNFs were used to modify Au electrodes, and cyclic 
voltammetry (CV) was done for glucose and lactose analysis. In the next section, to create 
materials with surface-assembled PNFs, PNFs were assembled on glass surface and 
characterised by a range of methods, to establish whether the simple methodology developed 
by Raynes (2012) [4] for creating surfaces with self-assembled insulin PNFs is applicable to 
PNFs obtained from other protein sources. The surface-assembled amyloid fibril nanoscaffold 
was then functionalised with a biotechnologically important enzyme, such as β-gal leading to 
the making of active bionanomaterial. The last part of this chapter explores PNFs for designing 
biomaterials with potential applications in tissue engineering. In addition to the PNFs, native 
proteins (crystallin, and whey) were also used to prepare silk-protein composite films, followed 
by characterisation and cell growth studies.
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Part A- Construction of a biosensing element for glucose and 
lactose detection 
5.2. Biosensors  
One of the main analytical applications of immobilised enzymes is to develop enzyme-based 
biosensors [5]. The most widely accepted definition of a biosensor is: “a self-contained 
analytical device that incorporates a biologically active material in intimate contact with an 
appropriate transduction element for the purpose of detecting (reversibly and selectively) the 
concentration or activity of chemical species in any type of sample”[6]. Biosensing is the 
detection and quantification of biological and chemical species, and is crucial for many areas 
of healthcare, clinical medicine, food safety, and environmental monitoring [7]. The use of 
high surface area nanomaterials in the sensing technology has allowed fabrication of biosensors 
with improved sensitivity, and faster response times [8, 9]. A range of nanostructures such as 
NPs, nanowires, NTs, nanoribbons, nanorods, nanobelts and nanosheets have been explored 
extensively in the construction of biosensors with set applications of biosensors 
nanotechnology for biological and chemical analysis [10].  
 
There have been some previous investigations into the use of nanomaterials as immobilisation 
scaffolds for the creation of enzyme electrode sensors, specifically using PNTs/PNFs such as 
nanotubes from the FF peptide [11, 12], the ionic complementary peptide EFK16-11 [13], 
fluorescent antibody nanotubes [14], cysteine-containing peptide nanofibrils [15], and more 
recently from the whey PNFs [16]. One of the advantages of using PNFs is that they can interact 
with a gold surface (electrode) via thiol groups, without any surface modification [11]. On the 
surface of the gold electrode, the amyloid fibrils interact with the gold surface via sulfhydryl 
groups, and an enzyme (GOX, and β-gal in this study) is in turn covalently bound to the 
amyloid fibrils, via the crosslinker, as illustrated in Figure 5.1.  
 
Figure 5.1. A schematic representation of Au electrode modified with PNFs. Functionalised 
PNFs can self-assemble onto metal electrode, such as Au via available sulfhydryl groups. 
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In this work, crystalllin PNFs – the industrially relevant amyloid forming protein was used to 
develop a biosensing platform for glucose and lactose detection, and the potential of dual-
functionalised whey PNFs was also investigated for developing a lactose-based sensor.  
5.3. Surface-assembly of functionalised PNFs - Towards biosensing 
As a proof of concept, and to verify the immobilisation of GOX and β-gal onto crystallin PNFs, 
electrochemistry studies were done on GOX- and β-gal-functionalised CPNFs. The 
electrochemical behaviour of the functionalised crystallin PNFs was examined using CV 
(section 7.14) in the presence of the mediator ferrocenemethanol (FcOH) (1.5 mM in PBS, pH 
7.4). Under normal circumstances, direct electron transfer between the active site of reduced 
GOX and a metal electrode takes place slowly or not at all because the gap between the active 
site and the electrode surfaces is too large for electron transfer [17]. Thus, an electron transfer 
mediator is used to overcome this problem. Ferrocene is usually used as an electron acceptor 
mediator, and derivatives of ferrocene being soluble in water are the largest class of one 
electron oxidants due to their water solubility properties [17]. In this work, FcOH (a ferrocene 
derivative) was used as a mediator because it can penetrate the active site of GOX [18]. Also, 
FcOH can be used in solution, unlike ferrocene which is water insoluble and thus, can diffuse 
freely between the enzyme and electrode [17]. 
For electrochemistry experiments, commercial screen-printed electrodes with an appropriate 
connector from DropSens (Oveido, Spain) were used. The functionalised crystallin PNFs were 
deposited onto the gold electrode, and the excess solvent evaporated (section 7.14). Modified 
electrodes were prepared fresh before each experiment for consistency.  
The catalytic activity of the modified electrodes with GOX-functionalised crystallin PNFs was 
quantified in the presence of excess glucose (500 mM), using FcOH as a mediator in solution 
(section 7.14.1). In the presence of GOX, glucose is oxidised to gluconolactone in the solution 
being examined. Electron transfer from the reduced enzyme to the gold electrode then occurs 
via the mediator molecule present, in this case FcOH solution. In the electron transfer reaction, 
ferrocenes are one electron oxidising systems, however, glucose/gluconolactone is two electron 
and two proton system. Thus, two equivalents of ferrocene and ferrocenium are involved in the 
reaction.  
The catalytic activity of the modified electrode can be expressed as the current amplification 
(CA), defined by:    
                                            CA= (iFcOH + iFcOH + Glu)/ iFcOH 
Where, iFcOH is the anodic peak current recorded at the electrode in the absence of glucose 
(for the mediator alone), and iFcOH + Glu is the anodic peak current recorded in the presence 
of glucose (mediator + Glucose) [19]. A typical cyclic voltammogram of the electrode response 
to glucose (500 mM) in a FCOH mediator is shown in Figure 5.2. 
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Figure 5.2. A typical cyclic voltammogram of the electrode response to glucose (500 mM) in 
a FCOH mediator (1.5 mM) (red-FcOH + Glu) and to the mediator (black-FcOH) alone. 
5.4. Response of single enzyme-based electrodes modified with 
(a) GOX-functionalised crystallin PNFs - GOX immobilised via adsorption 
onto reduced, and non-reduced crystallin PNFs  
The influence of the presence of the PNFs on current amplification was examined by 
comparing the average current amplification in the presence of excess (500 mM) glucose for 
the GOX-only modified gold electrodes (Au/GOX), and the GOX-functionalised amyloid fibril 
modified gold electrodes (Au/GOX-CPNFs for non-reduced crystallin amyloid fibrils, and 
Au/GOX-CPNFs-SH for reduced crystallin PNFs, obtained via TCEP treatment – refer Table 
3.5, Chapter Three). The GOX-only control was created by the same methods as detailed in 
section 7.14.1, with the exception that only GOX was deposited, and any anchorage of the 
enzyme to the electrode surface was due to nonspecific adsorption.  
The GOX sample used was diluted in PBS to obtain the same activity as of the functionalised 
PNFs used for modifying electrodes. The average CA in the presence of 500 mM glucose for 
each of these three samples is shown in Figure 5.3. An increase in CA value was observed 
when using GOX-functionalised crystallin fibrils as compared to adsorbed GOX-only, 
suggesting an increase in enzyme immobilisation due to the large surface-to-volume ratio of 
the amyloid fibril nanoscaffold. Similarly, an increase in the CA response was also observed 
for Au/GOX-CPNFs-SH electrode, where the electrode was modified using GOX-
functionalised reduced crystallin PNFs. 
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Figure 5.3. Average current amplification (CA) for GOX modified gold electrode (Au/GOX), 
and gold electrode modified with functionalised PNFs, where (a) – Au/GOX, (b) - Au/GOX-
CPNFs (gold electrode modified with non-reduced crystallin PNFs), and (c) - Au/GOX-
CPNFs-SH (gold electrode modified with reduced crystallin PNFs). Each value represents the 
average of three replicates, with error bars representing the standard deviation of the mean of 
three replicates. 
This increase was in agreement with the activity assay results that suggested better 
immobilisation efficiency for crystallin fibrils reduced via treatment with TCEP (Table 3.5, 
b). The other potential reason for this increase in current response could be due to the better 
attachment of reduced PNFs to the gold surface because of sulfhydryl-metal interactions as 
compared to physical adsorption only. This increase in the anchorage of the thiolated whey 
PNFs to the gold electrode has also been reported previously [16]. 
It should be noted that there was quite high error for the GOX-only modified electrodes as 
compared to the electrodes modified using PNFs. This is due to the GOX getting washed away 
and repeated use of GOX-only modified electrode resulting in lower responses. In contrast, 
washing and repeated use of the modified electrode resulted in little reduction in the observed 
response, indicating that the fibrils are well adhered to the gold electrode and the electrode is 
reusable. 
(b) Functionalised crystallin PNFs obtained via GA-based immobilisation  
The single enzyme based electrochemistry reaction was also done with functionalised CPNFs 
obtained via GA-based crosslinking (as discussed in Chapter Four). Two separate electrodes 
were prepared using GOX (section 7.14.1) and β-gal-functionalised CPNFs (section 7.14.2) for 
glucose and lactose analysis respectively, followed by CV (section 7.14).  
The ferrocene mediated electrochemical reaction for each of the enzyme system is illustrated 
in Figure 5.4. The electrochemical response for both glucose and lactose analysis is based on 
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For glucose sensing, immobilised GOX catalysis the oxidation of glucose using oxygen as an 
electron acceptor, leading to the production of H2O2 (equation 5.1). The H2O2 produced is then 
electrochemically detected at the electrode surface [20]. For lactose analysis, immobilised β-
gal cleaves lactose producing glucose and galactose, and the released glucose is cleaved further 
by the dissolved GOX (see equation 5.2).The current produced due to GOX catalysis reaction 




Figure 5.4. A schematic representation of ferrocene mediated electrochemical reaction, where 
equation 5.1 and 5.2 represents electrochemical reactions specific to glucose and lactose 
respectively.  
In the presence of analytes (glucose and lactose, red line) (Figure 5.5), the anodic current was 
amplified due to the catalytic oxidation of glucose by GOX modified electrode (Au/GOX-GA-
CPNFs) (Figure 5.5 (i)), and lactose by β-gal modified electrode (Au/β-gal-GA-CPNFs) 
(Figure 5.5 (ii)), mediated by FcOH. In the absence of analyte, no change in response due to 
the presence of functionalised crystallin PNFs in the ferrocene mediator solution was detected 
for Au electrodes modified with functionalised PNFs. These results, in agreement with the gel 
electrophoresis and solution activity assays (Chapter Four), confirm that GOX and β-gal were 
successfully crosslinked to the GA activated CPNFs. The electrochemistry results indicate that 
the functionalised crystallin PNFs retain activity when deposited on Au surface and are able to 
electrochemically react with the respective analyte i.e. glucose for GOX-, and lactose for β-
gal-functionalised PNFs. 
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Figure 5.5. Cyclic voltammogram of the functionalised crystallin PNFs (CPNFs) modified 
electrodes: (i) GOX-functionalised CPNFs (ii) β-gal-functionalised CPNFs in the absence 
(black line) and presence (red line) of excess glucose and lactose respectively (500 mM), using 
1.5 mM FcOH.  
(c) A comparative analysis - Free enzyme vs functionalised crystallin PNFs 
 
Previous studies have shown that the use of nanoscaffolds as a biosensing element can increase 
the overall sensitivity and stability of enzymatic biosensors [21, 22]. Thus, electrochemistry 
experiments were done to study the influence of functionalised crystallin PNFs on current 
amplification by comparing the electrode response in the presence of excess analyte for the 
enzyme-only modified Au electrodes, and the enzyme-functionalised crystallin PNFs modified 
electrodes (Figure 5.6). An increase in current response was observed (Figure 5.6 (i)) when 
using GOX-functionalised crystallin PNFs as compared to adsorbed GOX-only, proposing 
better enzyme attachment to the electrodes and an increase in immobilised enzyme due to the 
large surface-to-volume ratio of the crystallin PNF nanoscaffold.  
 
      (i) 
     (ii) 
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The results obtained are in agreement to a similar study done on whey PNFs, where several 
different variations of a glucose biosensing platform using PNFs obtained from WPI were 
investigated [16]. However, for the electrode modified with β-gal-functionalised crystallin 
PNFs, no significant difference was observed in current response in the presence of crystallin 
PNFs as compared to adsorbed β-gal-only (Figure 5.6 (ii)).     
 
  
                   
 
Figure 5.6. Comparison of electrodes modified with (i) GOX-, and (ii) β-gal-functionalised 
crystallin PNFs. with free enzyme, enzyme attached via non-covalent association, and enzyme 
covalently crosslinked onto the modified crystallin PNFs using GA. Potential sweep rates are 
100 mV s-1, using an Au counter and Ag pseudo-reference electrode. 
      (i) 
     (ii) 
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This difference in electrochemical behaviour of GOX-, and β-gal-functionalised crystallin 
PNFs could be due to the lower enzyme immobilisation efficiency for β-gal as compared to the 
GOX sample used (refer to Chapter Four, Table 4.3). Additionally, in contrast to the glucose 
analysis where GOX was immobilised onto the electrode, for lactose analysis GOX (equation 
5.2) was dissolved within the lactose solution, and could be responsible for the observed 
difference in current response as GOX was not present in close vicinity.   
5.5. Dual-functionalised amyloid fibrils 
To explore if the two enzymes could be bound to the same PNFs scaffold and function in a co-
operative manner, dual-functionalisation of PNFs was also investigated. The utilisation of dual-
functionalisation has several applications and advantages e.g. using a dual enzyme system 
enables a high local concentration of substrates in the microenvironment of an enzyme system, 
leading to kinetic advantages [23]. Reduced diffusion time of the substrate and significant 
enhancement in the sensitivity for co-immobilised enzyme based biosensing platform have 
been demonstrated previously, such as co-immobilisation of histamine dehydrogenase and 
putrescine oxidase enzymes onto screen printed electrode allowed selective, and sensitive 
determination of histamine, and putrescine (biogenic amines produced by microbial 
decarboxylation)[24].  
Further, GOX and β-gal were co-immobilised onto whey PNFs to obtain a dual-functionalised 
PNFs. Dual-functionalised PNFs were then used to evaluate if the presence of both enzymes 
on the same nanoscaffold (whey PNFs) improves electrode sensitivity for lactose analysis. 
Lactose is a disaccharide consisting of glucose and galactose units bonded through a β-1→4 
glycosidic linkage, and is most notably found in milk. Lactose analysis is often used to 
evaluate the quality of milk [25], and a precise control of lactose levels is also important 
because of the lactose intolerant population [26]. Therefore, lactose quantification is vital for 
both food industry and public health.  
To obtain dual-functionalised PNFs, both one step (simultaneous), and sequential 
immobilisation of GOX and β-gal was studied, via GA-based crosslinking. After the 
crosslinking reaction, SDS-PAGE and activity assays were used to determine the extent of 
crosslinking.  
5.5.1. Dual immobilisation crosslinking reaction 
Based on the results of amino group availability assays (section 3.4.1) suggesting the presence 
of lysine groups on the surface of whey PNFs, it was decided to use GA as a crosslinking agent 
for the co-immobilisation of GOX and β-gal onto whey PNFs. Different reaction orders, and 
conditions were initially investigated to optimise the crosslinking reaction. After the 
crosslinking method development, the immobilisation conditions chosen were: a starting 
concentration of 10 mg/mL whey amyloid fibrils (100 μL); with a starting concentration of 7.5 
mM GA (100 μL); and a starting concentration of 2 mg/mL GOX (50 μL), and 4.2 mg/mL β-
gal (50 μL); incubated for 1 h at 37 °C and quenched with 100 μL of 100 mM Tris buffer (pH 
8.0) (section 7.11.3). SDS-PAGE (Figure 5.7) was done for the immobilised enzyme samples 
to assess the extent of crosslinking. 
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SDS-PAGE shows that when enzymes (GOX+β-gal) are co-immobilised to the whey PNFs 
using GA (Fig. 5.7 - Lane 4 to Lane 8, different reaction orders as detailed in Table 5.1) the 
intensity of enzyme bands, when compared to the positive control (Lane 3 - enzyme + GA in 
the absence of whey PNFs), decreased, suggesting that the enzymes has been immobilised and 
therefore, were not able to enter the gel due to size restrictions.  
 
Figure 5.7. SDS-PAGE for the co-immobilisation reaction for whey PNFs via GA. L-Ladder; 
Lane 1 - Enzyme-only sample (GOX+β-gal); Lane 2 - Enzyme + WPNFs; Lane 3 - Enzyme + 
GA; Lane 4 to Lane 8 - Enzyme + GA + WPNFs, different reaction orders studied as detailed 
below in Table 5.1; Lane 9 - WPNFs + GA sample. Highlighted section correspond to the 
molecular weight of the enzymes in the presence of GA, and GA + WPNFs. 
Table 5.1. Summary of GOX-, and β-gal-functionalised PNFs activities, as determined by the 
enzyme-specific activity assays, where arrow indicates 15 min incubation time, at 37 °C. GOX 
activity was determined by using Amplex Red assay (Appendix B, section B1.1), and ONPG 
assay (Appendix B, section B1.2) was done for β-gal activity, for all the samples used for dual-
immobilisation reaction.  




1 ENZ+PBS+PBS 100 100 
2 ENZ+PBS+WPNFs 92±3 94±1.8 
3 ENZ+GA+PBS 91±2 93±3 
4 WPNFs+GA      Enz 48±14 52±9 
5 ENZ+WPNFs+GA 32±11 31±8 
6 GOX+WPNFs       GA+β-gal 34±13 38±4 
7 β-gal+WPNFs      GA+GOX 36±9 34±14 
8 GOX+WPNFs       GA      β-gal 32±3 38±5.9 
9 WPNFs+GA+PBS - - 
*The values given are the approximate values calculated from the activity assays and represented as 
% of initial activity remained after washing the fibrils (3X), with error represented as standard 
deviation of the mean of three replicates. Total reaction time was 1h, with samples kept at 37 °C.  
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5.5.2. Activity of dual-functionalised WPNFs 
To quantify the amount of enzyme that was being immobilised to whey PNFs in the presence 
of GA, activity assays were done on the immobilised enzyme samples pre- and post-
centrifugation, yielding the relative activity/amount of both the enzymes immobilised to the 
whey amyloid fibrils. Table 5.1, details different reaction orders used for the co-immobilisation 
reaction, and also the relative activity of the enzyme immobilised (via each reaction) onto the 
whey PNFs. As can be seen, the sample which had the most activity (48% of GOX and 52% 
of β-gal activity) associated with the whey PNFs was sample 4, where enzymes and whey PNFs 
were incubated first with GA for 15 min, followed by the addition of enzymes (GOX+β-gal). 
The activity assay results confirm that GA can be used to covalently immobilise both GOX and 
β-gal to whey PNFs in one step reaction.  
5.5.3. Lactose analysis using dual-functionalised WPNFs 
Dual-functionalised whey PNFs were used to prepare PNF-based electrodes as detailed in 
section 7.14, and investigated to analyse lactose. The catalytic activity of the modified 
electrodes was quantified in the presence of excess lactose (500 mM), using FcOH as a 
mediator in solution (section 7.14.3). The dual-functionalised whey PNFs sample chosen for 
electrochemistry studies was that prepared by one step reaction i.e. sample 4, Table 5.1, due 
to better immobilisation yield. The approach for determining lactose concentration was based 
on the electrochemical reaction as shown in equation 5.2 (Figure 5.4), and is illustrated in 
Figure 5.8.  
          
Figure 5.8. Mechanism of action of the Au electrode with dual-functionalised whey amyloid 
PNFs in the presence of lactose. Immobilised β-gal cleaves the disaccharide lactose, producing 
glucose and galactose. The glucose reacts with the immobilised GOX to produce H2O2. The 
sensor functional principle is based on FcOH oxidation by H2O2 at the Au electrode, as 
electron transfer from the reduced enzyme to the Au electrode occurs via ferrocene mediator 
and current response measured by using CV. 
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(a) Response of Au electrodes modified with dual-functionalised PNFs  
The enzyme-only control sample was created by the same method used for single enzyme 
electrochemistry studies, with the exception that a mixture of both the enzymes (GOX+β-gal) 
was physically adsorbed onto the electrode surface (see 7.14.3).     
                       
                          
Figure 5.9. Cyclic voltammogram of the dual-functionalised whey PNFs (WPNFs) modified 
electrodes: (i) Comparison of lactose responses for dual-functionalised whey PNFs (red line) 
where enzymes (GOX+β-gal) are covalently crosslinked onto whey PNFs using GA, with free 
enzyme attached onto the electrode via adsorption (black line). (ii) Comparison of lactose 
responses for bare electrode (Au) in the absence (red line), and in the presence of whey PNFs 
(green line - 1 mg/mL; and blue line - 2 mg/mL), where the signal is solely caused by the 
ferrocene mediator (1.5 mM FcOH). Potential sweep rates are 100 mV s-1, using an Au counter 
and Ag pseudo-reference electrode. 
(i) 
(ii) 
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The enzyme sample used was diluted in PBS (pH 7.4) to have the same activity in solution, as 
determined by the activity assays for the WPNFs-GA-Enz (GOX+β-gal) sample used. Dual-
functionalised whey PNFs were also adsorbed onto the Au electrodes to obtain PNF-based 
electrode (section 7.14 and 7.14.3). Similar to the results obtained with the single enzyme-
based electrodes, an increase in current response was observed (Figure 5.9 (i)) for the electrode 
with dual-functionalised whey PNFs (red line) as compared to the adsorbed enzyme mixture-
only (black line), ascertaining the advantages of using PNFs in biosensing applications. A 
control voltammogram for Au (bare electrode), and Au electrode with whey PNFs at different 
concentrations, in the presence of lactose, are also shown in Figure 5.9 (ii).  
(b) Electrochemical response as a function of lactose concentration 
Further, the electrochemical response studies of Au/WPNFs-GA-Enz electrode (electrode 
modified with dual-functionalised PNFs) was done as a function of lactose with different 
concentrations from 0–100 mM at scan rate of 100 mV/s, using a single electrode for all the 
concentrations, and electrochemical response detected via CV technique (section 7.14). The 
corresponding calibration curve (inset (a), Fig. 5.10) shows the magnitude of peak current 
increased with increasing lactose concentration. These current values were used to form the 
calibration plot (concentration vs current – Figure 5.10). A linear working range of the 
Au/WPNFs-GA-Enz electrode shows linear response to lactose from 0.3 to 2.5 mM as shown 
in Figure 5.10, with linear regression coefficient of 0.976.  
        
Figure 5.10. A linear graph between lactose concentration and value of current obtained from 
CV with different concentration of lactose (0-100 mM). Inset (a) the electrochemical response 
of Au/WPNFs-GA-Enz electrode as a function of lactose concentration showing variation from 
0.0-2.5 mM. Detection limit (LOD) of the fabricated Au/WPNFs-GA-Enz electrode for lactose 
analysis was calculated from slope of the curve (using 3 sigma method) and was found to be 
0.53 mM.   
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5.6. Conclusion 
The electrochemistry work done on both functionalised crystallin, and whey PNFs has shown 
that functionalised PNFs can be self-assembled onto Au electrodes leading to the creation of 
an amyloid fibril-based biosensing element. The voltammograms with GOX-functionalised 
crystallin PNFs, and dual-functionalised whey PNFs exhibited an increase in anodic peak 
current response in the presence of PNFs, compared to free enzyme attached to the electrodes 
via adsorption suggesting an increase in enzyme loading due to the improved surface-to-
volume ratio in the presence of PNFs. These results look promising for the development of 
PNF-based biosensing platform with improved sensitivity and also provide a useful step 
towards understanding the potential applications of functionalised PNFs, and other protein 
nanostructures with similar surface chemistries, in the biosensor field. Future work is needed 
for improving sensitivity and selectivity of dual-functionalised PNFs based electrode, and to 
use dual-functionalised PNFs for simultaneous detection of both the analytes (glucose and 
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Chapter Five 
Part B- Surface-assembled PNFs and industrial applications 
5.8. Surface-assembly of PNFs 
Two methods by which immobilisation of amyloid PNFs to different surfaces can be achieved 
are – adsorption (as demonstrated in Part A) and covalent bonding. The fibrils self-assembly 
process relies on a nucleated growth mechanism (section 1.6.2) [1]. Considering that, the 
surface-assembly process developed in this project was based around covalent immobilisation 
of amyloid seeds to the surface, from which mature amyloid PNFs can then assemble. An 
overview of the template-directed protein nanofibril surface-assembly process is shown in 
Figure 5.11. First, the material surface (glass beads) is derivatised to allow binding of the 
amyloid template, followed by self-assembly of the PNFs, which can leads to formation of the 
mature amyloid PNFs from the bound seeds. The surface assembled PNFs can then be 
functionalised with biomolecules to create novel nanomaterials.  
 
Figure 5.11. Overview of template-directed amyloid fibril surface-assembly process. First the 
surface (glass beads) is chemically derivatised, followed by covalent binding of the seeds, 
which can leads to assembly of the mature PNFs from the bound seeds. The surface assembled 
amyloid fibrils can then be decorated with biomolecules (enzymes in this case) by either 
physical adsorption or covalent coupling. 
5.8.1. Derivatisation of glass surface 
Glass (SiO2) was chosen as a model surface as glass chemistry is well understood [2], and 
derivatisation methods can be directly applied to other organic materials used as a support for 
covalent enzyme immobilisation, including cellulose because of the similar surface chemistry 
in the form of the hydroxyl groups [3]. Additionally, bovine insulin PNFs have previously been 
self-assembled on a glass surface [4], and the transparency of glass allows for 
spectrophotometric assays to be used.  
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Most of the surfaces used need to be chemically modified to create active surfaces which can 
be then readily functionalised. Surface activation or modification depends upon the 
immobilisation/functionalisation method to be employed. For example, the surface of gold is 
activated with aminoethanethiol for the covalent immobilisation of the enzymes [5] or 
alternatively can be modified by alkanethiols for facilitating enzyme adsorption [6]. In this 
work, to chemically activate glass surface before assembling PNFs, amine functionalisation of 
the glass surface was achieved by a chemical treatment with 3-aminopropyl triethoxysilane 
(APTS). APTS is an organo-functional silane that has a non-hydrolysable amino group, and 
three ethoxy groups which can react with the surfaces containing hydroxyl groups, followed 
by a condensation reaction to create an aminated surface coating (Figure 5.12) [7]. In the case 
of APTS modified glass, the reaction is self-catalysed by the amine groups of APTS. The APTS 
reaction is often a preferred choice for modifying glass surfaces as it offers a chemical link 
between the silane and the glass surface, and not a physical coating of molecules on the surfaces 
as in other surface immobilisation approaches [8]. 
Firstly, to remove all contaminants and to generate surface hydroxyl groups, glass beads were 
treated with freshly prepared Piranha solution (70% H2SO4, 30% H2O2) overnight at room 
temperature. The glass beads were then cleaned with copious amounts of distilled water and 
dried (section 7.15.1). Glass beads treated in this way were enriched with surface hydroxyl 
groups and were therefore suitable for functional silanisation [9]. Glass beads with the OH-
enriched surface were then immersed in APTS solution and incubated at room temperature for 
silanisation (section 17.5.2). The procedure is illustrated schematically in Figure 5.12. 
 
Figure 5.12. Reaction scheme of APTS hydrolysis (step i), followed by condensation to a 
surface containing hydroxyl groups such as glass or cellulose (step ii) [10]. 
The reaction between APTS and a glass surface firstly involves a hydrolysis step of the APTS 
(step (i) Figure 5.12), followed by condensation reaction (step (ii), Figure 5.12).  
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In this process, the silanol groups of the hydrolysis product interact with the exposed hydroxyl 
groups of the silicon substrate on the silica surface/glass beads through a covalent interaction 
to form the –Si–O–Si–R–NH2 structure, leaving the amine functionality on the surface. These 
reactive primary amines on the surface then serve as a functional platform for derivatisation 
chemistry to serve a variety of technological applications [10]. 
5.8.2. Characterisation of the chemically derivatised surfaces  
The amino group activation of the glass surface was investigated using a qualitative ninhydrin 
assay for the presence or absence of free amino groups, using the methods adapted from Sarin 
and Kent (1981) [11]. The underlying principle is the reaction of ninhydrin with a primary 
amine to form Ruheman’s purple, which is highly conjugated with a strong absorption around 
570 nm (section 7.6.2). The measurements were done by measuring the absorbance of 
Ruheman’s purple complex at the wavelength of 570 nm (as explained earlier in section 
3.3.1.2).  
 
Figure 5.13. Amino group availability of APTS treated bead samples as detected by the 
ninhydrin assay. The obtained readings are represented as relative absorbance to the 3 % 
APTS solution, taken as the 100 % value, corresponding to the amount of NH3 groups initially 
present in the solution. Error bars represent the standard deviation of the mean of three 
replicates. 
The results of ninhydrin assay for beads with and without APTS treatment, and also post-
heating (after curing) APTS treated beads at 110 °C are shown in Figure 5.13. The high 
readings obtained for APTS treated and cured samples are indicative of successful reactions of 
ninhydrin with primary amines present on the surface, due to the surface bound APTS on the 
glass surface. These primary amine groups sticking off the surface are readily available for 
conjugation and can then be directly coupled with biomolecules containing carboxyl or 
aldehyde groups. Alternatively, the APTS derivatised surface can be modified further with 
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In this work, the APTS activated surface was then further activated with N, N’ – disuccinimidyl 
carbonate (DSC) (section 7.15.4) to yield a N-hydroxysuccinimide ester (NHS) reactive surface 
(Figure 5.14), that is able to spontaneously react with proteins or PNFs through their ε-amino 
group of lysine residues and the N-terminal α-amino group [10, 12, 13]. This surface chemistry 
is a straight forward procedure allowing the covalent immobilisation of proteins through amide 
coupling chemistry [14] and is readily applicable to other types of materials such as polyesters, 
polyamides and polycarbonates, where silanes have been used as coatings for many different 
applications [7, 13].  
 
Figure 5.14. . Reaction scheme of DSC activation of APTS treated glass surface to form 
terminal NHS-carbonate groups, which then could be coupled to amine groups [10]. 
5.9. Template-directed growth of PNFs 
Amyloid fibril formation proceeds via a nucleated growth mechanism which allows the 
assembly of mature amyloid fibrils from the covalently bound amyloid oligomeric species 
(seeds or fragments), when the seeded surface is placed in a solution of native protein, and 
heated at low pH. Therefore, the first step in template-directed growth is the covalent 
immobilisation of the amyloid template (seeds or fragments) to the glass bead surface.  
Previous work by Ha and Park (2005) [15] used insulin seeds as their template for the surface-
assembly of insulin PNFs. The protein seeds were created by incubating a fresh solution of 
insulin and heating it until the end of the lag phase or just before the exponential growth phase 
(see section 1.6.2).  The protein species formed just before the exponential growth phase are 
classified as seeds if they are able to eliminate the lag phase in a fresh solution of the same 
amyloid forming protein [16]. Alternatively, fragmented fibrils obtained by mechanical means 
or by overnight freezing [17] can also be used for template-directed growth of mature PNFs, 
as  demonstrated by Raynes (2012), where insulin amyloid fibril fragments were produced by 
exposing mature insulin PNFs to -20 °C overnight freezing, followed by thawing [4].  
In this work, both seeds (obtained by heating the protein solution (10 mg/mL) for 5 h at the 
conditions used for making PNFs, section 7.2), and fragmented amyloid fibrils (obtained by 
sonicated mature amyloid fibrils, section 7.16) were initially studied for template-directed 
growth of crystallin, and whey PNFs onto the surface of glass-beads.  
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However, the incubation time required for producing seeds varied between repetitions thus, 
amyloid fragments were chosen over amyloid seeds for reproducible template-directed amyloid 
fibril formation.  
5.9.1. Method development for template-directed assembly of whey PNFs 
A sonication method similar to the one used for fragmenting crystallin PNFs (as explained 
earlier in Chapter Two, section 2.5) was used for the fragmentation of whey PNFs (section 
7.16). Mature whey PNFs were subjected to a range of sonication times (0-40 sec). The 
resulting solutions were assessed for fragmentation by TEM, and it was found that a sonication 
time of 15 sec was needed to fragment the whey PNFs. TEM images for whey PNFs, before 
and after sonication are shown in Figure 5.15.  
 
Figure 5.15. Representative TEM images of whey PNFs, where (a) - mature fibrils and (b) - 
fragmented PNfs obtained after sonication (15 sec). Scale bar is 200 nm. 
To study the impact of the addition of fragments onto the amyloid fibril growth (in solution) 
for both crystallin and whey PNFs, fragmented amyloid fibrils (section 7.16) were added at 
20% v/v concentration of the crystallin, and whey protein solution kept at 80 °C for fibrillation, 
respectively (section 7.2). As shown in Figure 5.16, the addition of fragments induced amyloid 
fibril formation faster, with a reduced lag phase of 30 min, compared to 2-3 h in the absence 
of fragments, starting from 2-3 h. The results are in agreement with literature suggesting that 
the addition of a preformed nucleus (or ‘seed’) to a supersaturated protein solution accelerates 
fibrillation relative to the spontaneous self-assembly of fibrils [18].  
The optimum pH required for effective amide coupling between the fragmented PNFs and 
activated glass surface reaction is pH 9.0, thereby, the fragments were buffer exchanged into 
50 mM HEPES (pH 9.0), and then added to the whey protein solution kept at 80 °C, at pH 2.0, 
and at pH 3.7 for crystallin PNFs. The exchanging of buffer does not have any negative impact 
on the ability of fragments to seed the formation of PNFs, as demonstrated in Figure 5.16 – 
both pH 2.0 or pH 3.7 (dotted lines) for whey and crystallin PNFs respectively, and pH 9.0 
(dashed lines) show a similar trend, suggesting accelerated amyloid fibril growth in the 
presence of fragmented PNFs.  
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Figure 5.16. Time course profile of (a) crystallin (green), and (b) whey amyloid PNFs (red) 
formation at 80 °C, where solid line - in the absence of fragmented PNFs, dotted line - in the 
presence of 20% (v/v) fragments at pH 2.0 for whey (red), and pH 3.7 for crystallin (green), 
and dashed line - in the presence of 20% (v/v) fragments at pH 9.0, as monitored by ThT 
fluorescence. For seeded and fragmented measurements, readings were normalised to the 
initial ThT reading of the seeded or fragmented solution. Measurements are the average of 3 
replicates of each sample and the error is the standard deviation of the mean of three 
replicates. 
5.9.2. ThT assay for glass beads 
The self-assembly process of PNFs from the surface bound fragments was studied using the 
ThT fluorescence assay, in a 96 well plate reader (section 7.15.5). To eliminate the auto-
fluorescent effect of the glass beads from the study, a solution of mature PNFs was prepared, 
and the fluorescence was measured with and without a glass bead in the wells of the 96 well 
plate. ThT fluorescence for mature PNF samples in the presence and absence of glass beads is 
shown in Table 5.2. Glass beads placed in amyloid fibril/ThT solution decreases the ThT 
fluorescence by ~10% (Table 5.2). This confirmed that the glass beads only hinder ThT 
fluorescence slightly, and thus ThT fluorescence measurements in the 96 well plates was used 
further for the verification of surface-assembled PNFs. 
Table 5.2. ThT fluorescence of samples with and without glass beads. Measurements are the 
average of three replicates of each sample and the error is the standard deviation of the mean. 
Sample ThT fluorescence (RFU) Error 
Bead 198 ± 3 
No bead 189 ± 2 
Bead + whey PNFs 818 ± 53 
Whey PNFs 898 ± 72 
Bead + crystallin PNFs 698 ± 58 
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5.9.3. Template-directed self-assembly of whey PNFs 
The glass beads were placed in a solution of fragmented whey amyloid solution (pH 9.0) to 
covalently bind them to the glass surface via amide coupling chemistry for 2 h. The beads with 
the covalently bound whey amyloid fragments were then rinsed with water to remove any 
unbound amyloid fragment from the bead surface. After washing, the beads with surface 
attached fragmented whey PNFs only were placed into a solution containing dissolved whey 
protein (10 mg/mL) at pH 2.0, and incubated for 22 h (section 7.15.6). The self-assembly of 
whey PNFs from the surface bound fragments was studied using ThT fluorescence assay, in 
the 96 well plate reader (section 7.15.5). Glass beads were taken from the protein solution at a 
given time intervals and washed thoroughly in water to remove any unbound PNF, followed 
by the ThT assay.  
As can be seen in Fig 5.17, the glass beads which had been seeded with the fragments (red 
bars), followed by amyloid fibril assembly, exhibited a significant increase in ThT fluorescence 
indicating the presence of mature whey amyloid fibrils. This implies that by seeding the surface 
of the glass beads with the fragments, template-directed amyloid fibril assembly can occur. The 
high ThT readings obtained for the beads which were not immersed in the fragmented solution 
(non-seeded), but directly placed into the whey protein solution suggests that amyloid fibrils 
can also be directly-assembled onto the surfaces and seeding is not essentially required for the 
amyloid fibril assembly process (Fig. 5.17, green bars). However, the glass beads which had 
been seeded with the fragments, then amyloid fibrils assembled, had the shortest lag phase for 
amyloid fibril formation.  
 
 
Figure 5.17. Time course profile of template-directed assembly of whey amyloid fibrils at 80 
°C, as monitored by ThT fluorescence, where blue bars- seeded, not immersed in solution, 
green bars - not seeded, immersed in solution, and red bars - seeded, immersed in solution. 
Measurements are the average of 3 replicates of each sample and the error is the standard 




















134 |                                                                       Chapter Five – Part B - Surface assembly 
 
To ensure that the obtained ThT readings were for the fibrils assembled on the surface of the 
beads, ThT assay was done on the (a) Washed bead samples: The bead samples were washed 
thoroughly in water to remove any unbound PNFs, and (b) Stored and washed bead samples: 
The washed bead samples were stored at 4° C for the time period of 7 days, followed by the 
ThT assay. The obtained ThT readings are shown in Table 5.3. Both seeded (beads seeded 
with fragments) and non-seeded bead samples with mature amyloid fibrils assembled retain 
significant fluorescence compared to the control bead samples, even after storage and 
subsequent washing step. This implies that the obtained ThT readings were for the fibrils 
covalently attached onto the surface and not because of the fibrils present free in solution.  
Table 5.3. ThT fluorescence of whey PNF samples assembled on glass beads after (a) washing 
to remove amyloid fibrils from the solution phase, and (b) after storage at 4° C and subsequent 
washing after 7 days. Measurements are the average of 3 replicates of each sample and the 
error is the standard deviation of the mean. 
Sample ThT Fluorescence (RFU) 
        (a)                   (b) 
Error 
 (a)                   (b) 
Bead (control) 208        205       ±8    ±4 
Bead + fragmented WPNFs 229        214        ±15    ±14 
Seeded, immersed in solution 934        901          ±121    ±98 
Non-seeded, immersed in solution 844        867          ±119      ±143 
 
5.9.4. Template-directed self-assembly of crystallin PNFs 
The same protocol used for the derivatisation of the glass beads with the whey template- 
directed amyloid self-assembly was used for the crystallin template-directed PNFs self-
assembly (section 7.15.7). To study the crystallin protein self-assembly process, three different 
approaches were used: 
i. Seeded beads: Similar to the whey PNFs assembly, glass beads were placed into the 
fragmented crystallin PNFs solution and incubated for 2 h. The beads were then washed 
with dH2O, and left to dry, followed by ThT assay to ensure the attachment of the 
fragments onto the glass beads (shown in Table 5.4). Glass beads with covalently 
bound crystallin were placed in a solution of crystallin protein extracted from fish eye 
lenses and heated for 24 h at 80 °C. The beads were then left in the crystallin solution 
at room temperature for at least 3 days.  
ii. While heating: Surface activated non-seeded glass beads were placed into crystallin 
protein solution, and heated for 24 h at 80 °C. The beads were then left in the crystallin 
solution at room temperature for at least 3 days.  
iii. After heating: Crystallin protein solution was heated for 24 h at 80 °C, and surface 
activated non-seeded glass beads were added to the heated crystallin protein solution 
before leaving the crystallin protein solution at room temperature for 3 days. 
 
Glass beads were taken from the protein solution after 3 days of incubation at room temperature 
and washed thoroughly in water to remove any unbound PNFs, followed by ThT assay.  
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To ensure that the obtained ThT reading was due to the mature amyloid PNFs assembled onto 
the glass beads, bead samples after initial washing step were further placed into dH2O (200 
µL), and incubated for 10 min at room temperature (3X) and left to dry, followed by ThT assay.  
Table 5.4. ThT fluorescence of bead samples before and after glass beads were placed into the 
fragmented crystallin PNFs solution. Measurements are the average of three replicates of each 
sample and the error is the standard deviation of the mean. 
Sample ThT Fluorescence (RFU) Error 
Bead 199 ±4 
Bead + fragmented CPNFs 398 ±16 
 
As shown in Figure 5.18, there is negligible difference in the ThT readings obtained for each 
of the samples before and after washing step and samples retain fluorescence. High ThT 
reading was obtained for not only the seeded beads but for all the methods studied suggesting 
the presence of mature crystallin PNFs. This implies that crystallin PNFs can be self-assembled 
onto the surfaces via both template-directed and direct-assembly process.  
             
Figure 5.18. ThT fluorescence of glass bead samples with surface assembled crystallin PNFs, 
where blank - initial, and filled bar - after washing. Measurements are the average of 3 
replicates of each sample and the error is the standard deviation of the mean.  
5.10. Impact of chemical derivatisation 
Experimentation was carried out to ensure full surface derivatisation was necessary for 
maximum surface-assembly of the PNFs. This was achieved by performing ThT assay on a 
variety of control bead samples. All three conditions as discussed earlier in section 5.9.4, such 
as seeded beads, while heating, and after heating were studied for the glass beads obtained after 
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As shown in Figure 5.19, for both whey and crystallin PNFs, the non-seeded bead samples, 
which had the full surface derivatisation (sample e, red bars), placed into the protein solution 
while heating have the highest ThT fluorescence indicating presence of surface-assembled 
PNFs. 
 
Figure 5.19. ThT fluorescence of glass bead controls, (i) crystallin bead samples, and (ii) whey 
bead samples. Measurements are the average of 3 replicates of each sample and the error is 
the standard deviation of the mean, where a - no treatment, b - Piranha treated, c - APTS 
treated, d - after curing, and e - DSC treatment. Red bars - while heating (non-seeded beads 
were added to the protein solution kept at 80 °C), green bars - seeded beads (seeded beads 
were added to the protein solution kept at 80 °C, and blue bars - after heating (non-seeded 
beads were added to the heated protein solution before leaving the protein solution at room 
temperature for 3 days  
High ThT readings were also obtained for the seeded beads, followed by the beads added to 
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Interestingly, bead samples without any surface derivatisation (sample a) also show a relatively 
high ThT fluorescence implying that there is a relatively strong intrinsic association between 
the glass beads, the amyloid fragments and PNFs. The obtained result show that PNFs can also 
be surface-assembled onto the glass beads without any surface activation. This is 
understandable, as crystallin PNFs do not have sufficient lysine groups available for 
crosslinking (discussed in Chapter Three, section 3.4.2), and template-directed assembly relies 
on the availability of lysine groups to react with the DSC surface activated surface, and is likely 
possible that mature amyloid PNFs are assembling via both adsorption (direct-surface 
assembly), and crosslinking (through APTS, or DSC activated functional groups). However, 
the glass beads which had been activated and then amyloid PNFs assembled, had the highest 
ThT fluorescence confirming that full surface derivatisation is required for maximum surface-
assembly of the PNFs. 
5.11. Confocal microscopy 
Confocal microscopy has been used previously by Kerb et al. (2005) to study the binding of 
ThT to amyloid fibrils, and thus in addition to the ThT assay, confocal microscopy was also 
used as an alternative method to investigate the presence of PNFs on the surface of the glass 
beads. For the confocal microscopy study, in addition to 5 mm beads, 425-600 µm glass beads 
were also used. The use of small beads for attaching PNFs was considered to aid with confocal 
imaging. The use of microbeads will also provide the large surface area for enzyme 
immobilisation, leading to better packaging efficiency for industrial applications.  
The PNF assembled bead samples and associated controls were kept in clear wall glass bottom 
dishes, followed by the addition of ThT stain and incubation in dark for 6 min, and viewed 
using confocal microscopy as described in section 7.17. Unbound ThT gives a fluorescence 
spectrum with an excitation/emission maximum of 385/435 nm, whereas bound ThT undergoes 
a spectral shift with an excitation/emission maxima at 450/482 nm.[19] Therefore, to avoid 
background fluorescence from the unbound ThT, excitation of 425 nm and an emission 
detection of 485-495 nm was used.  
The micrographs of the surface of the template-directed amyloid fibril glass bead samples is 
shown in Figure 5.20. As can be seen, the blank glass bead (sample a and b) surface does not 
have any fluorescence whereas the bead sample with PNFs assembled via template-directed 
growth showed significant fluorescence on the surface (sample c-f), confirming the presence 
of PNFs onto the glass bead surface. The coverage of the amyloid fibrils on the glass surface 
is regular, and the micrograph results provide evidence that both whey and crystallin PNFs can 
be surface-assembled on glass beads via template-directed growth. 
5.12. Surface assembled PNFs for biomolecule immobilisation 
β-Gal immobilisation was investigated on glass surface assembled whey PNFs as a potential 
manufacturing route to create enzymatically functional PNF-based nanomaterials.  
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Figure 5.20. Representative confocal micrographs of the surface of 5 mm (scale bar – 2 mm), 
and 425-600 µm glass beads (scale bar – 1mm), where left side - 5 mm bead samples, and right 
side- micro bead samples. Row 1 - control bead samples, Row 2 - seeded, plus whey PNFs, 
and Row 3 - seeded, plus crystallin PNFs. The beads were stained with ThT dye, an excitation 
of 425 nm and an emission detection of 485-595 nm were used. 
5.12.1 β-Gal functionalisation and characterisation of surface-assembled 
whey amyloid fibrils  
β-Gal surface immobilisation was based on the method developed for dual-immobilisation of 
GOX, and β-gal onto the whey amyloid PNFs using GA (Chapter Five, Part A, section 5.4). 
Briefly, all of the bead samples were first immersed in a solution containing 5 mM GA for 1 h, 
then washed thoroughly and placed in a 2.9 mg/mL solution of β-gal for 2 h at 37 °C, before 
being thoroughly washed again (section 7.18.1).  
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The resulting immobilised β-gal samples were investigated for activity in a plate reader using 
the ONPG assay (section 7.18.2), and the presence of amyloid fibrils determined using ThT 
assay (section 7.15.5). The results as obtained from both assays are summarised in Table 5.5. 
The sample that showed the most β-gal activity and highest ThT fluorescence is sample 8, 
where β-gal was immobilised onto GA-treated surface-activated beads, with PNFs assembled 
via template-directed growth. Both ThT readings and β-gal activity of sample 5 was also 
relatively high, implying that there were mature whey amyloid fibrils attached to the surface 
of the glass beads, even without seeds present. The relative higher activity readings for sample 
6, again suggests that seeding is not essential for the growth of mature PNFs onto the surfaces. 
On comparing bead samples with PNFs in the presence (sample 5 and 8) and absence (sample 
4 and 7) of GA, sample 5 and 8 showed higher activity, reflecting on the importance of the use 
of GA for immobilising β-gal onto the amyloid fibril functionalised beads.  
The samples 2, 3, and 6 also exhibited β-gal activity indicating a strong interaction between β-
gal and the activated glass surface, because the ThT fluorescence of these samples is low, 
implying the lack of PNFs present on the surface that are aiding in immobilisation. However, 
the beads which were seeded, the amyloid fibrils assembled, and β-gal immobilised (sample 
8), had the highest β-gal fluorescence detected in the plate reader, proposing that surface-
assembly of whey PNFs on glass beads, and subsequent immobilisation with β-gal, enabled 
more β-gal to be immobilised to the glass surface.  
Table.5.5. ThT fluorescence (ThT) and β-gal activity (ONPG assay) of whey PNF samples 
immobilised to glass beads. Surface activation - APTS and DSC derivatised beads, Seed - beads 
seeded with whey PNFs, PNFs - whey amyloid fibrils assembled, GA - GA activation. Each 
sample had six replicates, three for the ONPG assay (absorbance measured at 420 nm), and 
three for the ThT assay (RFU). The errors represent the standard deviation of the mean. 
Sample   Surface activation    Seed       PNFs      GA      ONPG    O. Error*    ThT    T. Error** 
    1.                    -                         -            -          -         0.1506      ±0.012        202        ±6 
    2.                    +                        -            -          -         0.4356      ±0.034        228        ±12 
    3.                    +                        -            -          +        0.4496      ±0.025        221        ±19 
    4.                    +                        -            +         -         0.5023      ±0.056        954        ±67 
    5.                    +                        -            +         +        0.6986      ±0.080        953        ±59 
    6.                    +                        +           -          -         0.2891      ±0.021        283        ±16 
    7.                    +                        +           +         -         0.4967      ±0.007         976       ±102 
    8.                    +                        +           +         +        0.8983      ±0.058         995       ±95 
*O.Error – standard deviation of the mean of three replicates for ONPG assay 
 **T.Error – standard deviation of the mean of three replicates for ThT assay 
 
The high β-gal activity readings obtained for sample 2, 3, and 6 revealing β-gal absorption to 
the control glass beads was not an unexpected result as the surface chemistry on the glass can 
react with the amine groups of β-gal, leading to the covalent linking of the enzyme. To get rid 
of this background reading an extensive washing step was undertaken. The glass bead samples 
were placed in a small beaker with β-gal buffer (100 mM PBS, pH 7.4), and changed to the 
fresh buffer every 6 h for ~24 h. Washing the beads for a long period of time will wash the 
loosely bound β-gal, leaving only the strongly bound β-gal.  
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The bead samples were then analysed for β-gal activity by the ONPG assay, and the ThT assay 
to ensure the washing step did not remove any of the surface assembled PNFs, see Table 5.6.  
Table 5.6. ThT fluorescence (ThT) and β-gal activity (ONPG assay) of whey PNF samples 
immobilised to glass beads. Surface activation - APTS and DSC derivatised beads, Seed - beads 
seeded with whey PNFs, PNFs - whey amyloid fibrils assembled, and GA - GA activation. Each 
sample had six replicates, three for the ONPG assay (absorbance measured at 420 nm), and 
three for the ThT assay (RFU). The errors represent the standard deviation of the mean. 
Sample   Surface activation   Seed     PNFs     GA      ONPG    O. Error    ThT    T. Error 
    1.                    +                        -            -          -          0.3981     ±0.015          219         ±8 
    2.                    +                        -            -         +          0.3687     ±0.011          196         ±26 
    3.                    +                        +           -          -          0.4393     ±0.046          235         ±43 
 
As can be seen in Table 5.6, the extensive washing step produced very similar results to 
samples in Table 5.5, suggesting that the β-gal in the bead samples without PNFs is covalently 
crosslinked onto the surface activated beads via amine groups. Following the successful 
immobilisation of β-gal to the surface assembled PNFs, it was decided to try and create a 
reusable β-gal nanomaterial bead system with potential commercial applications. The β-gal- 
functionalised surface-assembled PNFs were then tested for their ability to be reused 
sequentially. 
5.12.2. Reusable surface-assembled PNF-based bead system 
Studies have shown that glucose and galactose, two monosaccharides obtained by hydrolysis 
of lactose have several advantages in comparison to lactose, such as they are four times sweeter 
than lactose, are more soluble and digestible [4], and can be consumed by people with a lactose 
intolerance [1, 5]. Thus, lactose hydrolysis has significant importance and immobilised β-gal 
offers the possibility of continuous flow processing, so that easy regeneration of the 
immobilised enzyme and low cost operation can be achieved in industrial processing. By 
immobilising β-gal to the surface-assembled whey amyloid PNFs, it was anticipated that the 
β-gal PNF glass beads would be easily recovered and reused after each reaction. Therefore, a 
reusable system can be created that saves on production cost, allow a higher enzyme loading 
and better catalytic efficiency. The hydrolysis reaction was set up for the bead samples listed 
in Table 5.7. 
Table 5.7. List of bead samples used for hydrolysis reaction. 
                  Bead samples                                          Surface activation   Seed     PNFs     GA       
    1.   Surface activated bead                                           +                       -            -           -          
    2.   Surface activated and GA                                      +                       -            -          +         
    3.   Surface activated with PNFs                                 +                       -            +         -          
    4.   Surface activated, with PNFs and GA                  +                       -            +         +         
    5.   Surface activated, seeded                                       +                      +            -          -          
    6.   Surface activated, seeded with PNFs                     +                      +           +         -          
    7.   Surface activated, seeded with PNFs and GA       +                      +           +         +         




Figure 5.21. (a) Image of the bead samples used for the hydrolysis reaction, showing the 
presence of yellow coloured cleaved product - o-nitophenol, after ONPG assay.(b) ThT 
fluorescence (grey bars) and β-gal activity (black bars) of glass beads with β-gal-
functionalised surface-assembled whey PNFs. (i) after first hydrolysis reaction, (ii) after 
second hydrolysis reaction, and (iii) after third hydrolysis reaction. Bead samples: b - Not 
treated, 1 - surface activated, 3 – surface activated with GA, 4 -surface activated with PNFs, 
5- surface activated seeded, 6 – surface activated, seeded, with PNFs, and 7 – surface 
activated, seeded, with PNFs, and GA. Each sample had six replicates, three for the ONPG 
assay (absorbance measured at 420 nm), and three for the ThT assay (RFU). The errors 
represent the standard deviation of the mean. 
    (i) 
  (ii) 
   (iii) 
     (iii) 
     (ii) 
      (i) 
      (a) 
     (b) 
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To determine the activity of β-gal immobilised onto the whey PNF glass beads, it was decided 
to use ONPG (a lactose analog) instead of lactose, as ONPG assay has been used previously in 
this work for analysing β-gal activity (Appendix B, section B1.2), where β-gal activity is 
measured directly by the amount of ONPG cleaved, leading to the production of galactose and 
o-nitrophenol, which can be easily quantified using a spectrophotometer. For hydrolysis 
reaction, all the bead samples were incubated with ONPG solution, and kept in dark at 37 °C 
for 30 min (section 7.18.2). The beads were thoroughly washed in dH2O before being used for 
the next hydrolysis reaction. This procedure was repeated until immobilised β-gal activity had 
ceased for controls samples. The hydrolysed solution of each of the samples was carefully 
removed after 30 min without touching the glass beads, and analysed for β-gal activity. The 
results as obtained by the ONPG assay, for each of the hydrolysis reaction are shown in Figure 
5.21. The image of all the bead samples showing the presence of o-nitrophenol (a hydrolysed 
or cleaved form of ONPG) solution after each of the hydrolysis reaction, for all the bead 
samples is shown in Figure 5.21 (a). 
In first hydrolysis reaction, all of the bead samples showed β-gal activity, with the ONPG assay 
readings showing very similar results (Figure 5. 21 (i)). The second hydrolysis reaction as 
shown in Figure 5.21 (ii), had a very similar trend, but this time the amount of ONPG 
hydrolysed by the bead sample which had all the treatments, was much more prominent 
compared to the other bead samples (sample 7). By the third next reaction (Figure 5.21 (iii)), 
the bead sample that retained maximum β-gal activity was that with amyloid fibrils assembled, 
sample 4, and 7 (with and without seeding, respectively), and GA used for β-gal 
immobilisation. The reason that reduced β-gal activity was observed for the other bead samples 
could be due to leaching of the immobilised enzyme over time, under the studied conditions.  
This provides evidence that the presence of the surface-assembled amyloid fibrils provides 
better stability to the immobilised β-gal. Functionalisation of the surface-assembled whey 
amyloid PNFs with β-gal showed that the glass beads which were seeded and amyloid PNFs 
assembled, displayed the maximum activity. The catalytic activity of the immobilised β-gal 
was preserved over three uses. Considering the immobilised β-gal beads as a proof-of-concept 
system, the results are promising as the studied hydrolysis reaction was based on single bead 
sample-only.  
5.13. Conclusion 
This chapter demonstrated the commercial potential of amyloid PNFs as a nanoscaffold. Novel 
amyloid fibril based biomaterials can be created by functionalising surface attached PNFs with 
enzymes or active components. Previous work by Raynes (2012) has shown that bovine insulin 
amyloid fibrils can be surface-assembled via template-directed growth. In this work, both 
crystallin and whey PNFs were surface-assembled via both template- and direct-surface-
assembly methods, with and without surface-derivatisation. The results shown in this chapter 
demonstrates that the presence of PNFs on the surfaces allows for a greater amount of enzyme 
immobilisation or a better environment leading to the improved stability and activity of the 
enzyme.  
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Also, these findings propose that surface-assembly could be applicable to any amyloid forming 
protein, and any other surface with similar surface chemistry. PNFs were also successfully 
surface-assembled onto the microbeads, however due to difficulty in handling, and performing 
enzyme-specific activity assays, functionalisation or enzyme immobilisation studies were 
conducted using only 5mm glass bead samples. Further optimisation of the enzyme 
immobilisation conditions could increase the enzymatic activity, reusability and storage life of 
the immobilised enzyme bead system, and optimisation of this technology towards smaller 
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Chapter Five 
Part C - PNFs in biomedical applications 
5.15. Protein and PNF-based scaffolds for tissue regeneration 
More recently amyloid fibrils have been investigated for their suitability as self-assembling 
biomaterials or hybrid materials for biomedical applications [1-4]. A number of amyloid 
forming proteins and peptides have been shown to form hydrogels with potential applications 
in tissue engineering or drug delivery [5-7]. For example, Kyle et al. (2011), showed that a 
peptide derived from hen lysozyme forms pH dependent gels, which may be used in scenarios 
where a responsive material is desirable [8]. Responsive materials such as these have potential 
biomedical applications, where biocompatibility and/or biodegradability is sought after [9]. A 
number of published studies have demonstrated that amyloid fibril coated surfaces promote 
cell growth and adhesion [1, 10]. Recently, Jacob et al. (2015), developed amyloid-based 
nontoxic hydrogels, capable of forming a 3D meshwork, and demonstrated the use of these 
hydrogels for 2D/3D cell culture and stem cell differentiation [5]. Based on reported literature, 
in this work, PNFs obtained from crude proteins were studied to create PNF-based biomaterials 
with potential applications in tissue engineering.  
5.16. Tissue engineering and composite materials 
Tissue engineering is defined as the application of principles and methods of engineering and 
life sciences for the development of biological substitutes, to restore, maintain or improve 
tissue function [11]. The field of tissue engineering is highly multi-disciplinarily and relies 
extensively on the use of scaffolds/biomaterials to act as a template for tissue formation [12].  
These cell scaffolds are typically seeded with cells and/or growth factors, and are either 
cultured in vitro to synthesise tissues, followed by the implantation into an injured site, or are 
implanted directly into the injured site for in vivo regeneration of tissues or organs, using the 
body's own systems [12].  
The state of the art in the biomaterial design has continuously evolved over past few decades. 
Various biomaterials as broadly categorised into three individual groups: ceramic, natural and 
synthetic polymers have been studied and used in different manners for tissue engineering 
applications [12-15]. Each of these individual biomaterial group has their own advantages and 
disadvantages, and in order to obtain amalgamated properties of the two or more materials, 
polymer/biomaterial blending is becoming increasingly common. Synthetic materials such as 
poly-lactic-glycolic acid (PLGA), polylactic acid (PLA), polyglycolic acid (PGA) have 
reduced bioactivity but high mechanical strength. In contrast to the synthetic polymers, 
biological/natural materials such as collagen, elastin, chitosan, have high biologically activity 
and typically promote excellent cell adhesion and growth, but generally have poor mechanical 
strength [12].  
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Hence, a composite material obtained by mixing synthetic polymer with a natural material will 
help in omitting the disadvantage associated with each of the individual group. For example, 
the (PLGA)-collagen (synthetic-natural blend) composite materials with better 
biocompatibility and mechanical properties have been used to prefabricate a tissue engineering 
trachea [16]. Irrespective of the choice of biomaterial from which the scaffold is fabricated, a 
number of key features that needs to be considered while designing a biomaterial with potential 
applications in tissue engineering include: biocompatibility, rate of 
degradation/biodegradability, mechanical strength and stability, scaffold architecture including 
porosity, microstructure, shape, and size, and cost effective manufacturing technology [12].   
5.17. Silk as a biomaterial for tissue engineering 
Silk proteins, especially the fibroin produced by Bombyx mori, due to their tuneable mechanical 
properties, biocompatibility, morphological flexibility, controlled proteolytic degradation, 
ambient processing conditions, and ability to immobilise growth factors via amino acid 
modifications [17], have been extensively investigated as a scaffolding material for tissue 
engineering applications [18-27]. Silks are unique group of fibrous proteins with remarkable 
mechanical properties produced in fibre form by silkworms and spiders [17]. The most 
extensively characterised silks are from the domesticated silkworm, Bombyx mori, and from 
spiders (Nephila clavipes and Araneus diadematus). The Bombyx mori silkworm cocoon is 
generally comprised of three main proteins: sericin, a glue like glycoprotein, and light and 
heavy fibroin chains, 25 and 325kDa, respectively [18]. Silk fibrous proteins, are characterised 
by a highly repetitive primary sequence (dominance of hydrophobic domains with short side 
chain amino acids in the primary sequence) that leads to significant homogeneity in secondary 
structure (β-sheets in the case of many of the silks) [17]. The highly organised β-sheet crystal 
regions and semi-crystalline regions within the fibroin proteins imparts high mechanical 
strength to the silk fibres [17], and also contributes to silk’s elasticity compared to fibres of 
similar tensile integrity [18]. 
Silk fibroin offers a number of advantages to current tissue regeneration materials. Silk 
processing is a simple, highly-scalable, and robust process unlike other biopolymer materials, 
such as collagen and fibrin which require more intense purifying and processing steps [28]. In 
addition, silk has been found to be highly biocompatible upon implantation, and induces lower 
inflammatory responses than collagen and PLA films [29]. Silk also offers slow biodegradation 
rates and increased native tissue re-modeling time, and enhanced mechanical stability of the 
re-modelled native tissue [17]. Other materials such as synthetic PGA or natural collagen 
degrade much more rapidly and do not offer extended native tissue re-modeling time [30, 31]. 
Despite the various advantages, due to their brittle nature [32], shortage of cell specific-binding 
sites, and limited growth factor-adsorbing capacity [33], the blending of silk fibroin materials 
with other polymers has been investigated to improve the functional shortcomings while taking 
advantage of the structural benefits from using silk fibroin [34-37]. 
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5.18. Silk-PNF composite materials for tissue engineering 
Both amyloids and silk fibroin exhibit remarkable structural and physical properties as 
discussed in section 1.9, Chapter One and section 5.12 (above), respectively. Although these 
two classes of β-sheet-rich, natural proteinaceous fibrous materials are among the most 
intensively investigated types of protein assemblies, however, they have not yet been combined 
as a biomaterial to support cell growth. To the best of my knowledge there has been only one 
reported study in which both of these materials have integrated together into artificial materials, 
and investigated for structural and material properties by controlling the molecular design of 
each of the component (i.e. amyloid fibrils obtained from lysozyme and silk fibroin [38]. In the 
present work, the focus was to develop a PNF-based scaffold for tissue engineering, hence silk-
PNF composite films were cast and initial characterisation of the resulting composite materials 
was carried out.  
5.18.1. Silk-blend films 
Bombyx mori silk fibroin solution was prepared as described in Rockwood et al. (2011) [39]. 
Briefly, degummed fibres (achieved by boiling fibres for 20 min in 0.02 M sodium carbonate 
(Na2CO3) solution) were dissolved in 9.3 M lithium bromide (LiBr) solution in 1:4 (w/v) ratio 
at room temperature, and kept at 60 °C for 4 h. The extracted solution was then dialysed 
(MWCO 3500) in water for 48 h. The final concentration of aqueous silk solution was 
determined by weighing the remaining solid after drying (section 7.19.1). Protein solutions 
were prepared by dissolving 40 mg/mL of dry whey protein isolate powder and freeze dried 
crystallin proteins in dH2O (section 7.19.2). Mature amyloid PNFs prepared as described in 
section 7.2, were centrifuged and concentrated to 4% solution (section 7.19.3). The 
concentration of all the constituents i.e. silk protein solution, PNFs (both whey and crystallin), 
and proteins (WPI and crystallin protein powder) was kept at 40 mg/mL (section 7.19). Silk-
blend films were prepared on flat polydimethylsiloxane (PDMS) substrate of 0.5-1.0 mm 
thickness as detailed in section 7.20, and allowed to dry overnight.  
5.18.2. SEM analysis of silk-blend films 
Scanning electron microscopy (SEM) was used to observe physical changes in film topography 
(Figure 5.22). Dried film samples were peeled off from the PDMS substrate and placed on top 
of conductive tape mounted on a SEM sample stub, followed by platinum coating (section 
7.21). Under SEM, silk only sample showed a highly smooth surface (Figure 5.22 a-b), which 
does not change significantly after the addition of proteins (Figure 5.22 c-f). The SEM images 
obtained for silk-crystallin and silk-whey protein blends showed that both proteins have similar 
impact on the surface morphology of the films, as expected due to similar molecular weight 
range of both protein (16-18.5 kDa). The morphology of blend films was drastically influenced 
as anticipated by the addition of PNFs. The surface of silk-PNFs blend films showed a high 
degree of surface roughness relative to the silk-only and silk-protein blend films (Figure 5.22 
g and i). The presence of PNFs within the silk films was clearly observed at higher 
magnification (Figure 5.22 h and j).  
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Figure 5.22. SEM images of film topography, where (a-b) - silk only, (c-d) - silk:crystallin 
protein, (e-f) - silk:whey protein, (g-h) - silk:crystallin PNFs, and (i-j) - silk:whey PNFs in 1:1 
ratio. Left panel - 5000x, and right panel - 15,000x magnification. Scale bar – 1 µm. 
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5.19. Proteolytic degradation 
In tissue engineering, biodegradability of the biomaterials is of great importance as a scaffold 
should allow the formation of cells to produce their own extracellular matrix, over time, to 
eventually replace the implanted scaffold [40]. An ideal scaffold should, therefore, degrade at 
a similar rate as the growth of new tissue [22]. The by-products of this degradation should be 
non-toxic, and easily metabolised and cleared from the body without interference with other 
organs [12]. Understanding the factors that control the rate of degradation is, thus, critical in 
designing functional tissue scaffold materials.  
Silk fibroins have been investigated for diverse range of applications in the biomedical field, 
and are classified as enzymatically degradable biomaterials [17, 40]. Several biodegradation 
studies on silk fibroins have demonstrated that proteases play a significant role in the enzymatic 
degradation of silk fibroins [41-44]. Considering this, in vitro proteolytic degradation of silk- 
only, and silk-blend samples was done using proteases, including α-chymotrypsin, protease 
type XIV, and collagenase. Weight loss to determine the degradation rate, and SDS–PAGE 
was used to analyse the degradation products. 
To assess if there is any loss in enzymatic activity of proteases used over the time period of 7 
days at 37 °C, enzymatic solutions (1mg/mL in PBS, pH 7.4) were prepared (section 7.22.1) 
and incubated at 37 °C. A 50 µL aliquot was taken for each of the enzyme solution every 24 h, 
and added to the BSA solution (5 mg/mL in PBS, pH 7.4), followed by 1 h incubation at 37 °C 
(section 7.22.1).  Decay of the enzymatic activity was determined using SDS-PAGE (section 
7.1.1). The results, suggested that at least 60-75% of the initial enzyme activity was lost after 
3 days of incubation (results not shown). Thus, enzyme solutions were replaced every 24 h, 
over the time period of 7 days to account for protease activity loss due to 37 °C incubation.   
For enzymatic degradation of the silk-only and silk-blend films, pre-casted films (S1-S9) 
(section 7.20, Table 7.14), were immersed in 75% ethanol for 4-6 h to induce crystallinity 
(section 7.20.1), followed by 1 h drying. Previous studies have shown that the immersion in 
alcohal, such as methanol or ethanol can induce crystallinity in silk films, making films more 
stable [45], and is possible to control the degradation rate of the silk fibroin scaffolds by 
controlling the β-sheet structure content for a specific tissue engineering application [46]. After 
ethanol annealing, annealed films were removed from the PDMS discs and immersed in 250 μL 
of enzyme solution (or PBS for control) prepared as detailed in section (7.22.1), and incubated 
at 37 °C. After every 24 h, samples were centrifuged (section 7.22.3) to accumulate blend film 
residues, and supernatant removed (section 7.22.2) to run SDS-PAGE immediately. The blend 
film residues were then dried overnight and the mass determined using an analytical balance 
(section 7.22.3). After drying, samples were weighed and the percent weight loss was 
calculated by comparing each group to the control samples (films incubated in PBS at 37 °C, 
without enzymes). Nine samples from each group were taken at each time point to get 
statistically significant data. Fresh enzyme solution was added to each tube, followed by 
incubation at 37°C.  
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The samples were analysed every day for weight loss and SDS–PAGE to determine when the 
degradation of materials by different enzymes became significantly different. 
5.19.1. SDS-PAGE analysis 
Background controls for each group were enzyme solutions without silk materials incubated at 
37 °C for 24 h, and controls for silk-blend films were incubated in PBS (pH 7.4). As detailed 
in section 5.12, silk fibroin is composed of a high molecular weight chain (H-chain) of 350 
kDa and two lower molecular mass protein components: the light chain and P25 glycoprotein 
[47]. For all the samples (films incubated in PBS, and with proteases) no distinct bands were 
observed for silk fibroin light chain (L-chain) of 26 kDa [48], and glycoprotein P25, 30 kDa 
[49] (Figure 5.23 (a), ~25-30 kDa). Both light chain and P25 glycoprotein combined account 
for approximately 5% of the amino acids present in silk fibroin [47], and is possible that the 
concentration of these proteins in the supernatant was too low to be detected by SDS-PAGE, 
as also reported by Brown et al. 2015 [44]. Additionally, silk proteins are obtained from 
hydrolysed fibroins, and thus will have a random assortment of peptides, instead of any intact 
proteins. In Figure 5.23 (a), a faint protein band of soluble protein fragments was observed for 
silk only sample at ~20 kDa.  
It is not possible to see distinct bands for PNFs on SDS-PAGE due to their size restrictions (as 
mentioned previously in Chapter Four); however, low molecular crude non-fibrillated protein 
bands as can be seen in Figure 5.23 (a), (Lane 4-9) would be observed on gel image if, PNFs 
were leaching or silk:PNF films were degraded. 
 
Figure 5.23. SDS-PAGE of silk-only, and silk-blend samples. L - Ladder, 1 - silk-only, 2 - silk-
CP (50:50), 3 - silk-WP (50:50), 4 - silk-CPNFs (75:25), 5 - silk-CPNFs (50:50), 6 - silk-
CPNFs (25:75), 7 - silk-WPNFs (75:25), 8 - silk-WPNFs (50:50), 9 - silk-WPNFs (25:75), 
where a - solutions diluted at 2 mg/mL, b - supernatant taken from the film samples incubated 
in PBS (pH 7.4) - after 1 day, c - after 3 days, and d - after 5 days.  
For the film samples incubated in PBS, no distinct bands were seen for silk-only, and silk-PNF 
blends films, suggesting that the silk-only, and silk:PNF blend films are stable in PBS (Figure 
5.23 b-d, Lane 1, and 4-9) up to 5 days. In contrast to the silk-PNF blend films, silk-protein 
blend films were not as stable and proteins bands for crystallins and whey proteins were 
detected after 24 h incubation (Figure 5.23 b, Lane 2-3).  
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For silk-protein films a slow release of proteins was observed as protein bands were present 
throughout the incubation period (5 days) (Figure 5.23 (b-d), Lane 2-3). The proteases 
(protease type XIV, α-chymotrypsin) used in this work are serine proteases, and cleave amide 
bonds adjacent to aliphatic, aromatic or hydrophobic residues. Chymotrypsin cleaves peptide 
bonds that are next to aromatic amino acid residues (phenylalanine, tyrosine or tryptophan) 
[50], whereas collagenase cleaves amino acid sequences found in collagen i.e. Gly–Ile, Gly–
Leu, Gly–Val, Gly–Phe, Gly–Asn, Gly–Ser [44]. Table. 5.8 shows cleavage sites for protease 
type XIV, α-chymotrypsin, and collagenase.   
Initially films samples were incubated in proteases at the concentration of 1 mg/mL at 37°C 
for 24 h, but film samples with proteins formed irregular debris that could not be washed and 
weighed. Previous work by Lu et al. (2010) on silk film degradation has demonstrated that 
reducing protease concentration (5.6 to 2.3 U/mL) inhibits debris formation [51]. Therefore, a 
lower concentration (0.5 mg/mL) was used further to slow down the degradation rate (section 
7.18.3.3).  
Table 5.8. Summary of protease cleavage sites. Taken from Brown et al. (2015) [44]. 
Protease                         Source                             Cleavage sites                               Reference 
Protease type XIV  Streptomyces griseus     Adjacent to His, Tyr, Trp, Phe, Lys, Arg        [52] 
α-Chymotrypsin      Bovine Pancreas            Adjacent to Trp, Tyr, Phe, Ile, Val, Leu       [41, 52] 
Collagenase           Clostridium histolyticum   X-Gly-Pro, where X= any amino acid           [44] 
 
For the films incubated with protease type XIV (Figure 5.24, top panel), at 24 h of enzyme 
exposure, no distinct bands were observed for any of the sample, but the intensity of lower 
molecular weight bands increased for silk-protein blend film samples (Figure 5.24, top panel-
a, Lane 2-9) relative to the silk-, and enzyme-only lanes (Lane 1 and Lane 10, respectively). 
After 3 days, the intensity of low molecular weight bands increased significantly for 
silk:protein blend films (Figure 5.24, top panel-b, Lane 2-3), indicating the degradation of 
crystallin and whey proteins into small peptides with a molecular weight ranging from 15-25 
kDa. Protease type XIV is a mixture of serine proteases and a reported molecular mass range 
from 16-26 kDa. Thus, it is likely possible that degradation bands overlapped with the protease 
bands, as can be seen the intensity of lower molecule weight bands for silk-protein blend films 
(Figure 5.24, top panel-b, Lane 2 and 3) is more, relative to the enzyme only (Figure 5.24, 
top panel-b, Lane-10) sample. The appearance of a smear of lower molecular weight bands 
after 5 days (Figure 5.24, top panel, Lane 2-9) was observed for all the samples except silk- 
and enzyme-only (Figure 5.24, top panel, Lane 1 and 10, respectively), proposing that films 
degraded rapidly after 3 days. Supernatant from silk films incubated with protease XIV did not 
contain detectable silk bands or smear of bands at any day, suggesting better stability than the 
blend films.   
For the samples incubated with chymotrypsin (Figure 5.24, middle panel), distinct bands at 
50 and 30-40 Kda were seen for all the samples, along with a smear of lower molecular weight 
bands after 24 h incubation (Figure 5.24 (a), middle panel, Lane 1-9 relative to the enzyme-
only, Lane 10).   
152 |                                                Chapter Five – Part C - PNFs in biomedical applications 
 
Similar to the 24 h incubation, a smear of low molecular weight bands was also observed after 
3 days (Figure 5.24 (b), middle panel), with degradation bands (between 10-20 kDa) 
appearing for silk blend films (more distinct for silk:protein blend films, Lane 2-3, relative to 
silk:PNF blend films, Lane 4-9). After 5 days (Figure 5.24 (c), middle panel), lower molecule 
weight degradation bands were more prominent for silk-PNF (Lane 4-9), and silk-only (Lane 
1) samples relative to the silk-protein samples (Lane 2-3). This observed difference is likely 
due to the different degradation rates of silk:protein, and silk:PNF or silk-only films.  
 
Figure 5.24. SDS-PAGE of degradation products released from silk-only, and silk-blend films, 
in the presence of protease type XIV (top panel), α-chymotrypsin (middle panel), and 
collagenase (bottom panel), where a - after 1 day, b - after 3 days, and c - after 5 days. L- 
Ladder, 1 - silk-only, 2 - silk-CP (50:50), 3 - silk-WP (50:50), 4 - silk-CPNFs (75:25), 5 - silk-
CPNFs (50:50), 6 - silk-CPNFs (25:75), 7 - silk-WPNFs (75:25), 8 - silk-WPNFs (50:50), 9 - 
silk-WPNFs (25:75), and 10 - enzyme-only sample. Supernatant was taken from film samples 
incubated with enzymes (PBS, pH 7.4).  
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This decreased intensity of lower molecular weight bands for silk:protein films after 5 days 
(Figure 5.24 (c), middle panel, Lane 2-3) compared to the 3 days image (Figure 5.24 (b), 
middle panel, Lane 2-3) suggests that silk:protein blend films were degraded rapidly and the 
concentration of proteins remained in the supernatant after 3 days was lower than initially 
present, thus, after 5 days no significant protein or degradation bands can be detected. On the 
contrary, strong degradation bands were observed for silk-only, and silk-PNF blend films after 
5 days, suggesting to slow degradation of these films. Lack of any distinct protein band for 
silk-protein blend films, and appearance of degradation bands for all the samples after 24 h 
incubation suggests that chymotrypsin degradation is relatively faster than protease type XIV, 
and degradation peptides released from films degraded by α-chymotrypsin are of molecular 
mass less than 15 kDa. The appearance of lower molecular weight bands with size smaller than 
2.5 kDa has also been reported previously by Brown et al. (2015) for silk film degradation by 
chymotrypsin [44].  
For collagenase (Figure 5.24, bottom panel), supernatant from silk-blend films had no distinct 
protein bands for any of the samples except silk-crystallin protein (Lane 2) due to leaching of 
the proteins after 24 h of incubation (Fig 5.24 (a), bottom panel, Lane 2).  After 3 days (Fig. 
5.24 (b), bottom panel), multiple mid- and low-molecular weight protein degradation bands 
ranging from 92 kDa to 3.5 kDa were observed for silk-protein blend films only (Lane 2-3). 
After 5 days (Fig. 5.24 (c), bottom panel), the degradation bands as observed after 3 days for 
silk-protein films were still present suggesting continuous slow degradation of the proteins. 
Additionally, a distinct band between 25-30 kDa was observed for silk-protein (Lane 2-3) and 
silk-CPNFs (Lane 4-6) blend films. The absence of any distinct degradation bands for other 
samples, suggests that crystallin proteins and crystallin PNFs were least stable to collagenase 
relative to the other film samples. For both proteins (crystallins, and whey), there are not many 
collagenase cleavage sites (Appendix F, Table F1), and degradation of proteins was not 
expected. However, previous work by Li et al. (2003) showed that despite the scarcity of 
collagenase cleavage sites, collagenase can degrade porous silk sheets more than α-
chymotrypsin [42], and it is likely that longer incubation time would result in degradation of 
all the film samples despite of the scarcity for collagenase cleavage sites.  
5.19.2. Mass loss 
In agreement with the SDS-PAGE results for protease type XIV degradation, silk-protein blend 
films showed no significant change in weight for 72 h in the presence of protease type XIV, 
with films retaining 85% of their weight similar to the weight loss observed for films in PBS 
(Figure 5.25 i). A significant drop (52%) was observed in the weight of the films after 5 days, 
for films with proteins relative to the films with PNFs (40%), and silk only (31%) sample.  
For the samples incubated with chymotrypsin (Figure 5.25 ii), a gradual loss in weight was 
observed with blend films showing 10% decrease in mass after 24 h incubation relative to the 
films dissolved in PBS. A further 10% decrease was observed after 3 days, followed by a 
further drop of 5% in 5 days. The silk-only sample retained 75% of mass after 5 days.  
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Figure 5.25. Weight loss from enzymatic degradation of silk-blend films, where blank bars -
after 3 days, and filled bars - after 5 days. S1 - silk-only, S2 - silk-CP (50:50), S3 - silk-WP 
((50:50), S4 - silk-CPNFs (75:25), S5 - silk-CPNFs (50:50), S6 - silk-CPNFs (25:75), S7 - silk-
WPNFs (75:25), S8 - Silk-WPNFs (50:50), S9 - silk-WPNFs (25:75), and (i) protease type XIV, 
(ii) α-chymotrypsin, and (iii) collagenase. The remaining mass of degraded silk-blend films 
was measured after each time point and compared against the samples incubated in the 
presence of PBS (pH 7.4). Values are mean standard deviation of n=9.  
For the samples incubated with collagenase (Figure 5.25 iii), no significant drop in the mass 
was observed relative to the films incubated in the PBS, with all film samples exhibiting 15-
20% loss in mass after 5 days as anticipated from the SDS-PAGE results. Amongst all the 
enzymes studied, minimum weight loss was observed for the samples incubated in collagenase, 
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A similar trend for chymotrypsin and protease type XIV have been reported previously for silk 
film degradation and it was stated that the observed difference could also be due to the inability 
of chymotrypsin to cleave β-sheet structure [44]. This could also be held true for this work, as 
in this case silk, both proteins (whey and crystallins), and PNFs have native β-sheet structure. 
Silk-protein blend films showed high degree of weight loss in comparison to the silk only 
sample, due to the proteins dissolving/diffusing out of the carrier film, as demonstrated by the 
distinct protein bands observed on the SDS-PAGE in the presence of PBS only (Figure 5.23). 
Silk-PNF blend samples showed slower degradation (absence of any distinct bands for 72 h 
and least drop in weight) relative to silk-protein blend films in the presence of enzymes, and 
therefore, were more stable than the silk-protein blends, corroborating with the PNF stability 
results (section 2.2, Chapter Two). However, longer incubation for silk-PNF samples is 
required to understand the proteolytic degradation of silk-PNF, with PNFs only sample as a 
control.    
Both weight analysis and SDS-PAGE results suggested that the silk-blend films can be 
degraded by serine proteases, and different proteases exhibit different degradation rate. The 
number of cleavage sites for protease type XIV, and chymotrypsin are similar, and thus both 
enzymes should degrade films at the same rate. In this case, the α-chymotrypsin degradation 
was relatively faster than the protease type XIV degradation but mass loss was relatively higher 
for protease type XIV, suggesting more degradation at a slow rate. Previous studies have 
reported such difference in the behavior of these two enzymes, and demonstrated that protease 
type XIV has the potential to cleave silk at multiple locations along the length of the protein 
[53]. Although SDS-PAGE results corroborated with the mass loss studies, a further study 
using SEM is required to understand the surface topography of degraded films, and to conclude 
on the observed degradation results. However, these results suggest that degradation rate of the 
silk-blend films is dependent on the film composition, and could be matched to the potential 
application by tuning the film composition. 
5.20. Optical transmittance 
Optical transparency of blend films was investigated as for some applications, such as corneal 
regeneration, transparent material is needed. The human cornea is a transparent tissue and is 
mainly responsible for the refractive property of the eye. Thus, it is very important for corneal 
replacement materials to fulfil specific optical standards. Based on the spectrophotometric 
quantification, Ventura et al. (2005) established that a minimum threshold of 60% transparency 
is required for materials for corneal tissue engineering [54]. In a recent study, Andrades et al. 
(2015) evaluated optical transparency of tissues and materials used for corneal tissue 
engineering such as amniotic membrane and collagen scaffolds via a photographic-based assay 
and suggested a new threshold value of 72% [55]. All the films were prepared directly through 
drying the silk and blend solutions into a 24 well plate without lids, at room temperature 
(section 7.23). In ethanol annealing process, the films obtained after drying were immersed in 
75% ethanol solution for about 6 h to increase β-sheet content (section 7.20.1). Transparency 
of the solutions (Figure 5.26), and films were investigated with UV-visible spectrophotometry 
(Figure 5.27). 
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Figure 5.26. Percentage transparency of silk-only, and silk-blend solutions, where S1- silk-
only, S2 - silk-CP (50:50), S3 - silk-WP ((50:50), S4 - silk-CPNFs (75:25), S5 - silk-CPNFs 
(50:50), S6 - silk-CPNFs (25:75), S7 - silk-WPNFs (75:25), S8 - silk-WPNFs (50:50), S9 - silk-
WPNFs (25:75), and blank- 150 µL of dH2O. Error bars represent the standard deviation of 
the mean of three replicates. 
 
Figure 5.27. Percentage transparency of silk-blend films with different ratios, where (i) control 
silk films, (ii) annealed silk films, (iii) control silk films in the presence of PBS (pH 7.4), and 
(iv) annealed silk films in the presence of PBS (pH 7.4). S1- silk-only, S2 - silk-CP (50:50), S3 
- silk-WP (50:50), S4 - silk-CPNFs (75:25), S5 - silk-CPNFs (50:50), S6 - silk-CPNFs (25:75), 
S7 - silk-WPNFs (75:25), S8 - silk-WPNFs (50:50), S9 - silk-WPNFs (25:75), and blank- 24-
well plate with no films in (i and ii), and 150 µL of PBS (pH 7.4) in (iii and iv). Error bars 
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Spectral evaluation showed high transmission (transmittance between 85 and 90%) across most 
of the visible spectrum, which established the samples to be transparent. There was no major 
difference in the light transmission spectra obtained for solutions (Figure 5.26) and films 
(Figure 5.27 – dried films (i) and annealed films (ii)).  
In the visible spectrum (between 400 and 700 nm) each film sample transmitted between 85% 
and 92% of incident light, and in the middle of the spectrum (at 500 nm) 92 ± 0.1% of light 
was transmitted (Figure 5.27). No distinct change in the transparency of the silk film (S1) was 
observed on the addition of either proteins (sample S2 and S3), or PNFs at selected 
concentrations (sample S4-S9). Further, to evaluate the impact of PBS or solution on the 
transparency of the films, pre-cast films were hydrated in PBS before (1 h) and during the 
measurement. Transmission spectra of both control and ethanol annealed pre-casted films in 
the presence of PBS showed high transmittance (85-92%) (Figure 5.27, iii and iv). Spectral 
evaluation of both pre-casted dried and hydrated films showed that each of the blend film 
sample (S1-S9) exhibits good level of optical transparency (85-92%) and meet the 
requirements of minimum threshold (60-72%) required for materials for corneal tissue 
engineering. 
5.21. Hydrophobicity 
Considering that surface wettability of biomaterials plays an important role in cell 
biocompatibility, static contact angle measurements were carried out on the films obtained 
from silk-only, silk-proteins, and silk-PNF blends to assess differences in surface wettability, 
as a function of material composition. It is generally believed that hydrophillic surfaces 
promote greater cell attachment and proliferation relative to hydrophobic surfaces [56, 57]. 
However, Menzies et al. (2010) reviewed various biomaterials used for different tissue 
engineering applications, and substantiated that depending upon the potential application of the 
concerned biomaterial, enhanced wettability (low contact angle/hydrophilic) may not 
necessarily be an advantageous property [58]. The wettability of the films as determined using 
static contact angle measurements (section 7.24) for both as-cast (control or not annealed) and 
ethanol annealed films as shown in Figure 5.28, is summarised in Figure 5.29..  
The contact angle measurements of silk blend films (~38°±4 for both silk-crystallin-S2, and 
silk-whey protein blends – S3) were significantly lower than the silk-only film sample that had 
a contact angle of ~53°. An increase in contact angle was anticipated for the films with PNFs 
as SEM analysis of silk:PNF blend films showed rough surfaces for the films with PNFs. 
However, no drastic difference was observed in the contact angle measurements of silk:PNF 
blend films relative to silk-only sample (refer Table in Figure 5.29). Blend films with 25% 
and 50% PNFs (75:25 (S4 and S7), 50:50 (S5 and S8)) exhibited lower contact angle values, 
and 75% PNF-blend films (S6 and S9) showed a slight increase relative to silk-only films, for 
both whey and crystallin PNFs. 
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Upon annealing, a drop in contact angle values for the silk-protein (S2 and S3), 25:75 (S4 and 
S7), and 50:50 (S5 and S8) silk:PNFs blended films was observed, whereas, samples with the 
high amount of silk i.e. silk-only (S1), 75:25 (S4 and S7) silk:PNFs blend films displayed an 
increase. 
 
      
Figure 5.28. (i) Wet contact angle measurements of the silk-blend films, blank bars – not 
annealed films, and filled bars - after ethanol annealing, where S1-silk-only, S2 - silk-CP 
(50:50), S3 - silk-WP (50:50), S4 - silk-CPNFs (75:25), S5 - silk-CPNFs (50:50), S6 - silk-
CPNFs (25:75), S7 - silk-WPNFs (75:25), S8 - silk-WPNFs (50:50), and S9 - silk-WPNFs 
(25:75). Error bars represent the standard deviation of the mean of three replicates. (ii) Images 
of the water droplets on the silk, silk:whey protein, and silk:crystallin PNF (50:50) blend films.  
 
It should be noted that there was quite a high error for the films with PNFs due to the 
heterogeneity of the fibrils in films, as also evident from SEM images. Figure 5.29, shows 
contact angle measurement of 75% crystallin PNF film (25:75 silk:PNF blend) at two different 
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As scan be seen, two different contact angle values (56±6.4), and (84±7.8) were obtained for 
the same film at two different points, confirming that within the same film, PNFs are not spread 
homogeneously. The contact angle value obtained for the silk-only sample (S1) co-related well 
with the published literature, which also showed decreased wettability (higher contact 
angle/hydrophobicity) for silk films after water, or methanol annealing [59, 60]. These results 




Figure 5.29. Summary of contact angle measurements for all the samples, as illustrated in 
Figure 5.28. (i). Bottom - images of contact angle measurements for silk:crystallin PNFs 
(25:75) showing different contact angle measurements (i) 56±6.4 and (ii) 84±7.8, for the same 
film sample, at different points. 
5.22. Biocompatibility of silk-PNF blend films 
To evaluate the potential of using the blend films in tissue engineering application and to 
investigate the biocompatibility of blend films, in vitro cell culture experiments were 
performed. Mouse embryonic fibroblast cells were cultured on the blend films for 72 h, and 
cell attachment and spreading study was done (section 7.25). Initially, cell culture experiments 
were also conducted on silk-protein blend films, but silk-protein blend films were not stable, 
in the presence of Dulbecco's Modified Eagle's Medium (DMEM) media at 37 °C. 
     (i)                                        (ii) 
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Thus, further cell viability studies were done using silk-only, and silk-PNF blend films. All 
experiments were repeated multiple times (3×3 images were recorded for 3 separate 
experiments done on different days) to ensure reproducibility of silk-blend films. An attempt 
was made to evaluate the proliferation rate of fibroblast cells on the blend films using 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay; however, due to the 
proteinaceous nature of the films there was increased background absorbance values and assay 
artifacts were observed (see Appendix F, Figure F1). Instead, cell quantification (Figure 5.30) 
and cell morphology (spreading) (Figure 5.31) were analysed from the light microscopy 
images taken at each time-point, for each of the sample, using ImageJ methods adapted from 
Li et al. (2014) [61], as detailed in section 7.25.2.  
 
Figure 5.30. (i) Average of number of cells per 5x image on different surfaces, where a - silk-
only, b - silk:CPNFs (50:50), c - silk:WPNFs (50:50), and d - TCP surface. (ii) Average of 
number of cells per 5x image in the presence of increasing concentration of PNFs, where a -
silk:CPNF (75:25), b - silk:CPNFs (25:75), c - silk:WPNF(75:25), and d - silk:WPNFs (25:75). 
Blank bars - 24 h and filled bars - 72 h. Error bars represent the standard deviation of the 
mean of three replicates. * represents significance values: p ≤ .05, where solid-line – silk-only 
(sample a)to silk-PNF(b and c) and TCP samples (sample d) in (i), and lower concentration of 
PNFs (25%, sample a and c) to higher concentration of PNFs (75%, sample b and d) in (ii).  
For all the samples, up to 72 h of cultivation, the number of fibroblast cells cultured on the silk-
PNF blend films increased with the increasing culture period. As can be seen in Figure 5.30 
(i), silk-PNF blend films (sample - b and c), and TCP (sample d) had similar cell number and 
rate of proliferation over 3 days. Amongst silk-only (sample a) and silk-PNF blend films (b 
and c), silk-PNF blend films showed better proliferation and cell viability, with significant 
differences (p ≤ .05).  
    (i) 
    (ii) 
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On comparing, the number of viable cells on the silk:PNF blend films with increased 
concentration of PNFs, an increase in the number of cells, after 72 h, was observed for films 
with higher percentage of PNFs (Figure 5.30 (ii) filled bars, sample b and d) relative to the 
film samples with lower percentage of PNFs (Figure 5.30 (ii) filled bars, sample a and c). 
Cell images for 25% and 75% PNF content films at 24 h, and 72 h time-point, for both whey 
and crystallin fibrils are shown in Appendix F, Figure F2. 
 
Figure 5.31. Images of mouse fibroblast cells cultured cultured on - silk only (a and b), 
silk:CPNF (50:50) (c and d), silk:WPNFs (50:50) (e and f), and TCP (g and h), where (left 
panel) is 24 h, and (right panel) is 72 h. Scale bar-100 µm. 
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For investigated cell morphology, adhesion and spreading, surface area of the cells was 
measured for each 24, 42, and 72 h time-point as spreading is quantified by a significant 
flattening of the cells and an increase in overall surface area [62]. An unspreaded fibroblast 
cells appear as a rounded structures, whereas with time cells adhere to the surface and achieve 
normal spreading, and typical elongated spindle-like morphology, resulting in increased 
surface area, as can be seen in Figure 5.31 (right panel). Under the light microscope, the 
extension of cells was observed within 18 h of incubation (results not shown). At the 24 h time-
point, it was observed that a few cells had adhered on to the scaffold (Figure 5.31, left panel) 
with the majority of the cells randomly distributed on the surface of the blend films. At the 42 
h time-point, the typical spindle-like morphology and adhesion of fibroblast cells on the blend 
films was observed (results not shown). After 72 h incubation, the cell number appeared to 
have significantly increased compared with that at the 42 h, and the cells displayed the 
appropriate, extended spindle shape morphology (Figure 5.31. right panel).  
Cell attachment and morphology, results showed that cells on the silk-only surface had slower 
proliferation rate relative to the silk-CPNF and silk-WPNF blend films up to 72 h. On 
comparing the cell proliferation rate of silk-PNF films to the TCP surface, significant 
difference for both silk:CPNF, and silk:WPNF blend films was noticed, with cells showing 
better proliferation rate on silk-PNF blend films at all the given time-points (p ≤ .05), except t 
= 24 h for silk:CPNF blend films (0.231, p ≥ .05) (Figure 5.32). The higher surface area values 
observed for silk-blend films compared to the silk-only, and TCP surface suggested that blend 
films could support fibroblast cells viability and proliferation. The improved cell adhesion, 
spreading, and proliferation of fibroblasts in the presence of PNFs could be due to increased 
roughness of the surface or due to the presence of cell adhesion sites; however, further studies 
are required to confirm the advantageous properties of PNFs to act as a cellular scaffold.  
 
Figure 5.32. Analysis of fibroblast cell spread area on silk blend, and TCP surfaces after 24, 
48 and 72 h incubation, where blank bars - silk-only, red bars - silk:CPNF (50:50), green bars 
- silk:WPNF (50:50), and blue bars - TCP (control samples). Error bars represent the standard 
deviation of the mean of three replicates. * represents significance values: p ≤ .05, where, 
solid-line – silk-only to silk-PNF samples, and dotted line – TCP to silk-PNF samples.  
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5.23. Conclusion  
This section has investigated the use of PNFs as a cellular growth scaffolds. PNFs were blended 
with other biocompatible fibrous protein, namely silk, and the obtained composite films were 
studied for their suitability as a biomaterial with applications in tissue engineering. The 
transmission of visible light through the blend films was found to be greater than 80%, which 
makes them highly suitable for ophthalmic applications. In vitro proteolytic degradation of the 
blend films in the presence of serine proteases, and collagenase over 5 days, demonstrated that 
the blend films are biodegradable, and silk-PNF blend films are more stable than silk-protein 
blend films. Silk-protein blend films were not stable for cell growth and proliferation studies; 
however, the rapid degradation of these films, releasing proteins in the environment, suggests 
the possibility of using silk-protein blend films in applications where rapid degradation is 
sought after, such as drug delivery.  
In vitro cell proliferation studies revealed that silk:PNF blend films support cell proliferation, 
and had better cellular adhesion and proliferation rate relative to the silk-only films. Thus, 
PNFs demonstrate their potential to be used as substrates for the attachment and proliferation 
of cells, and can be interesting materials for tissue regeneration or scaffold preparation that 
temporarily supports the formation of new tissue and organs. Further characterisation in terms 
of mechanical integrity, long term in vitro stability, and proliferation of other cell lines/cells is 
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Chapter Six 
Summary and Future work 
6.1. Overview  
Amyloid fibrils provide several advantages as a protein nanomaterial and have the potential to 
contribute significantly in future technologies. Previous work has identified crystallin proteins 
extracted from bovine [1], and fish eye lenses [2] as a cheap and readily available source for 
the self-assembly of amyloid PNFs; however little work has been done to realise their potential 
in bionanotechnology. Thus, the main focus of this research was to characterise crystallin PNFs 
obtained from hoki fish eye lenses in terms of their applicability to bionanotechnological 
applications, and to create a functional PNF-based nanoscaffold by incorporating 
enzymatically active components. The work was broadened to include whey amyloid PNFs 
and also to investigate the utilisation of PNFs for developing cell scaffolds.  
Enzymes were chosen in this work for creating functionalised or active PNFs as many 
industrial enzymes are quite expensive and suffer from the serious drawback of poor stability 
and reusability. Additionally, for the successful application of enzymes, these catalysts need to 
be fully functional under, often harsh, processing conditions. To address some of these issues, 
PNFs are ideally suited as a readily functionalised nanoscaffold for enzyme immobilisation 
because of their innate strength, stability, and proteinaceous nature, and successful 
immobilisation of industrially important enzymes onto amyloid fibrils leads to the creation of 
cheap and readily available protein-based highly efficient matrices. 
Stability and cytotoxicity studies were done to investigate the suitability of crystallin PNFs as 
a scaffold for industrial applications, followed by immobilisation of industrially relevant 
enzymes and subsequent characterisation. To investigate the potential applications of PNFs 
obtained from crude proteins, PNFs were either assembled onto surfaces (metal, and glass), or 
blended with other proteins to create novel PNF-based bionanomaterials. GOX- and β-gal-
functionalised PNFs were adsorbed onto Au electrodes to develop PNF-based biosensing 
elements, and cyclic voltammetry was done. Active glass beads were created by immobilising 
β-gal to the surface-assembled whey PNFs to create nanosupports with increased surface area 
for biomolecule adsorption or immobilisation. Silk:PNF blend films were studied in order to 
obtain PNF-based scaffolds for cell growth and tissue engineering applications.  
 
This was the first time that crystallin PNFs were characterised for their stability and bio-
compatibility, followed by successful functionalisation and utilisation for developing PNF-
based bionanotechnologies, such as crystallin PNF-based electrodes for glucose, and lactose 
analysis.  
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Previous work has used PNFs obtained from other proteins or peptides for developing GOX-
based biosensing elements; however, co-immobilisation and utilisation of the dual- 
functionalised whey PNFs for developing PNF-based electrodes for lactose analysis is reported 
for the first time. The preliminary results for PNF-based scaffolds with applications in tissue 
regeneration look promising, although further work is necessary to optimise the use of amyloid 
PNFs in this way.  
6.2. Characterisation and functionalisation of PNFs 
To assess the biophysical aspects of PNFs before exploring them for potential applications, 
bovine insulin, crystallin, and whey amyloid fibrils were formed in solution, and studied for 
their stability under various industrial conditions, such as at a wide range of pHs, a variety of 
temperatures, in the presence of industrially related solvents, on exposure to proteolytic 
enzymes, and over long periods of storage (Chapter Two). ThT assays and TEM imaging were 
used to analyse amyloid fibrils under given conditions.  
 
Under all the studied conditions, crystallin PNFs offered similar and often improved stability 
properties relative to amyloid fibrils obtained from whey, and bovine insulin proteins. Further 
to investigate the biosafety of crystallin PNFs, a cytotoxicity study using the Hec-1a cell line 
was done. Cell viability as measured by the CVS assay, showed no evidence of cytotoxicity. 
For long term stability studies of crystallin PNFs, the results obtained from IRM studies 
suggested that crystallin amyloid fibrils maintains their structural integrity over the time period 
of 36 months. This study provided evidence that crystallin PNFs can potentially be used as 
nanomaterials, particularly in applications such as biosensing and enzyme immobilisation, 
which require prolonged solvent contact and stability over a wide range of pHs and 
temperatures. Following stability studies, crystallin amyloid fibrils were further characterised 
for available surface residues and investigated as a novel nanosupport for immobilising 
enzymes (Chapter Three).  
 
Initially, a GA-based crosslinking method as described by Pilkington et al. (2010) was studied 
for crosslinking GOX to crystallin PNFs [3], but as the established method did not result in 
successful immobilisation, a number of alternative methods were investigated including: using 
different lysine group-based crosslinkers, TCEP-based reduction, and sodium periodate-based 
oxidation of crystallin PNFs (Chapter Three, Table 3.5). Different assays were used for 
characterising available amino groups such as, the OPA, and the ninhydrin assay for amino 
group determination, Ellman’s assay for detecting the presence of sulfhydryl groups, and the 
DNPH assay for carbonyl group estimation. After successfully characterising CPNFs for  
available amino residues, different immobilisation methods were studied to immobilise 
enzymes onto the crystallin PNFs, such as physical adsorption and covalent crosslinking. 
Different crosslinkers (GA, FA, MG, Sulfo-SMCC), reaction orders, and conditions were 
investigated to obtain active or functionalised crystallin PNFs. GOX-functionalised crystallin 
PNFs were successfully obtained via both physical adsorption and amine-thiol covalent linking 
(via Sulfo-SMCC reaction, Table 3.5).  
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The oxidised CPNFs were also successfully functionalised with GOX, and β-gal via indirect 
reductive amination, in the presence of reducing agent (STAB) (Table 3.5). However, due to 
reproducibility issues, GA-based crosslinking was investigated further to obtain active 
crystallin PNFs with improved enzymatic stability and reusability (Chapter Four). 
6.3. Functionalisation of PNFs 
Building on the observations made (Chapter Three) attention was focussed on developing a 
reliable crosslinking method to obtain functionalised crystallin PNFs. This was achieved by 
using simple, versatile GA-based activation of oxidised crystallin PNFs, followed by 
incubation with biomolecules (Chapter Four). To understand the potential of crystallin PNFs 
to act as a versatile nanoscaffold, a diverse range of industrially relevant enzymes including 
GOX, β-gal, pectinase, α-amylase, and laccase were studied. Gel electrophoresis (SDS-PAGE) 
was done to confirm the immobilisation of enzymes, followed by the enzyme-specific activity 
assay (Appendix B) to determine the extent of immobilisation. TEM analysis of the 
functionalised PNFs was also done to visually confirm the presence of immobilised enzymes, 
and to ensure that the crosslinking reaction had no adverse impact on the morphology of PNFs.  
For all the enzymes investigated in this work, covalent crosslinking of enzymes onto GA-
activated oxidised crystallin PNFs resulted in better immobilisation efficiencies relative to the 
non-covalent immobilisation (physical adsorption). Further to study the impact of 
immobilisation on the stability of the enzyme, thermostability study using α-amylase 
functionalised crystallin PNFs was done at 40, 55, and 75 °C. Free α-amylase prepared by 
dissolving the enzyme in PBS (pH 7.4) to have the same activity as the α-amylase-
functionalised PNFs was used as a control sample. The results showed that α-amylase 
immobilised to crystallin PNFs via covalent crosslinking had better stability relative to the free 
enzyme at all the selected temperatures. The results from the re-usability studies showed that 
α-amylase-functionalised crystallin PNFs retained ~80% of its activity when stored at 4 °C for 
at least 30 days without any inconsistency in results. In contrast, the free enzyme had complete 
activity loss within 16 days.  
The immobilisation method developed in this research suggests that crystallin PNFs can act as 
a versatile scaffold for immobilising biomolecules. All the enzymes studied in this work were 
successfully immobilised onto crystallin PNFs and no significant loss in the activity of 
immobilised enzymes was observed. However, immobilisation efficiency, and retained activity 
differed between the different enzymes used, suggesting that for individual biomolecules, 
optimisation of the method is required to ensure effective immobilisation.  
6.4. Potential applications and proof of concepts 
The second main objective of this work was to develop PNF-based bionanotechnologies. Thus, 
PNFs were further investigated to develop PNF-based nanomaterials, as assembling amyloid 
fibrils on surfaces could potentially allow for a bottom-up approach to functional 
bionanomaterial design [4, 5].  
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6.4.1. Biosensing 
GOX- and β-gal-functionalised PNFs were adsorbed onto the gold electrodes to create PNF-
based biosensing elements (Chapter Five, Part A). The electrochemical behaviour of the 
modified electrodes was then quantified in the presence of analytes (500 mM of glucose and 
lactose), using FcOH as a mediator in solution. For both GOX and β-gal modified electrodes, 
the anodic current was seen to be amplified in the presence of analytes (glucose and lactose for 
GOX and β-gal modified electrodes respectively). These results corroborated the SDS-PAGE 
and enzyme-specific activity assays, confirming that both GOX and β-gal can be successfully 
immobilised onto the PNFs. 
To study the influence of functionalised crystallin PNFs on current amplification the electrode 
response was measured for both the enzyme only modified Au electrodes, and the enzyme 
functionalised crystallin PNFs modified electrodes in the presence of excess analyte. For GOX- 
functionalised crystallin PNFs modified electrode an increase in current response was observed 
relative to the adsorbed GOX only electrode, suggesting improved sensitivity of the electrodes 
in the presence of PNFs. However, no significant increase in electrochemical response was 
detected for the electrode modified with β-gal-functionalised crystallin PNF relative to the β-
gal (enzyme-only) modified electrode. This could be due to the lower immobilisation efficiency 
of β-gal-functionalised PNFs as compared to the GOX-functionalised amyloid PNFs. 
Additionally, in contrast to the GOX electrochemical reaction, the β-gal electrochemical 
reaction was not directly dependent on the immobilised β-gal activity, but also on the dissolved 
GOX activity, and observed difference in current amplification could be due to the diffusional 
limitations.  
To further improve the sensitivity of the β-gal active PNF-based electrode, co-immobilisation 
of GOX and β-gal was considered. Co-immobilisation improves electron transfer between the 
redox center of the enzyme and electrode due to the localised high concentrations of the 
intermediates, thereby resulting in faster response times and often higher sensitivity [6]. To 
explore if the two enzymes could be bound to the same PNFs scaffold and function in a co-
operative manner, GOX and β-gal were co-immobilised onto the whey PNFs via the GA-based 
crosslinking reaction. The results obtained from amino group-based assays (section 3.4.1, 
Chapter Three), suggested the presence of available lysine groups onto the surface of whey 
PNFs, which can be potentially used for crosslinking. Thus, to confirm if simple methodology 
developed for crystallin PNFs can be applied to other PNFs or similar structures with available 
amino residues for crosslinking, whey PNFs were studied for dual-functioanalisation work. 
Dual-functionalised PNFs were then used to evaluate if the presence of both enzymes on the 
same nanoscaffold improved electrode sensitivity for lactose analysis.  
Current amplification achieved with dual-functionalised whey PNFs modified electrodes was 
compared to enzyme (GOX+β-gal) only modified electrode, where the enzyme sample used 
was diluted in PBS (pH 7.4), to have the same activity in solution as the dual-functionalised 
whey PNF sample used. The dual-functionalised PNFs modified electrode showed improved 
current amplification as compared to the enzyme only modified electrodes.  
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Successful development of PNF-based electrodes provides evidence that functionalised PNFs 
retain their activity even after being adsorbed onto the electrodes (Au surface), and also have 
a positive impact on the sensitivity of biosensing elements. Although an increase in current 
amplification was observed for all the samples studied in the presence of PNFs, the 
concentration of PNFs used for modifying electrodes was low (1.5 mg/mL to 2 mg/mL) due to 
the blocking behaviour of PNFs. This blocking behaviour has also been reported previously for 
similar bionanostructures, such as FF peptide nanowires [7]. 
Thus, work needs to be done to improve the sensitivity of the PNF-based electrodes to realise 
the full potential of the available surface area for enzyme immobilisation. Previous work in our 
lab has demonstrated that whey PNFs can be modified with conducting polymers [8]. To 
improve the sensitivity of the lactose electrode (dual-functionalised PNF-based electrode) and 
to overcome the blocking behaviour of PNFs, modifying whey PNFs with conducting polymers 
could be considered.  
6.4.2. Surface-assembly 
Previous work by Raynes (2012) has shown that insulin PNFs can be attached onto a glass 
surface via template-directed growth. To investigate if surface-assembly is a generic property 
of PNFs, and to establish that a simple methodology developed by Raynes (2012) [9] for 
creating surfaces with self-assembled insulin PNFs is applicable to the PNFs obtained from 
other protein sources, a surface-assembly study was done for both crystallin and whey PNFs. 
Different methods were investigated for surface-assembly studies, such as with and without 
chemical derivatisation, addition of glass beads at different stages of the fibrillation process, 
and template-directed or direct surface-assembly, followed by ThT assay and confocal 
microscopy.  
Whey and crystallin amyloid fibrils were successfully assembled on the surface of 5 mm and 
micro-glass beads. This is the first time that direct-surface assembly of amyloid fibrils was 
investigated. High ThT readings were obtained for the bead samples incubated with protein 
solutions during the fibrillation process (while heating) suggesting that crystallin and whey 
amyloid fibrils can be surface-assembled via both template and direct surface-assembly 
methods. The images obtained by microscopy (confocal microscopy) showed a reasonably 
complete surface coverage of the surface-assembled PNFs (Figure 5.20). To investigate the 
impact of surface-assembled whey amyloid fibrils on the immobilisation efficiency and 
enzyme activity, β-gal was immobilised to the surface-assembled whey amyloid fibrils via GA 
crosslinking (Chapter Five, Part B), to create a PNF-based active bionanomaterial. A gain in 
immobilised β-gal was observed in the presence of PNFs relative to the enzyme immobilised 
to the glass surface samples. The surface immobilised β-gal samples were further analysed for 
activity over repetitive uses in order to investigate the effect of the PNFs on the surface of the 
glass beads. 
β-Gal activity as determined by the ONPG assay showed that the glass beads with the surface-
assembled whey PNFs retained significantly more activity after three consecutive uses relative 
to the control bead samples. Glass beads or other materials with similar surface chemistry, such 
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as cellulose-based materials are widely used in industry, and have been used in applications in 
which a range of enzymes have been immobilised to them [10, 11].  
Reusability studies of the surface-assembled active PNFs suggest that surface-assembled PNFs 
could provide more surface area and a more stable environment, leading to better 
immobilisation and improved activity of the immobilised enzymes.  
6.4.3. Tissue engineering 
There have been a limited number of previous studies on the use of amyloid fibrils obtained 
from peptides and other proteins, as a scaffold to promote cell adhesion and proliferation 
studies [12, 13]. Silk fibroin offers a number of advantages to current tissue regeneration 
materials and has been extensively investigated as a scaffolding material for tissue engineering 
applications. In this work, PNFs were blended with silk fibroin to create a novel composite 
biomaterial with potential applications in tissue engineering. Despite the various advantages, 
the blending of silk fibroin materials with PNFs was investigated to improve the functional 
shortcomings, such as shortage of cell specific-binding sites, and limited growth factor-
adsorbing capacity, while taking advantage of the structural benefits from using silk fibroin. 
Silk-protein blend films with crystallin and whey proteins were also studied as a control.  
In this work, an initial study was carried out to investigate the suitability of PNF-silk films for 
tissue engineering applications. Composite films were characterised using SEM, followed by 
proteolytic degradation, wettability, and optical transparency studies. The results from 
degradation studies suggest that PNF-blend films are biodegradable, and that the degradation 
rate of the silk-blend films is dependent on the film composition, and could be matched to the 
potential application by tuning the film composition. Blend films had 85-92% transmittance 
over the visible range, and can be used for tissue engineering applications, in which 
transparency is sought after, such as corneal regeneration. Cell growth and proliferation studies 
were also done using fibroblast cell line. The preliminary results showed that PNFs obtained 
from crude protein sources are biocompatible, and cells showed better adhesion and 
proliferation in the presence of PNFs, relative to the silk-only or silk-protein blend films.  
6.5. Future work 
This work has shown that amyloid fibrils obtained from crude protein sources can act as a 
versatile nanoscaffold by increasing the surface area for biomolecule immobilisation. The 
intrinsic surface chemistry of the amyloid fibrils enabled functionalisation of PNFs with 
enzymes via covalent crosslinking and physical adsorption methods. The results from cell 
viability studies alleviates some concerns about the potential toxicity of amyloid fibrils 
obtained from non-amyloidogenic crude proteins. The results from biosensing, surface-
assembly, and cell growth studies provide evidence that PNFs can be utilised for the creation 
of functional bionanomaterials. Future work should implement industrial applications of the 
functionalised PNFs to develop reusable nanomaterials.  
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Initial research into the creation of PNF-assembled bead system using micro-sized beads was 
commenced, but analysis and handling of the microbeads proved more difficult than the 5 mm 
glass beads, therefore future work is needed to transfer the technology to the micro system, 
which could further improve enzyme packaging, and catalytic efficiency of the reaction. For 
tissue engineering applications, future cell viability (live-dead assays), and proliferation studies 
using different cell lines are needed to confirm the observed results.  
To understand the end product formation of films with PNFs, proteolytic degradation of PNFs 
needs to be studied for longer durations, using SDS-PAGE and SEM for visually confirming 
the degradation products and structural topography of degraded films with PNFs, respectively. 
The finding that PNFs improve fibroblast adhesion was interesting, and further studies will be 
carried out to investigate whether this was due to increased surface roughness or the presence 
of cell binding sites on PNFs. Building on the protein immobilisation platform developed in 
this thesis, there is also the opportunity to modify PNFs with growth factors. These studies, 
along with mechanical analysis of the materials formed, would increase the potential for PNFs 
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Chapter Seven  
Experimental 
7.1. General methods and materials 
Unless otherwise stated, chemicals, reagents, and solvents were purchased from Sigma-Aldrich 
or Thermo Fischer Scientific, and were of analytical grade. Whey protein isolate 895 (WPI) 
was generously supplied by Fonterra, New Zealand. Macruronus novaezelandiae (Hoki), fish 
eye lenses were obtained from the local fish suppliers, Christchurch, New Zealand.  
Unless otherwise stated, enzymes were manipulated on ice or at 4 °C, and for enzymatic assays 
BioRad SmartSpec Plus Spectrophotometer or a Labtech FLUOstar OPTIMA plate reader was 
used. Centrifugation was done using an Eppendorf 5810R on a small scale (< 2 mL) using an 
F-45-30-11. For medium and large scale centrifugation a Thermo Scientific Sorvall RC6 plus 
centrifuge was used with either a SS-34 or FiberLite F10-6x500y rotor, respectively. pH 
measurements were made using an UltraBasic 10 benchtop pH meter, fitted with a high 
performance glass body pH/Tris electrode, obtained from Denver Instrument Co. 
Polyacrylamide gel electrophoresis (SDS-PAGE), was routinely run using a NuPAGE gel run 
system from Thermo Fischer Scientific. All buffers and solutions were prepared in filtered 
water using a Vacuubrand 2C (John Morris Scientific, Chatswood, NSW, Australia). 
7.1.1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
SDS-PAGE was run to confirm the purity of proteins/enzymes, and also to assess the extent of 
crosslinking and proteolytic degradation of PNFs/proteins. SDS is an anionic detergent, 
meaning that when dissolved its molecules have a net negative charge, and binds non-
covalently to protein. The negative charge contributes to the linearisation of the polypeptide 
chain by electrostatic repulsion and consecutively allows for electrophoretic separation of SDS 
coupled proteins in an electric field.  
Regular analysis of protein samples used precast Invitrogen Bolt® 4-12% Bis-Tris gels with 
10 or 15 wells. Samples were mixed with sample buffer and reducing agent (DTT to reduce 
disulphide bonds in the sample) to give a total of ~5 ng/μL of protein. Samples were then 
incubated at 90 °C for 3-5 min and then briefly centrifuged before being loaded into the gel. 
An Invitrogen Novex Sharp pre-stained protein standard was also loaded into the gel. 
Electrophoresis was carried out at room temperature at a constant voltage of 165 V for ~35 
min. The gel was then immersed in stain and microwaved for ~30 sec before placing on a Bio-
Rad Ultra Rocker for 15-30 min. The gel was then immersed in destain and placed on the Bio-
Rad Ultra Rocker until appropriately destained. The gel was viewed and photographed using a 
SYNGENE GelDoc. All the solutions used for SDS-PAGE are summarised in Table 7.1.  
 
177 |                                                                                           Chapter Seven - Experimental 
 
Table 7.1. Details of SDS-PAGE gel solutions: 
Reagent Details 
MES-SDS running buffer, [pH 7.4] 50 mM MES 
50 mM Tris base 
0.1% SDS 
1 mM EDTA 
Coomassie R-250 
 
2.5 ng/L Coomassie R-250 
10% (v/v) glacial acetic acid 
45% (v/v) methanol 
45% (v/v) dH2O 
Destaining solution 40% (v/v) ethanol 
10% (v/v) acetic acid 
60% (v/v) dH2O 
 
7.1.2. Thioflavin T (ThT) assay 
ThT dye is an amyloid protein specific dye [1]. The increase of ThT fluorescence was used to 
monitor fibrillation of proteins, using methods adopted from Raynes (2012) [2]. ThT working 
stain was made up in ThT buffer as detailed in Table 7.2. This was filtered and stored in the 
dark for up to a maximum of two days. 180 μL of ThT working stain was added to the 96-well 
flat, transparent glass plate containing 20 μL of sample. After 6 min of incubation at room 
temperature, ThT fluorescence was measured using a BMG Labtech FLUOstar Optima plate 
reader with excitation/emission filters of 450 and 485 nm, respectively (LeVine III 1999) [3]. 
Three replicates of each sample were measured.  
Table 7.2. Details of ThT assay: 
Reagent Details 
ThT buffer 50 mM Tris base  
100 mM NaCl [pH 7.5],  
ThT dye 2.5 mM in ThT buffer 
Filter through 0.2 μm 
ThT working stain 176 μl of ThT buffer 
4 μl of ThT dye 
 
7.1.3. Transmission electron microscopy (TEM) 
Formvar-coated copper grids (200 mesh) (ProSciTech) were coated with protein samples and 
negatively stained with a 2% uranyl acetate solution. TEM micrographs (14,000 x and 89,000 
x magnification) were obtained on a Morgagni 268D TEM (FEI Company, Oregon, USA) 
operating at 80 kV, fitted with a 40 μm objective aperture. Micrographs were representative of 
3 images chosen as being an overall representation of the entire sample. Many thanks to Jackie 
Healy (University of Canterbury) for her efforts to obtain TEM micrographs.  
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7.1.4. NanoDrop protein determination 
Two μL of protein solution was pipetted onto a Thermo Fisher Scientific NanoDrop 1000 after 
being blanked against the appropriate buffer. Absorbance measurements were carried out at in 
triplicate at 280 nm. Proteins absorb light at 280 nm due to aromatic amino acids, such as 
tryptophan and tyrosine. The number of aromatic residues in a protein’s sequence gives rise to 
the extinction coefficient of a protein, which was predicted using the web-based program 
“ExPASy” [4]. For protein mixtures/crude proteins an absorbance coefficient of 1.0 M-1 cm-1 
was used. After calibration of the machine with water and blanking with respective buffer, the 
absorbance of 2 μL of protein solution was measured. Measurements were undertaken at 280 
nm in triplicate. Through application of Beer’s law the concentration of protein was calculated 
automatically by the NanoDrop software.  
7.1.5. Bradford assay for determining protein concentration  
Bradford assay was done using the Bio-Rad protein assay reagent and method based on the 
Bradford dye-binding procedure [5]. Bio-Rad reagent was diluted with nanopure water in 1:4 
ratio for obtaining working solution. 10 μL of appropriately diluted protein solution was added 
to 200 μL of Bio-Rad protein working solution, mixed thoroughly and incubated at room 
temperature for 5 min exactly. The absorbance of the solutions was measured at 595 nm against 
a blank, consisting of 10 μL buffer/dH2O and 200 μL of Bio-Rad protein assay reagent. A 
standard curve was generated using BSA in a concentration range from 0 to 0.2 mg/mL. 
7.2. Amyloid fibrillation  
Bovine insulin, WPI, and crude crystallin proteins were used for the formation of amyloid 
fibrils in this work.  
7.2.1. Insulin PNFs 
Insulin amyloid fibrils were formed using in-house methods modified from Nielsen et al. 
(2001) [6]. Bovine insulin powder was dissolved at a concentration of 5.8 mg/mL (1 mM) in 
insulin fibril incubation buffer as detailed in Table 7.3. The insulin solution was then incubated 
at 60 ºC for at least 24 h. The samples were then analysed for amyloid fibrils using ThT (section 
7.1.2), and TEM (section 7.1.3). 
Table 7.3. Details of insulin fibril buffer: 
Buffer Contents 
Insulin fibril buffer 25 mM HCl 
100 mM NaCl 
Sterile filter [pH 1.6] 
 
7.2.2. Whey PNFs 
A 10 mg/mL solution of WPIs in Milli-Q water was adjusted to pH 1.6 using 1M HCl. The 
solution was stirred at 4 °C overnight and then incubated at 80 °C for 22 h [7]. 
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After heat incubation, the samples were cooled down on an ice bath for 10 min and finally 
stored at room temperature for 7 days to allow for fibril formation. The samples were then 
analysed for amyloid fibrils using ThT (section 7.1.2), and TEM (section 7.1.3). 
7.2.3. Crystallin PNFs 
For crystallin PNFs, crystallin proteins were extracted from fish eye lenses in extraction buffer 
(Table 7.4), using an IKA® Ultra Turrax® Tube disperser with Tube ST-20. After 
homogenisation was complete, the sample was centrifuged for 30 min at 10,000 rpm, the 
supernatant collected and protein concentration estimated using the NanoDrop (section 7.1.4) 
with an extinction coefficient of 1. For detailed information on crystallin fibrillation process see 
Appendix G. Briefly, the crude crystallin stock solution was diluted to 10 mg/mL into pre-heated 
25% n-propanol to 80 °C, pH 3.8. The sample was incubated for 1 h at 80 °C in a heating block 
and then centrifuged at 12,000 rpm for 2 min and the supernatant collected and heated overnight 
at 80 ºC. The sample was then left at room temperature for at least three days for the amyloid 
fibrils to assemble, and analysed for amyloid fibrils using ThT (section 7.1.2), and TEM 
(section 7.1.3). 
Table 7.4. Details of crystallin extraction buffer: 
Buffer Contents 
Crystallin extraction buffer 50 mM Tris base 
1 mM DTT 
5 mM EDTA 
Sterile filter [pH 7.5] 
 
7.3. Stability studies 
To study the stability of PNFs, pre-formed fibrils (section 7.2) were subjected to the selected 
conditions by resuspending in an appropriate buffer/solvent. ThT assay was used to indicate 
the presence of fibrils, and TEM was then used to visually confirm the presence of fibrils. 
 
7.3.1. Effect of solvents 
To study the influence of solvents onto the pre-formed PNFs, PNFs prepared as detailed in 
section 7.2 were collected by centrifugation at 12,500 rpm for 10 min, and resuspended in the 
test solvent (Table 7.5). PNFs were incubated in the test solvent for time period of 3 h. Presence 
of fibrils was assessed by the ThT assay (section 7.1.2) at time = 0, and after 3 h of incubation 
at room temperature, followed by TEM analysis (section 7.1.3).  
 
7.3.2. Effect of pH 
To study the impact of pH, PNFs prepared as detailed in section 7.2 were collected by 
centrifugation at 12,500 rpm for 10 min, and resuspended in appropriate buffers at required pH 
(Table 7.5). Presence of fibrils was assessed by the ThT assay (section 7.1.2) immediately and 
also after 24 h of incubation at room temperature followed by TEM analysis (section 7.1.3).  
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Table 7.5. Details of various buffers and solvents used for stability studies: 
Solutions Details 
Acetate buffer 100 mM sodium acetate, [pH 2.0-4.0] 
Phosphate buffer 100 mM sodium phosphate, [pH 6-7.2] 
HEPES(4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid ) buffer 
100 mM HEPES, [pH 8.0-9.0] 
Borate buffer 100 mM sodium borate, [pH 11.0] 
Methanol (MeOH) 100% MeoH 
Ethanol (EtOH) 100% EtOH 
Iso-propanol (iPrOH) 100% iPrOH 
Dimethyl sulfoxide (DMSO) 100% DMSO 
Acetonitrile (ACN) 100% ACN 
 
7.3.3. Effect of temperature 
For temperature stability, pre-formed fibrils (section 7.2) were incubated at selected 
temperatures (-20 °C, 4 °C, 22 °C, 37 °C and 80 °C) for the time period of 24 h and aliquots 
were taken after 3 h, 6 h, 12 h and 24 h. The presence and morphologies of amyloid PNFs were 
confirmed using the ThT assay (section 7.1.2) and TEM imaging (section 7.1.3). 
7.3.4. Proteolytic degradation of amyloid PNFs 
PNFs prepared as detailed in section 7.2 were collected by centrifugation at 12,500 rpm for 10 
min, and resuspended in required buffers. For trypsin and Proteinase K hydrolysis, the pH of 
the fibril solutions was adjusted to 7.5. For pepsin it was kept at pH 1.6. The total volume was 
adjusted with distilled water to yield a final protein concentration of ~10 mg/mL. Enzymes 
were added in an enzyme:fibril ratio of 1:20 (w/w). The fibril samples were incubated with the 
enzymes for 3 h, taking 200 µL aliquots at various time intervals (0, 20, 60, 180 min).  
Proteinase K and trypsin hydrolysis were terminated by adjustment to pH 1-2 with 1 M HCl, 
and pepsin digestion through adjustment to pH 7 with 100 mM NaHCO3. The presence and 
morphologies of amyloid PNFs were confirmed using the ThT assay (section 7.1.2) and TEM 
imaging (section 7.1.3). Enzyme stock solutions were prepared (10 mg/mL) by dissolving 20 
mg/mL enzyme in appropriate buffer (see Table 7.6). Diluted 1:1 with 100% glycerol, 
aliquoted into 200 µL, snap frozen and stored at -20 °C.   
Table 7.6. Fibril proteolysis buffers: 
Solutions Contents 
Trypsin 50 mM Tris base  
100 mM NaCl  
Sterile filter  [pH 7.5] 
Pepsin 10 mM HCl  
100 mM NaCl  
Sterile filter [pH 3-4] 
Proteinase K (PK) 50 mM Tris base  
100 mM NaCl  
Sterile filter  [pH 7.5] 
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7.4. Cytotoxicity studies 
Due to the association of amyloid PNFs with neurodegenrative diseases, the potential toxicity 
of crystallin PNFs was investigated using Hec-1a cells.  
7.4.1. Hec-1a cell line-Subculturing 
Hec-1a cells (passage 10) were cultured in Minimum Essential Medium (MEM) (GIBCO®, 
Carlsbad, CA, USA) with GlutaMAX™ (1x), penicillin (100 U/mL), streptomycin (100 
mg/mL), and 5% fetal bovine serum (FBS). Cells were washed with sterile PBS and harvested 
in trypsin EDTA (1x) for 10-15 min. The cells were diluted 1:1 in PBS (pH 7.4) and centrifuged 
at 1,500 rpm for 5 min. The supernatant was replaced and the pellet taken up in 10 mL of 
medium. Viable cell density was determined using a hemocytometer. The Hec-1 cells were 
diluted to 4 x 108 cells/mL in media and used to seed 12-well plates (500 μL/well) for 48 h at 
37 °C (80% confluence).  
 
7.4.2. Treatment 
Medium was removed from the seeded Hec-1a cells prior to treatment. Each treatment 
consisted of 500 μL of sample protein at ~10 mg/mL in PBS (final concentration ~5 mg/mL) 
mixed with 500 μL of medium (MEM) respectively. Cells were incubated at 37 °C for 24 h. At 
least three replicates for each condition were measured. The control used was cells + medium 
+ buffer (PBS). Further, to assess if cells use protein as a nutrient source, cells were pre-
incubated in the absence of FBS overnight to starve them prior to the addition of treatments. 
 
7.4.3. Crystal violet assay 
The medium of the treated cells was discarded and 300 μL of crystal violet stain was added to 
each of the 12 wells. After staining for 15 min the excess stain was thoroughly washed off with 
distilled water until completely removed. The plates were dried before re-solubilising the 
stained cells in 1 mL of 2% SDS solution per well. After solubilising the dye-containing cells, 
the absorbance of the solutions was measured at 570 nm on a Labtech FLUOstar OPTIMA 
plate reader (BMG Labtech GmbH, Offenburg, Germany). 
 
7.5. Infrared (IR) microscopy studies  
After storage in the original solvent for long periods of time (up to 37 months), the fibril 
samples were washed in water 3 times by centrifugation (10,000 rpm for 10 min each wash) 
and concentrated to a final concentration > 100 mg/mL. Infrared microspectroscopy was 
carried out by Ljiljana Puskar, Mark J. Tobin, and Celine Valery at  the Australian Synchrotron, 
using the IRM beamline which combines a Bruker V80v Fourier transform infrared (FTIR) 
spectrometer and a Hyperion 2000 IR microscope with a liquid nitrogen cooled narrow-band 
mercury cadmium telluride (MCT) detector.   
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A small amount of washed fibril sample was placed between two diamond windows of a 
ThermoFisher (Waltham, MA, USA) micro compression cell and the data collected in 
transmission mode with a microscope aperture defining a measurement area of 5 μm x 5 μm 
on the sample. The supernatant from the last wash was used as the background. Each spectrum 
was collected in the mid-infrared spectral range (4000–700 cm-1) with 64 co-added scans and 
spectral resolution of 4 cm-1. Bruker OPUS 6.5 software was used for data collection and 
Bruker OPUS 7.2 for the spectral analysis and for the calculation of the second derivative using 
a 9 to 15 point Savitzky-Golay filter. Many thanks to Celine Valery and Luigi Sasso for the 
help with analysing the data. 
 
7.6. Characterisation of PNFs and assays 
7.6.1. o‐Phthaldialdehyde (OPA) assay  
The OPA assay was carried out using in-house methods, based on those of Roth (1971) [8]. 
The OPA solution was prepared as detailed in Table 7.7. OPA solution (200 µL) was added to 
20 µL of the sample of interest, in a 96 microwell plate and kept for five min in dark conditions. 
The absorbance of the sample was then read at a wavelength of 340 nm using a BioRad 
SmartSpec Plus Spectrophotometer.   
Table 7.7. Details of OPA assay reagent: 
Reagent Details 
OPA Buffer                      25 mL of 100 mM sodium borate  
OPA solution 40 mg OPA reagent in 1mL of methanol 
100 µL of mercaptoethanol 
Final volume adjusted to 50 mL with dH2O   
 
7.6.1.1. OPA standard curve  
A standard curve for the OPA assay was created using lysine, dissolved in nanopure H2O at 
concentrations from 0-200 µM, using the protocol described in section 7.6.1. All samples were 
assayed in triplicate.  
7.6.1.2. OPA assay of samples  
The OPA assay was carried out on samples containing either native protein or amyloid fibrils   
using the protocol described in section 7.6.1. A control sample containing the fibril formation 
buffer was also assayed.  All samples were assayed in triplicate.   
7.6.2. Ninhydrin assay  
The ninhydrin assay was carried out using in-house methods [9]. Ninhydrin buffer was 
prepared by a 1:3 mixture of lithium acetate buffer and ninhydrin solution (Table 7.8), and 
stored, covered with foil, at 4 °C. The ninhydrin buffer was added to diluted protein samples 
in a 1:1 ratio, along with a blank sample containing PBS. The samples were heated at 90 °C 
for ten min, vortexed after 5 min and then placed back to heat.  
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The samples were then cooled on ice. 300 µL of 95% (v/v) ethanol was then added to 300 µL 
of each sample and vortexed, followed by the absorbance measurement of the sample at a 
wavelength of 570 nm. 250 µL of the sample was added to the 96 microwell plate, and read at 
570 nm, using a BioRad SmartSpec Plus Spectrophotometer.  
Table 7.8. Details of ninhydrin assay reagent: 
Reagent Details 
Ninhydrin buffer 4 M Lithium acetate buffer 
[pH 5.2, adjusted with acetic acid] 
Ninhydrin solution 0.01 M ninhydrin  
0.01 hydridantin  
75% (v/v) DMSO    
7.6.2.1. Ninhydrin standard curve  
A standard curve for the ninhydrin assay was created using lysine, dissolved in dH2O at 
concentrations from 0 – 200 µM, using the protocol described in section 7.6.2. All samples 
were assayed in triplicate.   
7.6.2.2. Ninhydrin assay of samples  
The ninhydrin assay was carried out on samples containing either native protein or amyloid 
PNFs using the protocol described in section 7.6.2. Samples were diluted with 95% ethanol 
when needed to obtain an absorbance below 1.0. A control sample containing the fibril 
formation buffer was also assayed. All samples were assayed in triplicate. 
7.6.3. Ellman’s assay  
Ellman’s was carried out using in-house methods, based on those of Riddles et al. (1983) [10]. 
Ellman’s solution was prepared as detailed in Table 7.9. Ellman’s solution (250µL) was added 
to 50 µL of the sample of interest, in a 96 microwell plate and kept for 15 min in THE dark 
conditions. The absorbance of the sample was then read at a wavelength of 412 nm using a 
BioRad SmartSpec Plus Spectrophotometer. 
Table 7.9. Details of Ellman’s assay reagent: 
Reagent Details 
Ellman’s buffer 100 mM sodium phosphate, [pH 8.0] 
Ellman’s solution 4 mg/mL of Ellman’s reagent in Ellman’s     
buffer 
 
7.6.3.1. Ellman’s standard curve  
A standard curve for Ellman’s assay was created using cysteine, dissolved in dH2O at 
concentrations from 0 – 200 µM, using the protocol described section 7.6.3. All samples were 
assayed in triplicate.   
 




7.6.3.2. Ellman’s assay of samples  
Ellman’s assay was carried out on samples containing either native protein or amyloid fibrils   
using the protocol described in section 7.6.3. A control sample containing the fibril formation 
buffer was also assayed. All samples were assayed in triplicate.   
7.6.4. TCEP reduction of the crystallin PNFs 
Crystallin amyloid PNFs at the final concentration of ~10 mg/mL in PBS (pH 7.4), were treated 
with 20 mM TCEP bond breaker solution, purchased from Thermo scientific, for 30 min. TCEP 
treated fibrils were then collected by centrifuging the fibrils for 10 min at 12,500 rpm in an 
Eppendorf® Minispin® Plus benchtop centrifuge, with the fibrils then resuspended in 100 mM 
PBS (pH 7.4). This washing step was repeated thrice to ensure the removal of any residual 
TCEP. 
7.6.5. Traut’s reagent 
Traut’s solution was prepared by dissolving 2 mg/mL in PBS (pH 7.4), resulting in 14 mM 
stock solution. Amyloid fibrils (~10 mg/mL) were then treated using a 10 fold molar excess of 
Traut’s solution added - 46 µL of the 14 mM stock solution to each mL of amyloid fibril 
solution and incubated for 1 h at room temperature. To separate thiolated amyloid PNFs from 
excess Traut’s reagent, treated fibrils were then collected by centrifuging the fibrils for 10 min 
at 12,500 rpm in an Eppendorf® Minispin® Plus benchtop centrifuge (3X), and resuspended 
in 100 mM, PBS (pH 7.4). Sulfhydryl groups were then characterised using Ellman's assay 
(section 7.6.3). 
7.7. Glycosylation of crystallins 
7.7.1. Glycoprotein staining  
Glycoprotein gels were run using the Molecular Probes Pro-Q Emerald 300 Glycoprotein Gel 
and Blot Stain Kit (Invitrogen). Details of all the solutions used for glycoprotein staining are 
detailed below (Table 7.10). Proteins were first separated by standard SDS-PAGE (section 
7.1.1). The gel was then fixed by immersing the gel in approximately 100 mL of fix solution, 
and incubating at room temperature with gentle agitation for 45 min. This step was repeated to 
ensure the SDS was fully washed out of the gel. The gel was incubated in approximately 100 
mL of wash solution, with gentle agitation for 10-20 min. This step was also repeated. The 
carbohydrates were oxidised by incubating the gel in 25 mL of oxidising solution, with gentle 
agitation for 30 min. The gel was washed in approximately 100 mL of wash solution with 
gentle agitation for 10-20 min, and this step was carried out three times.   
The gel was stained by incubating in the dark in 25 mL of Pro-Q Emerald 300 staining solution, 
while gently agitating for 90-120 min. The gel was washed by incubation for 15-20 min in 100 
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mL wash solution with gentle incubation. The stained gel was visualised using a 300 nm UV 
transilluminator, and gel images captured using a BioImaging System (Syngene).   
 
Table 7.10. Details of glycoprotein gel solutions: 
Reagents Details 
Pro-Q Emerald 300 Stock Solution Pro-Q Emerald 300 reagent dissolved in 6 
mL of N,N-Dimethylformamide (DMF) 
Fix solution 50% methanol,  
5% glacial acetic acid, and dH2O 
Wash solution 3% glacial acetic acid  
Oxidising solution 2.5 g periodic acid,  
250 mL 3% glacial acetic acid  
Pro-Q Emerald 300 Staining Solution Pro-Q Emerald 300 Stock Solution diluted 
50-fold into Pro-Q Emerald 300 Staining 
Buffer,prepared fresh before each use. 
 
7.7.2. Periodate oxidation of crude crystallin proteins 
Periodate oxidation of crude crystallin proteins was done using sodium metaperiodate (Thermo 
Scientific), prepared in an oxidation buffer (Table 7.11). Different concentrations of sodium 
metaperiodate were investigated: 10 mM, 20 mM, 30 mM, 40 mM, and 50 mM. Reaction 
sample were incubated for 1 h at room temperature, in dark conditions. The extent of sodium 
metaperiodate oxidation was then assessed by running a glycoprotein staining gel (section 
7.7.1). 
Table 7.11. Details of periodate oxidation reaction: 
Solutions Details 
Oxidation buffer 100 mM sodium acetate 
Sterile filter [pH 4.5] 
Reaction solution 60 mM sodium meta-periodate dissolved in 
oxidation buffer, and diluted to obtain 
required concentration 
~20 mg/mL crystallin protein in extraction 
buffer 
Both in 1:1 ration [pH 4.5] 
 
7.7.3. Periodate oxidation of crystallin PNFs  
Crystallin PNFs at the final concentration of ~10 mg/mL was incubated with 30 mM final 
concentration of sodium metaperiodate in oxidation buffer (Table 7.11), and pH re-adjusted to 
4.5, for 2 h at room temperature, in dark conditions. Aliquots (500 µL) were taken every 30 
min, for 3 h, followed by centrifugation. To remove any excess periodate, treated fibrils were 
washed, and then collected by centrifuging the PNFs for 10 min at 12,500 rpm in an 
Eppendorf® Minispin® Plus benchtop centrifuge, and resuspended in 100 mM PBS (pH 7.4). 
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This washing step was repeated thrice to ensure the removal of any residual periodate. The 
presence of carbonyl groups were then characterised using DNPH assay (section 7.8) 
 
7.8. DNPH assay 
Carbonyl group quantification of oxidised crystallin PNFs was done by using the methods of 
Mesquita et al. (2014) [11]. DNPH solution was prepared at the concentration of 10 mM in 50 
mM phosphorous acid (H3PO3) buffer and vortexed until it is completely dissolved. For the 
assay, 400 µL of DNPH solution was added to 400 µL of oxidised crystallin amyloid fibrils 
and control samples, and incubated for 10 min at room temperature. To this, 200 µl of 6 M 
NaOH was added and samples incubated for another 10 min at room temperature. The 
absorbance of the sample was then read at 450 nm against a blank solution containing 100 mM 
PBS (pH 7.4) as a substitute for the crystallin amyloid PNFs. As hydrazone products formed 
by the reaction of DNPH with carbonyl groups are highly unstable in alkaline conditions, so 
incubation time after adding NaOH, was carefully monitored and readings were taken strictly 
after 10 min for each of the samples.  
7.9. Crosslinking experiments 
7.9.1. Physical adsorption  
GOX was incubated with PNFs in the absence of any crosslinking reagent. Both reduced 
(TCEP treated, section 7.6.4), and non-reduced crystallin PNFs were studied for physical 
adsorption experiments.  
7.9.1.1. Non-reduced crystallin PNFs  
The crosslinking reaction involved ~10 mg/mL crystallin PNFs, and GOX in 100 mM PBS (pH 
7.4), at a ratio of 1:1 (250 μL each). Different concentrations of GOX used for crosslinking 
reaction were: 0.5, 1, and 2 mg/mL. The samples were incubated either at 4 °C for 24 h, or 2 h 
at 26 °C, after which the samples were run on an SDS-PAGE to ensure that crosslinking had 
occurred (section 7.1.1).  
7.9.1.2. Reduced crystallin PNFs 
The reduced CPNFs obtained via TCEP reduction (section 7.6.4) were incubated with different 
concentrations of GOX for the crosslinking reaction as detailed in section 7.9.1.1.  
7.9.2. Procedure for sulfydryl group-based crosslinking using Sulfo-SMCC 
For Sulfo-SMCC based crosslinking, Sulfo-SMCC was purchased from Thermo Scientific, 
product number 22360. Method used for the crosslinking of GOX to crystallin amyloid PNFs 
were based on the protocol provided with the Sulfo-SMCC. Briefly, for GOX coupling to 
Sulfo-SMCC, ~2.5 mg/mL GOX dissolved in 100 mM PBS (pH 7.4), was treated with 10 molar 
excess of Sulfo-SMCC for 30 min at room temperature. To separate conjugated GOX-SMCC 
from unreacted Sulfo-SMCC in the solution, desalting column was used (section 7.9.2.1.). The 
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crystallin PNFs (~10 mg/mL) were then mixed by inversion with desalted GOX-SMCC in 1:1 
ratio (100 μL each) and incubated for 24 h at 4 ºC. To investigate crosslinking, SDS-PAGE 
was done (section 7.1.1).  
Functionalised amyloid PNFs were then collected by centrifuging the sample for 10 min at 
12,500 rpm in a Eppendorf® Minispin® Plus benchtop centrifuge (3X), with the fibrils then 
resuspended in 100 mM PBS (pH 7.4), and stored at 4 °C for activity assay (Appendix B, section 
B1.1) and TEM analysis (7.1.3). 
7.9.2.1. Desalting of crosslinked GOX-SMCC 
When using the desalting column, the column was first equilibrated with 3 column volumes of 
the PBS (pH 7.4) before loading the sample. The GOX-SMCC sample was then eluted and 
fractions collected. For protein quantification, nanoDrop measurements were taken (section 
7.1.4) and fractions containing the protein were then pooled. 
7.9.3. Direct coupling reaction for functionalising oxidised 
crystallin PNFs 
The crosslinking reaction involved ~10 mg/mL oxidised crystallin PNFs, and GOX in 100 mM 
PBS (pH 7.4), at a ratio of 1:1 (250 μL each). The sample was incubated for 1 h at 26 °C, after 
which the samples were run on SDS-PAGE to confirm that crosslinking had occurred (section 
7.1.1). Attempts were made by varying the reaction conditions, including using other enzymes, 
such as β-gal. Details of the different reaction conditions used are summarised in Table 7.12. 
Table 7.12. Details of different conditions attempted for functionalising oxidised crystallin 
PNFs, where GOX - glucose oxidase, β-gal - β-galactosidase, O-CPNFs - oxidised crystallin 
fibrils: 
Methods Conditions 
Total reaction time 30 - 120 min, 6 h, 12 h, and 24 h reaction 
Reaction temperature (°C)  26, 37, and 4 
Total reaction time  2-6 h, overnight, or 24 h 
O-CPNFs concentration (mg/mL)  10, 15, and 20 
Enzyme concentration (mg/mL)  1, 2, 2.5 and 4; alternatively β-gal at ~2.9 was 
also used 
pH of the reaction 100 mM sodium acetate, [pH 5.5] 
100 mM sodium phosphate, [pH 7.2] 
50 mM HEPES, [pH 8.0] 
 
7.9.4. Reductive amination reaction  
7.9.4.1. Using sodium borohdyride (NaBH4) and Boric acid (H3BO3) 
The method used for functionalising oxidised crystallin amyloid fibrils with GOX via reductive 
amination reaction using NaBH4 and H3BO3, was based on the methods of Cho and Kang 
(2005) [12]. The crosslinking reaction involved ~10 mg/mL oxidised-crystallin amyloid PNFs, 
10 mM NaBH4 and 0.6 mg/mL GOX in 100 mM PBS (pH 7.4), at a ratio of 1:1:1 (100 μL 
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each). Where H3BO3 activated NaBH4 was used, 10 mM H3BO3 was mixed with 10 mM 
NaBH4 (1 mL of each), in dH2O, and left on bench for 15-20 min for activation.  
The amyloid PNFs were first mixed by inversion with GOX, and pre-incubated for 15 min, 
after which the NaBH4 and H3BO3 activated NaBH4 was added and the sample mixed by 
inversion again. The sample was incubated for 1 h at 26 °C. The degree of crosslinking was 
then assessed by SDS-PAGE (Section 7.1.1). Alternatively, attempts were made by varying the 
reaction conditions (Table 7.13). Functionalised amyloid fibrils were then collected by 
centrifuging the sample for 10 min at 12,500 rpm in an Eppendorf® Minispin® Plus benchtop 
centrifuge (3X), with the fibrils then resuspended in 100 mM PBS (pH 7.4), and stored at 4 °C.     
Table 7.13. Details of different reaction conditions used for crosslinking via reductive 
amination: 
Conditions Details 
pH of the reaction 100 mM sodium phosphate, [pH 7.4] 
100 mM HEPES, [pH 9.0] 
Reaction temperature, and time 26, 37, and 4 °C 
Reaction time- 5 to 15 min 
Total reaction time- 30 min to 2 h 
Concentration of PNFs, and NaBH4 
solution 
5-20 mg/mL of PNFs; 5 mM-1mM of NaBH4 
Solvents 50% MeoH 
50% EtOH 
50% Tetrahydrofuran (THF) 
7.9.4.2. Reductive amination reaction using sodium triacetoxyborohdyride 
(STAB)  
Enzyme immobilisation using STAB was based on the methods of Abdel-Magid (1996) [13]. 
1 M STAB was prepared in isopropanol. A starting concentration of ~10 mg/mL oxidised 
crystallin amyloid PNFs; with a starting concentration of ~2.2 mg/mL GOX. The oxidised 
crystallin amyloid PNFs were first mixed by inversion with enzyme (~2.2 mg/mL GOX, and 
~2.9 mg/mL of β-gal), and pre-incubated for 10 min, after which the STAB was added, and 
mixed by inversion again. Total reaction volume was 300 μL, including 100 μL of each - 
crystallin PNFs, enzyme, and STAB. The reaction samples were incubated at 26 °C for 1 h, 
and a SDS-PAGE gel was done to confirm the crosslinking reaction (Section 7.1.1). 
Functionalised amyloid fibrils were then collected by centrifuging the sample for 10 min at 
12,500 rpm in an Eppendorf® Minispin® Plus benchtop centrifuge (3X), with the fibrils then 
resuspended in 100 mM PBS (pH 7.4), and stored at 4 °C.     
7.10. GA-activation of oxidised crystallin PNFs 
Methods used for GA-activation of oxidised crystallin amyloids were based on the protocol 
established by Pilkington et al. (2010) [14]. The reaction involved ~10 mg/mL crystallin PNFs, 
2.5 mM GA, in 100 mM PBS (pH 7.4), at a ratio of 1:1. The sample was incubated for 1 h at 
26 °C. GA-activated PNFs were then collected by centrifuging the sample for 10 min at 12,500 
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rpm (3X), with the fibrils then resuspended in 100 mM PBS (pH 7.4), and used for crosslinking 
experiments. 
7.11. Functionalising GA-activated oxidised crystallin amyloid 
PNFs 
GOX was the first enzyme to be immobilised to the GA-activated oxidised crystallin PNFs. 
The immobilisation methods developed for GOX formed the basis of the immobilisation 
methods for all subsequent enzyme immobilisation. A two-step immobilisation protocol was 
implemented, where the amyloid fibrils were first mixed with the GA, followed by the addition 
of the enzyme [15]. In all of the immobilisation reactions, the components of the 
immobilisation reaction were added in equal parts. A typical immobilisation reaction contained 
250 μL of each component.  
7.11.1. GOX immobilisation to the GA-activated oxidised crystallin amyloid 
fibrils 
GA-activated amyloid fibrils (~10 mg/mL) (section 7.10) were mixed with GOX (~2.2 mg/mL) 
and the reaction incubated at 26 °C for 1 h. To quench the reaction 100 mM Tris buffer (pH 
8.0) was added to the immobilisation mixture. Samples were then run on a SDS-PAGE (Section 
7.1.1), and analysed for activity using Amplex Red assay (Appendix B, section B1.1). 
7.11.2. Method development for functionalising crystallin PNFs with other 
important industrial enzymes 
To determine an appropriate concentration for crosslinking enzymes to the GA-activated 
CPNFs, OPA assay (section 7.6.1) was done on each of the enzyme sample, to ensure that the 
enzyme sample offers similar number of amine groups as offered by the GOX enzyme sample 
at the ~2.2 mg/mL concentration. Bradford assay was used (section 7.1.5) to determine the 
concentration of each enzyme. Enzyme at the selected concentration was added to the GA 
activated CPNFs (~10 mg/mL), and incubated for 30 min at room temperature. The extent of 
crosslinking was then assessed by using SDS-PAGE (7.1.1), and checked for their activity to 
assess the optimal concentration of enzyme for the crosslinking reaction without any significant 
loss in their activity as assessed by the activity assays (see Appendix B, section B1.2 – B1.5).  
For the crosslinking reaction, the GA-activated CPNFs (~10 mg/mL) and enzymes were mixed 
in 1:1 ratio, at the given concentration as determined by the Bradford assay: 2.5 mg/mL β-gal; 
3.5 mg/mL pectinase; 4 mg/mL α-amylase; and 3.5 mg/mL laccase. The reaction samples were 
mixed by inversion, and incubated for 1 h at 26 °C. To quench the reaction 100 mM Tris buffer 
(pH 8.0) was added to the immobilisation mixture, followed by SDS-PAGE analysis, to assess 
the extent of crosslinking. Functionalised amyloid fibrils were then collected by centrifuging 
the sample for 10 min at 12,500 rpm in an Eppendorf® Minispin® Plus benchtop centrifuge 
(3X), with the fibrils then resuspended in 100 mM PBS (pH 7.4), and stored at 4 °C.     
7.11.3. Co-immobilisation of GOX and β-gal 
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For co-immobilisation experiment, whey PNFs obtained as detailed in section 7.2.2 were 
centrifuged (for 10-15 min at 12,500 rpm in an Eppendorf® Minispin® Plus benchtop 
centrifuge (3X), collected, and resuspended in PBS (pH 7.4).  
A starting concentration of ~10 mg/mL whey PNFs (100 μL), with a starting concentration of 
7.5 mM GA (100 μL), and a starting concentration of ~2.2 mg/mL GOX (50 μL) and 4.2 
mg/mL β-gal (50 μL) were mixed by inversion, and incubated for 1 h at 37 °C. The reaction 
was quenched with 100 μL of 100 mM Tris buffer (pH 8.0), followed by SDS-PAGE (section 
7.1.1), and activity assay analysis (Appendix B, using Amplex Red assay (section B1.1) for 
GOX, and ONPG assay (section B1.2) for β-gal, respectively). 
7.12. Thermostability experiment 
Free α-amylase, crosslinked α-amylase, α-amylase with GA and control samples were 
incubated in temperature controlled dry bath heater (Labnet International Inc., Woodridge, NJ, 
USA). The temperatures used were 40 °C, 55 °C and 75 °C, and readings were taken at time 0, 
3, 6, 9, 12 and 24 h. Samples were allowed to cool by keeping them on ice (5-10 min) before 
performing starch hydrolysis reaction [16]. The activity of free and immobilised α-amylase 
samples was determined using starch-iodine test (Appendix B, section B1.4) using initial 
reading for starch (un-hydrolysed starch) as the 100% value. Subsequent activity readings were 
measured as a % decrease in the initial starch reading, which corresponds to the amount of 
starch being hydrolysed by the α-amylase samples.  
7.13. Reusability experiment 
The storage stability of free and immobilised α-amylase at 4 °C was measured by calculating 
the residual activity over the time period of 30 days. Reusability of immobilised enzyme was 
also investigated by measuring its activity after repeated cycles of use. After each hydrolysis 
reaction, the functionalised fibrils were thoroughly washed in 100 mM sodium acetate buffer, 
pH 4.5 and stored at 4 °C, before being used for the next hydrolysis reaction. The relative 
activity (compared to initial amount of starch present) of both free and immobilised sample 
and the amount of reducing sugar produced was determined by using both the starch-iodine 
and the DNS assay (Appendix B, section B1.3 and 1.4). 
7.14. Electrochemistry Studies 
Electrochemistry studies were done on functional amyloid PNFs, including GOX-, β-gal-, and 
dual-functionalised amyloid PNFs. Electrochemical characterisation of functionalised PNFs 
was carried out on commercial screen-printed electrodes (C223AT) from DropSens (Oveido, 
Spain). 2 µL of functionalised amyloid fibril solution were deposited onto the electrode, and 
excess solvent removed by evaporation for one h at 37 °C or overnight at room temperature.  
Cyclic Voltammetry (CV) was carried out in the presence of 1.5 mM FcOH in 100 mM PBS 
(pH 7.4) using a potentiostat from eDAQ Pty Ltd (Denistone East, Australia) with a Dropsens 
connector DRP-CAC to connect the screen-printed electrode to the potentiostat. 
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7.14.1. Electrochemical characterisation of GOX-functionalised crystallin 
amyloid PNFs 
The catalytic activity of the electrode modified with GOX-functionalised crystallin PNFs (2 
mg/mL) was quantified via cyclic voltammograms in the absence and presence of excess 
glucose (500 mM), using 1.5 mM FcOH in 100 mM PBS (pH 7.4) as a mediator in solution. 
Potential sweep rates were 100 mV/s, using an Au counter and Ag reference electrode. Control 
experiments were carried out on electrodes modified with GOX-only, which had been diluted 
in 100 mM PBS (pH 7.4) to have the same activity in solution as the GOX-functionalised 
crystallin PNFs used for the electrochemistry experiments. 
7.14.2. Electrochemical characterisation of β-gal-functionalised crystallin 
amyloid PNFs 
The catalytic activity of the electrode modified with β-gal-functionalised crystallin PNFs (2 
mg/mL) was quantified via CV, in the absence and presence of excess lactose (500 mM), using 
1.5 mM FcOH in 100 mM PBS (pH 7.4) and GOX (2 mg/mL) as a mediator, in solution. 
Potential sweep rates were 100 mV/s, using an Au counter and Ag reference electrode. Control 
experiments were carried out on electrodes modified with β-gal only, which had been diluted 
in 100 mM PBS (pH 7.4) to have the same activity in solution as the β-gal functionalised 
crystallin PNFs used for the electrochemistry experiments. 
7.14.3. Electrochemical characterisation of dual-functionalised PNFs  
The catalytic activity of the electrode modified with dual-functionalised whey PNFs (1 mg/mL) 
was quantified via cyclic voltammograms in the absence and presence of excess lactose (500 
mM), using 1.5 mM FcOH in 100 mM PBS (pH 7.4) as a mediator in solution. Potential sweep 
rates were 100 mV/s, using an Au counter and Ag reference electrode. Controls experiments 
were carried out on electrodes modified with GOX+β-gal enzyme mixture, which had been 
diluted in 100 mM PBS (pH 7.4) to have the same activity in solution as the dual functionalised 
whey PNFs used for electrochemistry experiments. For lactose dependent study, different 
lactose concentrations were prepared by dissolving 20, 40, 60, 80, and 100 mM lactose in PBS 
(pH 7.4). Stock 20 mM lactose solution was diluted further in PBS (pH 7.4) to obtain 0 - 2.5 
mM lactose solution.  
7.15. Surface-assembly 
5 mm diameter and micro beads (425-600 µm) borosilicate glass beads purchased from Sigma-
Aldrich were used as a model surface for the surface-assembly of PNFs. The methods used 
were adapted from Raynes (2012). [2] 
7.15.1. Glass bead surface activation  
Glass beads were cleaned overnight in a Piranha solution of 70% H2SO4, 30% H2O2 followed 
by rinsing in dH2O. For rinsing, glass beads were first immersed in dH2O (500 mL) for 2-3 
min, and dH2O replaced with fresh dH2O. This step was repeated up to 4-6 times.  
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7.15.2. APTS activation of glass beads 
The beads after Piranha activation (section 7.15.1) were then treated with a 3% APTS solution 
in ethanol/water (95:5 v/v) for 1 h, immersed in 99.9% ethanol and cured at 110 °C for 1 h. 
The beads were allowed to cool followed by washing in 95% ethanol and left to dry.  
7.15.3. Ninhdyrin assay for glass beads 
The ninhydrin assay was carried out on bead samples after surface activation with APTS 
solution, using the protocol described in section 7.6.2. A control sample containing the 3 % 
APTS solution was also assayed and used for calibrating the readings. All samples were 
assayed in triplicate. 
7.15.4. N, N’- disuccinimidyl carbonate (DSC) activation of glass beads 
The APTS-activated beads (section 7.15.2) were allowed to cool and washed in 95% ethanol 
followed by treatment with 20 mM DSC in a 50 mM sodium bicarbonate (NaHCO3) (pH 8.5) 
for 3 h. The beads were then rinsed with dH2O and left to dry prior to use. 
7.15.5. ThT assay on glass beads 
Each bead was placed into a well of a 96 well plate and immersed with 200 μL of ThT working 
stain (section 7.1.2, Table 7.2). ThT fluorescence was measured using a BMG Labtech 
FLUOstar Optima plate reader with excitation/emission filters of 450 and 485 nm, respectively 
All samples had three replicates. 
7.15.6. Glass bead template-directed whey amyloid fibril assembly  
Surface-activated glass beads were immersed in whey fragment solution (pH 9.0) (10 mg/mL, 
10-15 mL) at room temperature for 2 h. The beads were then rinsed twice with dH2O before 
being immersed in incubation buffer (Milli-Q at pH 2.0) containing 10 mg/mL whey protein 
solution for 22 h at 80 °C (section 7.2.2). The beads were then rinsed thrice in dH2O.  
7.15.7. Glass bead template-directed crystallin amyloid fibril assembly  
Surface-activated glass beads were immersed in crystallin fragment solution (pH 9.0) (10 
mg/mL, 10-15 mL) at room temperature for 2 h. The beads were then rinsed twice with dH2O 
before being immersed in incubation buffer containing ~10 mg/mL crystallin proteins for 24 h 
at 80 °C (section 7.2.3). The beads were then left at room temperature for at least 3 days before 
rinsing thrice in dH2O. 
7.15.8. Surface-assembly of PNFs with and without chemical derivatisation 
To ensure full surface derivatisation was necessary for maximum surface-assembly of the 
PNFs, glass beads with and without surface activation/derivatisation were incubated with 
protein solutions, at different stages. Control beads samples used included:  
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1. No treatment (beads without surface activation) - Beads as purchased from Sigma-Aldrich. 
2. Piranha treated - Bead samples obtained as detailed in section 7.15.1. 
3. APTS activated/treated - Bead samples were incubated with a 3% APTS solution in 
ethanol/water (95:5 v/v) for 1 h, followed by washing with 95% ethanol. Bead samples 
were left at room temperature to dry.  
4. After curing - Bead samples were immersed in 99.9% ethanol and cured at 110 °C for 1 h, 
followed by cooling and washing in 95% ethanol, and left to dry.  
5.  DSC treatment - Bead samples obtained as detailed in section 7.15.4.  
All the bead samples (as discussed above) were either incubated with fragmented amyloid 
PNFs for template-directed growth (section 7.15.6 and 7.15.7) or were incubated with protein 
solutions – while heating (bead samples (10-15 beads) were added to ~10 mg/mL protein 
solution (30 mL) kept at 80 °C for fibrillation (see section 7.2.2 and 7.2.3 for whey and 
crystallin fibrillation respectively) or alternatively, bead samples were added to the protein 
solution after heating – when protein solutions were removed and kept at room temperature for 
3-7 days.  
7.16. Amyloid fibril fragmentation 
7.16.1. Crystallin fibril fragmentation 
Formed crystallin amyloid fibrils (section 7.2.3) were first centrifuged (12,500 rpm, 10 min) 
and then buffer exchanged into 50 mM HEPES (pH 9.0) buffer before being subjected to 
sonication for a 0-60 sec pulse, amplitude 20%, using a microtip. The fragments were verified 
using TEM (section 7.1.3). 
7.16.2. Whey fibril fragmentation 
Formed whey amyloid fibrils (section 7.2.2) were first centrifuged (12,500 rpm, 10 min) and 
then buffer exchanged into 50 mM HEPES (pH 9.0) for surface-assembly work, and in PBS 
(pH 7.4) for cytotoxicity studies before being subjected to sonication for a 0-40 sec pulse, 
amplitude 20%, using a microtip. The fragments were verified using TEM (section 7.1.3). 
7.17. Confocal microscopy for glass beads 
Beads were kept in clear wall glass bottom dishes (one bead sample for 5mm beads, and for 
microbeads, a tiny amount using spatula was removed and kept in the dish), and stained with 
(200 µL) of ThT working stain (Table 7.2), and viewed using a Leica Microsystems TCS SP5 
confocal microscope with a Leica HCX PL 10x lens. An excitation of 425 nm and emission 
detection of 485-495 nm was used. The gain was adjusted to suit the most fluorescent sample 
and kept the same for all subsequent samples. The obtained images were processed using the 
Leica LAS AF Lite 2.4.1 software. Micrographs were representative of 3 beads (5mm), 3 
images were chosen as being an overall representation of the entire sample.  
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7.18. β-gal functionalisation of surface-assembled whey PNFs  
7.18.1. Immobilising β-gal on surface-assembled whey PNFs 
Glass beads with surface-assembled whey amyloid PNFs (section 7.12.2) were first immersed 
in a solution of 5 mM GA to activate the lysine residues and N-terminal residues of the amyloid 
fibrils before the addition of ~2.9 mg/mL β-gal for 2 h, at 37 °C. The beads were then rinsed 3 
times in dH2O and stored at 4 °C. The beads were assessed for β-gal activity using ONPG assay 
in the BMG Labtech FLUOstar Optima plate reader with absorbance measured at 412 nm 
(Appendix B, section B1.2). 
7.18.2. Reusability studies of β-gal functionalised surface-assembled whey 
PNFs 
Glass beads with surface-assembled whey amyloid PNFs and immobilised β-gal (section 
7.18.1) were covered with 250 μL of ONPG solution (Appendix B, section B1.2). The cleavage 
reaction was carried out for 30 min at 37 °C to allow cleavage of the ONPG. The supernatant 
(150 μL) was carefully removed and assessed for β-gal activity by measuring the absorbance 
of cleaved product at 412 nm. The beads where then washed 3-5 times in dH2O, and re-used 
for the next hydrolysis reaction.  
7.19. Silk blend films 
7.19.1. Preparation of silk solution 
Bombyx mori degummed silk fibres were kindly provided by David Kaplan, Department of 
Biomedical Engineering, Tufts University. Silk-fibroin solution was obtained by dissolving 
degummed silk fibroins in 9.3 M lithium bormide (LiBr) solution in 1:4 w/v ratio, at 60 °C for 
4 h, using previously published procedures [17, 18]. The extracted solution as dialysed against 
distilled water using Slide-a-Lyser dialysis cassettes (Pierce MWCO 3,500) for 72 h to remove 
salt. The obtained solution was then centrifuged to remove the small amount of silk aggregates 
or un-dissolved fibroin (3000 rpm, 15 min) (2X), to obtain optically clear solution. The final 
concentration of the solution was then determined by pipetting 1 mL of the obtained solution 
onto the weighing boat, followed by drying, and weighing the remaining solid after drying. 
The final concentration of aqueous silk solution was usually ~7.5 wt%, and was then diluted to 
4% with dH2O, when required. 
7.19.2. Preparation of protein solutions 
For crystallin protein solution, crystallin proteins extract obtained as detailed in section 7.2.3 
was freeze dried, and dissolved in dH2O at ~40 mg/mL concentration, whenever required. For 
whey protein solution, WPI were dissolved at 40 mg/mL concentration in dH2O. Solutions 
were either kept on ice or stored at 4 °C, and used with-in 3-4 h. 
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7.19.3. Preparation of PNF solutions 
Both crystallin and whey PNFs obtained at 10 mg/mL concentration, as described in section 
7.2 were centrifuged (12,500 rpm, 10 min), concentrated, and re-suspended in dH2O to obtain 
~40 mg/mL concentration.  
7.19.4. Preparation of silk-protein and silk-PNF blend solutions 
Silk, protein, and PNF solutions at 4% (wt/v) concentration was obtained as detailed above, 
and were mixed in different ratios as detailed in Table 7.14, to obtain silk blend solutions. 
After preparing silk blend solution, solution were mixed by inverting tubes, and kept for at 
least 1 h at 4 °C or on ice with frequent mixing by inversion, before casting films. 
7.20. Film formation 
To prepare silk-only, and silk blend films, a 75 µL of silk-only, silk-protein, and silk-PNF 
blend solutions, prepared in different ratios as detailed in Table 7.14, was cast onto 14 mm 
diameter PDMS disc and allowed to sit at room temperature overnight. For film formation in 
24-well TCP, 150 µL of each of the sample was added, and allowed to dry overnight at room 
temperature.  
Table 7.14. Lists different film samples, and ratios of blend films studied.   
Blends Ratio 
S1. Silk Silk only 
S2. Silk:crystallin proteins 50:50 
S3. Silk:whey proteins 50:50 
S4. Silk:CPNFs 25:75 
S5. Silk:CPNFs 50:50 
S6. Silk:CPNFs 75:25 
S7. Silk:WPNFs 25:75 
S8. Silk:WPNFs 50:50 
S9. Silk:WPNFs 75:25 
 
7.20.1. Ethanol annealing of films 
The films with PDMS were then transferred into 24 well plate, and immersed in 75% ethanol 
for 6-12 h for ethanol annealing. It has been shown previously that ethanol annealing increases 
the β-sheet content of the silk films, and thus makes them water insoluble. For films formed in 
24-well plate, 150 µL of 75% ethanol was added to the wells, and left for 6-12 h. Films were 
removed from the ethanol or ethanol allowed to evaporate and allowed to air dry on bench for 
12 h.  
7.21. Scanning electron microscopy (SEM) 
Surface morphology was examined with FEI (Philips) XL30 scanning electron microscope at 
5 KV acceleration voltage, after sputter-coated with platinum. 
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7.22. Proteolytic degradation of films 
7.22.1. Preparation of enzymes  
Protease Type XIV from Streptomyces greiseus, collagenase from Clostridium histolyticum, 
and α-chymotrypsin from bovine pancreas were all purchased from Sigma-Aldrich. Enzymatic 
solutions of protease type XIV, chymotrypsin, and collagenase were freshly prepared by 
dissolving the enzyme powder in PBS (pH 7.4). For each enzyme, 2 mg/mL stock solution was 
prepared in 100 mM PBS (pH 7.4), and diluted to 0.5 mg/mL final concentration, whenever 
required using PBS (pH 7.4). 
To check if there is any loss in the enzymatic activity of enzymes, at 37 °C, over the time period 
of 7 days, enzyme solutions prepared as above (1 mg/mL in PBS, pH 7.4) were kept at 37 °C. 
Samples (50 µL) were taken once every day for 7 days, and incubated with BSA solution, 
prepared at 5 mg/mL concentration in PBS (1:5) (v/v), pH 7.4 for 1 h, at 37 °C. After 
incubation, samples were rapidly frozen using liquid nitrogen, and kept at -20 °C, until the 
reaction was complete (7 days), followed by SDS-PAGE analysis (section 7.1.1).  
7.22.2. Degradation of silk blend films  
Silk-only and silk-blend films were removed from PDMS discs and immersed in 250 µL PBS 
(pH 7.4), or enzyme solution (section 7.22.1) and incubated at 37 °C. Once every 24 h for up 
to 5 days, samples were centrifuged and supernatant removed and replaced with fresh enzyme 
solution. After removal, supernatant was either directly run on SDS-PAGE (section 7.1.1) or 
heated to 100 °C for 10 min to denature the enzyme and stored at -80 °C for further analysis.  
7.22.3. Mass loss 
At each time point one set of films were removed and centrifuged (12,500 rpm, 10 min) to 
collect the supernatant. Blend films after removal of the supernatant were then dried at 37 °C 
overnight. Samples were weighed and percentage weight loss was calculated by comparing 
each blend film to the control (weight of the films incubated with PBS).  
7.23. Optical transmittance 
In-line transmittance spectra of the silk and blend solutions, films, and as aqueous dispersions 
in the visible region (400–800 nm) were obtained with a Perkin-Elmer Lambda 19 UV-Vis-
NIR spectrophotometer using 24-well glass plates. For solution, 150 µL of solution of each of 
the samples was added to 24-well plate. For films, 150 µL of solution was added to 24-well 
plate and allowed to dry overnight, to obtain films.   
For annealing, 150 µL of 75% ethanol was added to dried films and incubated for 6-12 h, 
followed by 1 h drying and spectral analysis (section 7.20.1). For the aqueous dispersion, 150 
µL of 100 mM PBS (pH 7.4) was added to each of the sample and incubated for 1 h, followed 
by spectra measurements in the presence of PBS.  
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7.24. Contact angle measurements 
Static contact angle measurements were done on dry films (n = 3) that were either treated with 
75% ethanol, annealed or untreated (control films) at ambient temperature using a contact angle 
meter (CAM-100). Ultrapure water droplets were used with a drop volume of approximately 
20 μL. 
7.25. Biocompatibility of silk blend films 
For cell culture studies, 150 µL of silk-only, and silk-blend solutions were added into the 24-
well TCP, and allowed to dry overnight to obtain films. After drying, 150 µL of 75% ethanol 
was added to each well to anneal the obtained films and also to surface sterilise the films. Films 
were left immersed in ethanol for 1 h, followed by 1 h drying within the fume hood.  
7.25.1. Cell culture 
Mouse fibroblasts (NIH/3T3 ATCC) was cultured in media (DMEM), supplemented with 10% 
FBS, and 1% Anti-Anti (Antimyocin-Antibiotic, GIBCO) solution, at 37 °C with 5% CO2/air 
atmosphere to 80% confluence. Cells were harvested by trypsinisation (5 mL Tryple Express, 
Invitrogen) and then washed by a twice repeated cycle of dilution in 15 mL media followed by 
centrifugation (300g for 5-10 min). Processed cells were counted using cell counter, and re-
suspended in media, and then added to samples (200 µL, 25,000 cells/cm2 of well area) and 
incubated at 37 °C with 5% CO2/air atmosphere.  
7.25.2. Cell imaging and data analysis 
At each time point, cells were imaged using optical or light microscope (Nikon EclipseTE2000-
U) 10x, and images were analysed using the particle analysis function in the software ImageJ. 
Before the particle analysis, the images were converted to 8 bit black and white images, and 
threshold adjusted. The results obtained by the software were compared to images counted by 
hand and were within 7% accuracy. To account for variations of cell attachment within each 
experiment, 3 individual samples were prepared.  
To account for batch to batch variations, the experiment was repeated 3 times on different days. 
Cell area was quantified from the same images used for cell number using the line, and wand 
(tracing) tool and measure function in ImageJ. For statistical analysis, GraphPad tool was used 
to perform one-tailed, un-paired T-test analysis using mean, SEM, and N data entry format, 
where mean is average value taken from 5 samples, SEM represents standard error of the mean, 
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Appendix A 
IR absorbance spectrum of crystallin PNFs 
   
    
Figure A1. Typical IR absorbance spectrum of amyloid crystallin nanofibrils, across the whole 
amide fingerprint region, showing the baseline. 
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Appendix B 
Enzyme-specific activity assays 
To determine enzymatic activity of functionalised PNFs, crosslinked samples were assayed for 
activity using the spectrophotometric assays, with a BioRad SmartSpec Plus 
Spectrophotometer. Three replicates of each sample were measured, each data point is 
representative of averages from triplicate samples, with subtracted blank values for each of the 
assay. Samples were assayed for initial activity, centrifuged, and the supernatant was retested 
for activity to assess the amount of activity retained by the enzyme that had been crosslinked 
to the PNFs. Functionalised amyloid fibrils obtained after crosslinking reactions were collected 
by centrifuging the sample for 10 min at 12,500 rpm in an Eppendorf® Minispin® Plus 
benchtop centrifuge, with the fibrils then resuspended in 100 mM phosphate buffer (pH 7.4), 
and stored at 4 °C.   
B1.1 Amplex Red assay 
For GOX activity determination, Amplex Red assay (Thermo Fisher Scientific) was used to 
detect hydrogen peroxide produced by GOX, in the presence of glucose, by using the methods 
adapted from Raynes (2012) [1]. Samples containing GOX were incubated with Amplex Red 
assay reagent (Table B1.1) for 30 min in dark conditions, and absorbance of the sample was 
then measured spectrophotometrically at a wavelength of 590 nm. Background fluorescence, 
as determined for a control sample with no GOX present, was subtracted from each value. 
Table B1.1. Amplex Red assay reagent 
Reagent Components 
Amplex Red assay solution 
 
Amplex Red assay buffer 
50 mM Amplex Red reagent 
 
0.1 U/mL horseradish peroxidise  
50 M glucose  
0.1 M sodium phosphate buffer [pH 7.4] 
 
B1.2. o-Nitrophenyl-β-D-galactopyranoside (ONPG) assay for β-gal activity 
For β-gal activity determination, ONPG assay (Sigma-Aldrich, MO, catalog no. KI455-01) was 
used. β-gal catalyse the hydrolysis of β-galactosides (ONPG) to the ONP anion producing a 
bright yellow colour with a peak absorbance at 420 nm that can be quantified using a 
spectrophotometer [2]. Samples containing β-gal (50 µl) were incubated with ONPG assay 
reagent (Table B1.2) for 30 min in dark conditions, at 37 °C. The reaction was then quenched 
by adding stop buffer (Table B1.2), followed by absorbance measurement at a wavelength of 
420 nm. Background fluorescence, as determined for a control sample (no β-gal present), was 
subtracted from each value. 
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Table B1.2. ONPG assay reagent 
Reagent Components 
ONPG assay solution 
 
Stop buffer 
17 µl ONPG reagent 
1 µl β-mercaptoethanol 
125 µl stop buffer 
Final volume 192 µl 
 
B1.3. 2, 4-Dinitrosalicyclic acid (DNS) assay 
To determine the activity of pectinase functionalised PNFs, 500 uL of pectin solution prepared 
in sodium acetate buffer (pH 4.5) was added to 250 uL of pectinase control and pectinase 
functionalised PNFs, followed by 30 min incubation at 50 °C [3]. To measure the amount of 
reducing sugars produced by the pectinase or functionalised pectinase PNFs, DNS solution 
(Table B1.3) was added in 1:1 ratio to the sample (300 µL each) and heated at 100°C for 5 
min, followed by cooling at room temperature. The absorbance of the cooled sample was then 
read spectrophotometrically at a wavelength of 575 nm. Background fluorescence, as 
determined for a control sample without pectinase, was subtracted from each value. 






1 mg/mL in 100 mM sodium acetate buffer 
[pH 4.5] 
1 g DNS  
0.05 g sodium sulphite 
1 g sodium borohydride 
Dissolved in 100 mL of Milli-Q, stored in 
dark at 4 °C. 
 
B1.4. Amylase activity assay 
For α-amylase activity, DNS assay as detailed in section B1.3 was used to measure the amount 
of reducing sugars produced, using starch as a substrate. Additionally, the extent of starch 
hydrolysis was measured by starch-iodine (KI) assay using the methods adapted from Xiao et 
al. (2006)[4]. Assay reaction was initiated by incubating 100 uL of starch solution with 100 uL 
of amylase control and amylase functionalised PNFs sample, incubated at 50 °C for 30 min. 
To stop the reaction 20 uL of 1 M HCl was added, followed by the addition of 100 uL of KI 
solution (Table B1.4). Following colour development, 200 uL of the reaction sample was 
transferred to 96 well plate and absorbance of the sample was then read spectrophotometrically 
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KI  solution 
 
1 g/L starch dissolved in boiling water, 
stirred until dissolved completely. Stored at 
4 °C (2-3 days)  
5 mM I2, 5 mM KI reagent in dH2O, stored 
in glass bottle at room temperature. 
 
B1.5. Laccase activity assay 
The activity of laccase functionalised PNFs was assayed spectrophotometrically by monitoring 
the absorbance increase at 530 nm due to the oxidation of syringaldazine (Sigma) in the 
presence of laccase [5]. The assay mixture consisted of 30 µl of syringaldazine (0.216 mM in 
absolute methanol), 50 µL mL of laccase enzyme or laccase functionalised crystallin PNFs 
sample (PNFs were centrifuged and resuspended in PBS (pH 6.5), using 1M KOH), and 100 
µL of 100 mM PBS (pH 6.5). Both buffer (PBS) and laccase sample were added first and 
readings were equilibrated at 37 °C, followed by initiation of the reaction by adding 
syringaldazine solution. The increase in absorbance at 530 nm was measured 
spectrophotometrically for each sample for 15 min.  
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[3] A.V. Gusakov, E.G. Kondratyeva, A.P. Sinitsyn, Comparison of two methods for assaying 
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degradation, Physiological Plant Pathology, 16 (1980) 187-196.   
203 |                                   Appendix C – GA-based crosslinking of GOX to crystallin PNFs 
 
Appendix C 
GA-based crosslinking of GOX to crystallin PNFs   
The method for GOX immobilisation to crystallin fibrils was based on the methods of 
(Pilkington et al. 2010), who showed that GOX can be covalently immobilised to insulin 
amyloid fibrils using GA [1]. The GOX (2 mg/mL) immobilised samples were crosslinked 
using a final concentration of 50 mM GA, with a final concentration of 3.3 mg/mL crystallin 
amyloid fibrils for 1 h at 25 °C .The extent of crosslinking was then assessed by SDS-PAGE. 
Native GOX runs as a monomeric protein band at 80 kDa in a SDS-PAGE gel, due to the dimer 
being denatured by SDS.  
 
Figure C1. SDS-PAGE of GA-based crosslinking of GOX onto the crystallin PNFs. L- ladder, 
Lane 1- GOX only, Lane 2- GOX+GA, Lane 3-5 GOX+GA+CPNFs, different reaction orders, 
Lane 6- CPNFs only, and Lane 7- CPNFs+GA.  
In Figure C1, the monomeric GOX band at approximately 80 kDa is seen in Lane 1. There is 
also a slight band at approximately 160 kDa, corresponding to the molecular weight of dimer 
GOX, indicating that the dimer was not completely denatured. Crosslinking GOX alone using 
GA produces a weak band at 80 kDa, and a strong band at 160 kDa, which corresponds to the 
stabilisation of the dimer by crosslinking (Lane 2). When GOX was immobilised to crystallin 
fibrils using GA (Lane 3-GA, CPNFs, and GOX were all added simultaneously) there is no 
decrease in the intensity of the GOX band on the gel, which indicates that no GOX was 
immobilised to the crystallin fibrils. When GOX is incubated with GA-activated crystallin 
fibrils (GA-activated CPNFs were collected by centrifugation, after 1 h incubation with GA) 
the same bands appear as for GOX only (Lane 4). Similar to Lane 3, no GOX was immobilised 
to the crystallin fibrils in lane 5, where GOX and GA were incubated first (5 min), and then 
fibrils were added in order to maintaining the maximum possible surface area for 
immobilisation of GOX by minimising fibril-fibril crosslinking.  
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Crude crystallin fibrils show no band, as they remain in the well (Lane 6-with GA and Lane 7-
without GA). This gel confirms that no crosslinking of GOX to the crystallin amyloid fibrils 
was occurring. As the established method did not result in successful immobilisation of GOX 
to crystallin fibrils, thus, research to achieve immobilisation via amino groups to crystallin 
amyloid fibrils was discontinued, and different methods were employed for immobilising 
biomolecules to the crystallin amyloid fibrils. 
References 
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Appendix D 
Standard graphs for assays 
 
Figure D1. (a) OPA standard curve for lysine concentrations ranging from 0.2-2.0 mM, 
absorbance taken at 340 nm. (b) Ninhydrin standard curve for lysine concentrations ranging 
from 0.2-2.0 mM, absorbance taken at 570 nm. (c) Ellman’s standard curve for cysteine 
concentrations ranging from 0.2-2.0 mM, absorbance taken at 412 nm. Error bars represent 
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Appendix E 
α-Amylase activity assay 
Both starch-iodide (KI) and DNS assay were done to assess the amount of starch being 
hydrolysed into sugars by α-amylase immobilised CPNFs. The relative activity (compared to 
initial amount of starch present) of both free and immobilised sample as determined by the KI 
assay, and the amount of reducing sugar produced as determined by the DNS assay (Figure 
E1) showed good co-relation, suggesting that immobilised enzyme effectively hydrolysis 
starch ~ 70 to 80% as compared to 80 to 90% for free amylase.  
 
Figure E1. Activity assay for α-amylase functionalised crystallin PNFs, where grey bars - 
amount of starch hydrolysed, characterised by KI assay, absorbance measured at 620 nm, and 
black bars - amount of reducing sugars produced as detected by the DNS assay, absorbance 
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Appendix F 
Silk-PNF blend films 
Table F1. Number of cleavage sites for crystallins and whey proteins determined from the 
available sequence information. The percentage values were calculated from the number of 
cleavages and the total residue number. 






























































































































































Note: Where possible, the sequence used was that from Danio rerio (zebrafish), as this is the only fish for which 
full crystallin sequence information is available. If no structure or sequence information from D. rerio was 
available, the sequence used was that of the UniProt files available, that had the highest sequence similarity to 
D. rerio. Previously Domigan (2012), studied various sequence allignments for crystallins and showed that the 
chosen structures had highest sequence similarity to D.rerio.   
 
 
Figure F1. Images of silk blend films after MTT staining, where (a) silk-only (50:50), and (b) 
silk:crystallin (50:50) blend films. Scale bar- 100 µm. 




Figure F2. Images of mouse fibroblast cells cultured for silk:PNF films at different ratios,  
silk:PNF (75:25) - left panel, and silk:PNF (25:75) - right panel, where top panel - crystallin 
PNFs and bottom panel - whey PNFs, after 18 h - sample a and b, and after 48 h - sample c 
and d. Scale bar - 100 µm.
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Appendix G 
Crystallin fibrillation process 
Fish eye lenses extracted from Hoki (Macruronus novaezelandiae) were obtained from the 
local fish suppliers, Christchurch, New Zealand. The method established by Kang (2011) as 
detailed below was then used to obtain high quality crystallin PNFs.  The process can be 
divided into four main steps:  Step 1: the protein extraction process, Step 2: preparation of 10 
mg/mL final concentration of crystallin protein homogenate with 25% n-propanol. Step 3: 
heating and centrifugation to remove amorphous aggregate to obtain high quality PNFs, Step 
4: the self-assembly process at room temperature. Previous work by Kang (2011), has 
demonstrated that three different PNFs products, based on their quality can be obtained via 
this PNF self-assembly process: low, medium, and high quality (Figure G1 and G2). The 
quality of PNFs obtained depends on the presence or absence (removed by centrifugation after 
incubation for an h) of amorphous aggregates formed during heating. 
 
Figure G1. Three different qualities of the final product contain protein nanofibres. Taken 
from Kang (2011). 
 
As the main focus of this work was utilisation of PNFs, therefore it was decided to remove 
amorphous aggregate formed after 1 h of incubation to obtain high quality PNFs. Briefly, 50 
mM Tris base, 5 mM EDTA, 1 mM DTT at a pH 7.5 was prepared and added to the extracted 
fish eye lenses in the ratio of 2 mL per one gram of fish lens. The lenses were homogenised 
in the buffer using an IKA ULTRA TURRAX Tube Dispersar set at maximum speed 9 for 20 
minutes at room temperature.  
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Figure F2.  TEM images showing different types of PNFs obtained, based on their quality. 
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After the protein extraction step, obtained crude crystalline homogenate was transferred into 
centrifuge tubes and spun at 12,000 rpm for 30 minutes. The supernatant was then collected 
into a new tube and diluted 1:100 with extraction buffer and the protein concentration was 
determined using the NanoDrop (section 7.1.4). For PNF synthesis, the crude crystallin 
homogenate obtained was further diluted using 25% n-propanol at pH 3.5 to obtain the required 
final concentration (10 mg/mL). The crystallin protein mixture at 10 mg/mL final concentration 
was then incubated at 80 °C for an h on a heating block. After 1 h incubation, the sample was 
removed from the heating block and centrifuged at at 12,000 rpm for 2 min at room temperature 
to remove the amorphous aggregates formed during heating. The supernatant was collected and 
incubated at 80 °C on a heating block for 24 h. 
After 24 h incubation, sample was then removed from the heating block and left at room 
temperature for the self-assembly process. The amyloid fibril samples were then analysed for 
quality and consistency using ThT (section 7.1.2), TEM (section 7.1.3), and Bradford assay 
(7.1.5).  
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